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Abstract
The complex relationship between structure, dynamics, and function will afford insights into the 
operational details of enzymes.  To understand, regulate, and create enzymes, this complex nature must 
be comprehensively understood.  In order to do so, perturbing a well-characterized enzyme in order to 
discern how changes in primary sequence, alter the structure and dynamics will begin to uncover these 
details.  These modifications and their functional consequences will explain not only how the model 
system behaves, but also can be extrapolated to better understand the foundational principles of 
enzymes in general.  These studies carried out in this thesis utilize a well-characterized enzyme, 
phosphoenolypruvate carboxykinase (PEPCK), as a structural and functional scaffold.  Three studies 
investigate increasing degrees of change to this scaffold.  The first perturbations of this scaffold start 
with a single point mutant that imparts a hysteretic kinetic behaviour in order to understand how an 
allosterically localized specific residue can control global dynamics.  The second study examines three 
isozymes of PEPCK from different organisms that have adapted to different thermal niches.  This study
attempts to understand how full sequence adaptations tune enzyme structure and dynamics to different 
thermal availability, balancing dynamics with turnover. The final study is a comprehensive evaluation 
of the third class of PEPCK,  a pyrophosphate-dependent enzyme, which is structurally and 
functionally distinct from the classical ATP and GTP-dependent PEPCKs. This study acts as a starting 
point for further investigations of this variant of PEPCK while also highlighting how adding different 
domains/lobes to a common central scaffold can drastically alter function.  An Appendix is also 
included which demonstrates how a series of related inhibitors can have drastic differences in potency 
for a potential therapeutic target, the enzyme cytosine triphosphate synthase. 
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Each protein biochemist hope should be to study their model system with an increasing amount of 
detail, in order to later extrapolate these findings to a general unified model of protein function.  
Although this model is continuously improving it has some well-established principles.  Some of these 
principles include (but are not exclusive to) seminal work from Koshland and Fisher first describing 
induced fit and lock-key models (later becoming a spectrum of induced-fit/conformational selection for
substrate recognition).1,2  Other descriptions by Frauenfelder, Karplus, and others showed proteins not 
as static structures but rather as a dynamic ensemble.3–5  A great many more features are coming to the 
forefront to become widely accepted throughout the field.  Each of these advancements help us 
understand proteins as a whole.    In order to understand these mechanisms to form a unifying theory, a 
few extremely well-characterized proteins have been used as models.  Although this likely works in 
describing the general features of proteins, more models are necessary to broaden the understanding of 
the unified model and its nuances.  
It is well understood that proteins can be described as rugged, complicated, changing free-energy 
landscapes that take into account each atom of the system, that is protein, water/salts, substrates, among
any other biomolecules present.  This complexity means that it is impossible to describe accurately, but 
rather can be used as a relative representation of an enzyme.  Throughout each step of an enzymes role, 
this energetic landscape changes according to the environment it finds itself in.  For instance, as a free 
enzyme, the landscape will take into account all conformational modes that accompany this state.  
Upon ligand binding to the active site, the free-energy landscape must adapt resulting in a change in the
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distribution of sampled conformations.  Thus, there direct relationship between the energetic landscape 
and dynamics. This free-energy landscape can be thought of as a series of barriers (local maxima) or 
valleys (local minima) of free-energy, the former describing transient high-energy states, while the 
latter describes longer-lasting low-energy ones.  When an enzyme functions, as it would do when 
converting a substrate to a product, this system must traverse the free-energy landscape moving over 
the barriers to find new stable lows.  Each barrier represents the probability of being able to transition 
from one state to the next.  Each of these jumps over a barrier has associated with it an associated 
thermodynamic cost,  which can change depending on how the enzyme has adapted or been 
manipulated within its environment.  Evolution will tweak the primary sequence of a given protein 
depending on what environment it finds itself in, and how to best adapt the protein for its cellular 
function.  As researchers attempt to understand and “map” this landscape, we may use single point 
mutations, or more numerous changes throughout the sequence, to perturb a proteins’ energetic 
landscape in order to determine the consequences of these changes. Traditionally, mutational studies, 
swapping out residues that are deemed important, are usually reserved to studying only a few changes 
in the proteins primary sequence targeting specific interactions and how these change the functionality 
of the enzyme.  This can lend insight into what specific structural features are responsible for particular
functional steps. However, single mutation studies do not give us insight as to how the entire primary 
sequence leads to function.  Studying isozymes, that is structurally and functionally related proteins 
like those from varying organisms differing by sequence, can give us insight into how the entire 
primary sequence dictates the properties of a protein.   Finally, beyond isozyme sequence variability, 
evolution has seemingly used set of common structural scaffolds (domains/motifs), adding together 
specific features to invent enzymes with new functions.  The differences from the sequences, 
manifested as changes in structure and function, will further lend information to add to a unified model 
of protein function, and hopefully lead to the pinnacle of protein biochemistry, de novo protein design. 
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Here is described a series of studies using a well-studied model enzyme, phosphoenolpyruvate 
carboxykinase (PEPCK), as a common functional and structural scaffold to better understand how these
sequence changes, at varying degrees of modification discussed, leads to functional differences.  The 
three areas that are investigated here are a point mutation in a dynamic region of PEPCK leading to 
hysteretic behaviour, isozyme differences dictated from thermal adaptation of three PEPCKs, and 
finally a relatively uncharacterized class of PEPCK which uses the same core protein fold, but 
additional domains and lobes have appended leading to both structural and functional changes.  Finally,
the appendix contains other work completed in my doctoral studies on the inhibition of an enzyme, 
cytosine triphosphate synthase (CTPS) by a series of fluorinated analogues.  
3
1.2 Phosphoenolypyruvate carboxykinase history and overview
PEPCK has a storied history beginning in the 1954 where it was initially characterized in a series of 
papers initially naming the enzyme oxalacetic carboxylase.6–8  This enzymes’, purified from chicken 
liver, chemical mechanism was generally described as oxaloacetic acid’s (OAA) decarboxylation in the
presence of ITP to form phosphoenolpyruvate (PEP).  From this starting point and after a name change 
to PEPCK, the in vivo cellular role of the enzyme has been elucidated showing its vital role in 
metabolism.9–11  A therapeutic avenue for regulating PEPCKs activity has been highlighted through its 
role in diseases such as cancer12, Mycobacterium tuberculosis (mtb) infections13, and diabetes14, but it 
also has ascribed roles in aerobic capacity15 and longevity.16  This apparent importance has led to many 
functional studies of PEPCK from many different organisms17–27, and many high resolution crystal 
structures of different isozymes28–36, some which are published while others are only deposited in the 
Protein Data Bank (PDB).  Coupled with this structural information, kinetic data understanding the flux
of substrates through this enzyme, as well as mechanistic details of its catalysis have been 
uncovered.29,37–41   Although it has been studied extensively, the story of this enzyme continues to 
evolve as even recently it has been implemented in lipogenic regulation through a new purported 
protein-kinase activity.42
1.3 Metabolic role
PEPCK works adjacent to the tricarboxylic acid cycle (TCA cycle) by removing anionic molecules to 
maintain cycle flux.  In almost all cellular contexts, PEPCK removes OAA to form PEP.  This PEP can 
have many downstream fates such as: gluconeogenesis (PEPCKs most traditionally identified role), 
glyceroneogenesis, amino acid synthesis, or  phosphoenolpyruvate (PEP) can be converted to pyruvate 
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through PEP carboxylase and later feed back into the TCA cycle.(reviewed in 43)   The vast array of metabolic
consequences of PEPCK activity have given it the title of master regulator of the TCA cycle, and as 
having a crucial role in metabolism as a whole.44 
1.4 Regulation
Due to PEPCKs’ role in whole organismal homeostasis, it is likely tightly regulated.  Surprisingly, there
have not been that many regulatory mechanisms of PEPCK determined.  At a genomic level, the 
expression of the genes for PEPCK (PCK) are regulated by small molecules such as cAMP45 and 
insulin46,47 or through environmental changes such as acidosis48–50, all resulting in lower expression.  
DNA51 and histone methylation47 of the PCK gene have also been shown to regulate PEPCK, where 
tissue specific increases in methylation lead to decreased expression of PEPCK. There are only a few 
indicated post-translational modification (PTM) that regulate PEPCK, although many residues of the 
enzyme have been implicated as potential PTM sites.  The first PTM identified was lysine 
acetylation52,53, although the details are still contentious.54  Lysine acetylation of PEPCK has been 
reported to increase ubiquitin labelling by UBR5, leading to recycling of PEPCK through the 
proteosome.  A second PTM has been recently identified, although the results are still waiting for peer 
review.  It was shown that the mitochondrial PEPCKs activity can be allosterically regulated by 
sulfhydration of a non-active site cysteine.55  Finally, as previously mentioned, phosphorylation of 
cytosolic PEPCK can lead to a change in activity, where it may become a GTP-dependent protein 
kinase involved in the regulation of lipogenesis.42
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1.5 Phosphoryl donor specificity
PEPCKs can be classified into three categories dependent on their specificity for the phopshoryl donor; 
ATP- (EC: 4.1.1.49/K01610), GTP- (EC: 4.1.1.32/K01596) and most recently added PPi-[(EC: 
4.1.1.38/K20370) dependent PEPCKs.  Of these three families, they are all phylogenetically distinct 
and are widely spread throughout the tree of life.  There are a few trends amongst how these enzymes 
are distributed throughout life, with some interesting but rare exceptions.  First, an organism will 
usually only have a one PEPCK.  C-4 Plant PEPCKs are ATP-dependent, while all mammalian 
PEPCKs are GTP-dependent.  Of the chordata phylum, there are two compartmental GTP isozymes, 
one found in the cytosol and one found in the mitochondria.  Both ATP and GTP PEPCKs can be found
distributed amongst bacteria and fungi.  Finally, Archael organisms have only utilized GTP-dependent 
PEPCKs apart from Aeropyrum pernix which uses ATP.  Of the odd exceptions that are noted, 
Candidatus kuenenia stuttgartiensis does not have a defined nucleotide binding site and is only 23-36%
identity to both ATP and GTP PEPCKs, suggesting the potential for promiscuity.56  Finally, PPi 
PEPCKs are widely distributed in both Eukaryotes and bacteria but are absent in the Archaea.  There 
has not been a comprehensive study to look at the distribution of PPi PEPCK within Eukaryotic and 
Bacterial phyla as has been completed as with the nucleotide dependent enzymes.56 
Using Annotree57, some high-level details can be discerned about the representation of the PEPCKs that
the updated tree of life offer as much of this data was not accessible in previous studies (Table 1).56  As 
seen indicated in previous studies, PPi PEPCK are absent from Archaea, while all three forms are 
widely dispersed in Bacteria.56,58  The majority of sequenced bacterial genomes are ATP PEPCKs 
(10148) followed by GTP (5571), and finally PPi (417), while the majority of archael genomes have 
ATP (321) PEPCKs, followed by the GTP form (140).   There do appear to be a few bacterial genomes 
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annotated as containing two types of PEPCK, and 2 genomes with all three present.  There is also 1 
archael genome with both ATP and GTP PEPCK present.  Unfortunately, Annotree does not have have 
the sequenced Eukaroytic genomes available for analysis.  Because of the recent addition of the third 
PPi-dependent PEPCK to the PEPCK family and with recent improvements bioinformatic tools, an 
update to the distribution of these three enzymes should be completed.
Table 1.1: Representative distribution of each isoform of PEPCK from Annotree
1.7 Global architecture
Structurally the ATP- and GTP-dependent PEPCKs are identical, with the “core” of PPi PEPCK having 
a similar fold to the nucleotide-dependent isoforms despite having a general lack of sequence 
conservation between the the PPi- and nucleotide-dependent PEPCKs (E-value ≥ 1).  Of the most well 
studied nucleotide-dependent PEPCKs, the rat cytosolic GTP PEPCK and E. coli ATP PEPCK, there is 
a 30% sequence similarity.  The phosphoryl binding sites are distinct between the three isoforms, as 
they bind different phosphoryl donors. GTP and ATP PEPCKs have a N- and C-terminal domains 
(residues 1-249 and 260-622 respectively – rat cytosolic PEPCK (rcPEPCK) numbering), with the 
active site situated between them (Figure 1.1).  Furthermore, the C-terminal domain can be separated 
into the nucleotide binding domain (residues 260-625, 426-622) and the PEPCK-specific domain 
(residues 326-425).39
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ATP + GTP + PP
i
Figure 1.1: Nucleotide PEPCK domains.  Rat cytosolic PEPCK (PDB ID# 2QEW) coloured by 
domains.  The N-terminal domain is presented in red. The C-terminal domain (green) can be further 
broken down into sub-domains, the nucleotide binding domain (purple) and PEPCK-specific domain 
(yellow). All figures are rendered using CCP4MG with solvent removed for clarity.
The PPi PEPCK isoform consists of two domains, both a N- (residues 85-346, 648-721, and 758-792 
Actinomyces israelii numbering (AiPEPCK)) and C-terminal (residues 347-359, 475-496, 649-684, and 
817-1047).  In addition to these two domains, 4 lobes were described named lobe 1 (residues 1-84), 
lobe 2 (360-475, 497-649, and 793-817), lobe 3 (722-758), and lobe 4 (1048-1149) (Figure 
1.2).31 Although the additional lobes increase the mass of PPi PEPCK by 50kDA (nucleotide PEPCK ~ 
70kDA, PPi PEPCK ~130kDa), the core of the PPi and nucleotide-dependent enzymes are structurally 
conserved (Cα RMSD – 2.9Å) (Figure 1.3).  
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Figure 1.2: PPi PEPCK domains and lobes. AiPEPCK (PDB ID# 6K31) coloured by domains and 
lobes.  The N- and C-terminal domains are coloured in red and green respectively.  Lobe 1 is coloured 
in purple, lobe 2 in yellow, lobe 3 in coral, lobe 4 in grey. 
Figure 1.3: Alignment of nucleotide (GTP) and PPi-dependent PEPCK.  Alignment between rcPEPCK 
(PDB ID# 2QEW) and AiPEPCK (PDB ID# 6K31) with domains coloured.  RcPEPCK N-terminal 
domain is in tan, with the C-terminal domain coloured in light green.  AiPEPCK is shown in ice blue, 
with the N-terminal domain in red and the C-terminal domain in dark green. 
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1.8 Catalytic Loop Elements
Enzymes, in general, must undergo a series of motions in order to perform their catalytic function.  Of 
these motions, loops are utilized to bind and orientate substrates in proper configurations to allow for 
the breaking and forming of chemical bonds.  These active site loops, generally are mobile while 
unbound, and upon binding become rigid and ordered.  Nucleotide PEPCKs have three active site loops
that have been characterized (Figure 1.4).  The generalities of these loops will be discussed below. 
Figure 1.4: Nucleotide PEPCK active site loops.  Alignment of holo-rcPEPCK (PDB ID# 2QEW, steel 
blue) and oxalate-GTP-rcPEPCK (PDB ID# 3DT2, hidden).  The open-state R-, P-, and Ω-loops are 
shown in coral, magenta and yellow respectively.  The closed-state R-, P-, and Ω-loops are shown in 
red, purple, and gold respectively.  As seen, oxalate and GTP are present along with two Mn2+ ions.  




The R-loop (residues 85-92) is responsible for binding the substrates OAA and PEP.  Upon binding, it 
reorders and allows for the closure of the active site lid, otherwise known as the Ω-loop, by removing 
steric hindrances as well as offering stabilizing bonds.  A conserved R87 is responsible for substrate 
recognition and binding through the electrostatic interaction between the guanidine and the substrate, 
while E89 is responsible for stabilizing the Ω-loop in a closed conformation by forming a H-bond with 
H470.39,41   Together, R87, E89, and E470 form a network which has been shown to be vital in 
stabilizing the closed conformation of PEPCK upon nucleotide and substrate binding.40 
1.8.2 P-Loop
The P-loop (residues 284-292) is a kinase 1a motif which binds the nucleotide, stabilizing the negative 
charges of the polyphosphate tail and coordinates the nucleotide for phosphoryl transfer.  This loop, 
like the R-loop, is important in allowing the closure of the lid.  Upon entering the closed state, this loop
removes steric hindrances between A287 and T465 of the Ω-loop.39,41   
1.8.3 Ω-LoopLoop
The Ω-loop (residues 464-474), acts as a lid to cover the active site while the chemical reaction is going
on.  This covering sequesters water from the reaction site, preventing unwanted chemistry from 
occurring.  Ω-loops are a well-characterized non-regular secondary structure element in which it is 
described as a loop with close entry and exit points (as seen from the βSP-strands in Figure 1.4).  Aside 
from PEPCKs  Ω-loop, a similar structure found on triosephosphate isomerase (TIM) has also been 
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well characterized.  These two loops differ in that PEPCKs Ω-loop does not directly coordinate with 
the substrates29,59, and closes through a folding mechanism as opposed to a rigid-body 
motion.60  Further details of this concerted closure of the active site loops will be discussed elsewhere.
1.9 Catalytic Cycle
Extensive work has gone into understanding the reaction mechanism and conformational changes 
required for nucleotide PEPCKs to turnover.  This overview of the catalytic cycle will be done in the 
context of rcPEPCK working in the cataplerotic direction converting OAA to PEP, even though this 
enzyme can operate bidirectionally.  All other evidence suggests that these events are conserved 
throughout the nucleotide PEPCKs.  To date there is no published data for the details of the catalytic 
cycle of the PPi-dependent PEPCK. 
1.9.1 Reaction Mechanism
As mentioned, nucleotide-dependent PEPCKs can freely inter-convert OAA and PEP in vitro, while the
OAA decarboxylation reaction is predominate in vivo.  For this reaction to occur, two metals are 
utilized by PEPCK.  The M1 metal, is an active site co-factor that bridges the gap between the substrate
and nucleotide binding pockets.  In almost all cases, this metal has been shown to be Mn2+.  The two 
exceptions are Co2+ was found to be most activating for Anaerobiospirillum succiniproducens26 (an ATP
PEPCK) and all previously characterized PPi PEPCKs.58,61  The second M2 metal, coordinates with the 
nucleotides βSP- and γ-phosphates to stabilize the anionic charges.  In truth, the M2 acts with the 
nucleotide as a M2-nucleotide substrate complex.  The M2 metal has always shown to be Mg2+ 
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although other divalent metals can substitute for either the M1 and M2 metal, with a kinetic deficit that 
is typically enzyme-dependent.  The reaction begins with the decarboxylation of OAA to form a 
reactive enolate species.  This enolate is then phosphorylated by the nucleotide through an in-line 
transfer, creating PEP, the nucleotide diphosphate (NDP) and CO2 from the first step.  This reactive 
enolate species, for which oxalate is an analogue, can be protonated by bulk solvent to form pyruvate if
the Ω-loop prematurely opens (Figure 1.5).38   
Figure 1.5: Reaction scheme for nucleotide PEPCK.  ND(M)P represent nucleotide di- mono-
phosphate. Reaction scheme was rendered in ChemDrawJS.
1.9.2 Binding of OAA and GTP
The first step of catalysis is the binding of the substrates OAA and GTP.  Upon this binding and 
subsequent ordering of the active site loops, there is also a global transition of the N- and C-terminal 




Figure 1.6: Global transitions through catalytic cycle.  Superimposition of holo rcPEPCK (PDB ID# 
2QEW – aqua) and oxalate-GTP bound rcPEPCK (PDB ID# 3DT2 – pink).  The active site loops are 
coloured as R- P- Ω-loop in red, purple and yellow respectively.  All atoms are coloured by type with 
oxygen as red, nitrogen as blue, and carbon as green. 
OAA binds to the active site through coordination with the M1 metal.  In addition to this, S286 of the 
P-loop interacts with O5 of OAA, and two arginines, R87 of the R-loop and R405, extensively 
coordinating with OAA.29  After OAA (Beta-sulfopyruvate (βSPSP) is used in Figure 1.7, an OAA 
analogue) and GTP binding, the enzyme transitions from an open to closed state (Figure 1.7).  In this 
transition, the nucleotide is shifted towards the M1 metal while also rearranging the polyphosphate tail 
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(Figure 1.7C).  This change in nucleotide conformation is coincident with the closing motion of the N- 
and C-terminal domains and with the ordering of the active site loops.  
Figure 1.7: OAA and GTP binding.  Panel A shows molecule B of βSPSP-GTP rcPEPCK complex (PDB 
ID# 3DT7 steel blue) in which the lid is open.  Panel B shows molecule A (gold) of the same complex 
but the lid is now closed.  Panel C shows the conformational change of GTP upon lid closure. Active 
site loops are coloured as R- P- Ω-loop in red, purple and yellow respectively.  Atoms are coloured by 
type as carbon in green, sulfur as yellow, oxygen as red, nitrogen as blue, phosphate as fuchsia.   
1.9.3 Decarboxylation and enolate intermediate
Prior to this phosphoryl transfer, OAA must be decarboxylated to form a reactive enol-pyruvate 
intermediate (represented by oxalate) (Figure 1.8).   Structural evidence suggests that OAA is polarized
through both R87 and N403, increasing the propensity for the carboxylate to break off.  Y235 now 
rotates inwards to likely stabilize CO2, although the actual CO2 binding site has not been 





Figure 1.8: Enolate Intermediary Structure.  This complex with oxalate and GTP (PDB ID# 3DT2) is 
shown in pink.  Y235 and its transition upon decarboxylation of OAA is shown in grey (from PDB ID# 
3DT7 molecule B). Active site loops are coloured as R- P- Ω-loop in red, purple and yellow 
respectively.  Atoms are coloured by type as carbon in green, sulfur as yellow, oxygen as red, nitrogen 
as blue, phosphate as fuchsia.   
1.9.4 Phosphorylation and release of PEP and GDP
The γ-phosphate of GTP can now be transferred to the reactive enolate to form PEP.  In doing so, PEP 
is likely initially found in a conformation where the phosphate is occupying the γ-phosphate binding 
pocket as seen in the phosphglycolate (PEP analogue) – GDP structure (PDB ID# 3DTB).  In order for 
release to occur, PEP then moves away from its direct coordination with the M1 and M2 metals (Figure
1.9A), and shifts to an outer-sphere coordination geometry (Figure 1.9B).  In this position, the Ω-loop 
opens again to allow for PEP and GDP to be released.  To accommodate PEP in the outer shell Y235 
must rotate away from the active site and forms an edge-on interaction with the carboxylate of PEP 





Figure 1.9: PEP and GDP binding.  Panel A shows GDP and phosphoglycolate (PEP analogue) (PDB 
ID# 3DTB molecule A) at the suspected PEP binding conformation after phosphoryl transfer.  Panel B 
shows PEPCK bound with sulfoacetate (PEP analogue) (PDB ID# 2RKE) at the outer-shell 
conformation prior to release.  Active site loops are coloured as R-, P-, Ω-loop in red, purple and 
yellow respectively.  Atoms are coloured by type as carbon in green, sulfur as yellow, oxygen as red, 
nitrogen as blue, phosphate as fuchsia.   
With this biochemical understanding of the snapshots during turnover in nucleotide dependent 
PEPCKs, further studies to elucidate the coupling of these transitions and their relationship to catalysis 
are important to have a comprehensive understanding of this enzyme.  The studies below highlight how
modifications of the enzyme may not alter these end-points, but rather the ability to transition from one 
state to the next.  These transitions and the accompanied changes in the free-energy landscape will lend




2.0 Understanding a Hysteretic PEPCK Mutant Through a 
Structural Lens
2.1 Introduction
Enzymes and their free-energy landscapes can be modulated and changed under differing 
environmental conditions.  Of these conditions, the enzyme itself can be tuned through covalent and 
non-covalent modifications. In a simplistic sense, these modifications change the structure and 
dynamics, which alter the function of an enzyme by either increasing or decreasing its activity.  These 
covalent PTM’s can include but are not inclusive to; phosphorylation, oxidation, lipidation, and 
glycoslyation.(reviewed in 64)  Non-covalent modifiers are small molecules which bind and alter the enzymes
activity.  Most of these are allosteric modulators have been studied with respect to modifying the 
quaternary state of an enzyme, although monomeric enzymes are now being recognized as being under 
the influence of these small molecules.65,66  
The tune-ability described above can be a result of the change in the free-energy landscape of the 
modified enzyme, as well as other copies with which they are interacting within its quaternary state.  
This cooperativity between copies can either be  positive or negative.  The most well studied and 
recognized example of cooperativity is in hemoglobin.  These studies showed the cross-talk between 
different copies of the tetramer where upon binding of oxygen in the first active site, the affinity for the
other copies sequentially increased.(reviewed in 67)  Cooperativity is also related to the time-dependent 
phenomenon of hysteresis.  Although they are readily exchanged, the distinction between the two is 
that cooperativity can affect both kinetics, as well as affinity (as seen in hemoglobin), whereas 
hysteresis is only affecting the kinetic response.68  The time-dependency of hysteresis is described by a 
slow response to the addition of substrate on the activity of the enzyme.  These hysteretic lags or bursts 
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were recognized very early, although have not been studied in depth to determine specific causes of this
atypical behaviour.  Seminal work by Frieden outlined common characteristics of hysteresis.68  These 
common characteristics will be described in the context of a lag in activity for a monomeric enzyme, 
however multimeric enzymes can also undergo hysteresis through these same principles.  With a non-
hysteretic enzyme, the time required for a rate limiting step will be on average, the same for each 
molecule, and the highest free-energy barrier will dictate the maximal rate of turnover.  Thus, for 
steady-state reactions, the rate of product formation is constant over the experimental time-frame.  In 
the hysteretic enzyme, there is a change in the free-energy landscape with time, and therefore either the 
height of the barrier, or potentially which barrier is highest, changes for the rate limiting step. In 
general, two forms of the enzyme with variable barrier heights most simply represent this change in 
activity.  When a reaction begins, the free enzyme will bind its substrate and form product at a given 
rate.  If this reaction rate increases over time, the second form of the enzyme must have a different, 
lower, free-energy barrier, and thus is structurally and functionally distinct from the initial population 
of reacting enzyme.  Also, if the only changing experimental parameter with time is the enzyme 
completing catalysis, the changes it undergoes during catalysis are producing the high-activity form.  
Hysteresis is best formalized with two models.  This first of which is the LIST (ligand induced slow 
transition) model.69,70  This model is an adaptation of MWC (Monad-Wyman-Changeux) model of 
allostery71,72 and states that rather than the transfer from low to high activity states being solely induced 
fit (see 73 for alternative KNF (Koshland-Nemethy-Filmer) induced fit allostery model), it can be 
thought of as a change in equilibrium.  It is likely that free enzyme can interconvert between the 
inactive and active forms through stochastic fluctuations, but the addition of substrate alters this 
equilibrium to favour that of the active form.  A previous single-molecule study investigating βSP-
glucuronidase suggested that thermal treatments only in the presence of substrates can alleviate 
hysteresis.74  This suggests that an increase in the available thermal energy is not sufficient in forming 
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the active form of the enzyme.  This highlights that it is the transition through the catalytic cycle that 
produces the inactive state, and the presence of substrate more strongly shifts the equilibrium constant 
between the inactive and active form more than temperature. The second foundational model 
describing hysteresis is that under saturating conditions, the probability must be higher for the newly 
formed high-active state to turnover again to maintain this state, than being unbound long enough to be 
able to revert to its previous low energy form.   This “memory” of the enzyme has been described as 
the active forms “remembers” and can relax back into the inactive form75,76, where a slower memory 
implies a larger free-energy barrier between the active-inactive transition. 
This transformation of a low-activity enzyme to high-activity enzyme can likely be accomplished by 
many mechanisms.  What can be said is that under typical experimental conditions, the rates and 
duration of hysteresis are measured on time-scales of seconds to minutes.68  This suggests that the 
transitions between low and high activity forms must be occurring also on these time scales, leaving 
one or many  conformational changes as the most likely candidate.68,72    Substrate binding at the active 
site may induce conformational change in the monomer, which then converts itself or sub-unit partner 
to a high activity state.68   Alternatively, the slow response to substrate addition could also be due to an 
allosteric mechanism where the substrate can bind elsewhere, albeit slowly and tightly, and induce the 
transformation to the high-activity state.68  Active site inhibitors, like in the allosteric mechanism, with 
slow and tight binding/release characteristics have been shown to manifest as burst hysteresis.77  
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Hysteretic enzymes can be great models in beginning to understand the free-energy landscape, as they 
can be experimentally probed throughout this process.   As free-energy landscapes are impossible to 
precisely describe, the mechanisms of hysteresis are very challenging to parse apart.  A point mutant of 
PEPCK has been shown to induce hysteresis, and with the mechanistic understanding of PEPCK, it 
may be an exceptional model to attempt to understand these causal mechanisms of hysteresis.  The 
L153D mutation (Figure 2.1), has the aforementioned hysteretic lag in the PEP carboxylating reaction, 
while the OAA decarboxylating reaction is unaffected (Figure 2.2).  This residue is found at the hinge 
region of the enzyme, in a surface loop.  This hinge region is the pivot point for the N- and C-terminal 
domains to rotate towards one another in ordered to reduce the volume of the active site as well as 
position coordinating residues to do PEPCKs chemical steps.  In the open state of PEPCK, this surface 
loop and leucine are ordered and buried towards the interior of the enzyme.  As PEPCK transitions to a 
closed state, this loop becomes disordered and solvent exposed.  The dynamic interplay between this 
hinge loop and global conformational changes provided the impetus behind changing this residue to an 
aspartic acid, becoming more hydrophilic and shifting its favourability to remain solvent exposed.  
Previous worked completed by Sarah Sullivan in the Holyoak Lab, showed kinetic changes for the 
enzyme after fully activated, but further structural characterizations are needed to understand the 
structural basis for this observed phenomenon.  I aimed to determine various structures of this mutant 
in order to begin to rationalize the kinetic findings, as well as being to describe the conformational 
changes that may be responsible for this behaviour.  
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Figure 2.1: L153D mutant location.  This figure is of the holo enzyme (PDB#2QEW) showing in 
yellow, the location of the L153D mutant situated between the N- (red) and C-terminal (green) domains
at the hinge of the enzyme.  
Figure 2.2: Representative kinetic trace from hysteretic mutant. This figure shows a kinetic trace 
readout from spectrophotometric measurements of the L153D mutant.  The black line indicates the 




Rattus norvegicus (rat cytosolic) (NP_942075/XP_342593) was cloned as described elsewhere into 
pESUMO-Star (Kan) vector (LifeSensors) between the BSA1 and XHO1 sites so that the final 
expressed protein had the SUMO 6xHIS fusion tag at the N-terminus.39  Upon cleavage of the fused 
protein, the resultant protein would have no additional amino acids.
2.2.2 Expression
The expression of all GTP-dependent PEPCKs studied were completed as followed. The purification 
buffers are show in Table 2.1.  
Table 2.1: Buffer composition for protein purification of GTP PEPCKs.
Four flasks with 50mL (supplemented with 50ug/mL of kanamycin) of LB media was inoculated and 
grown overnight at 37°C from glycerol stocks of PEPCK (BL21-DE3).  The cells were centrifuged for 
5 minutes at 5000g and the resultant pellets were resuspended into four flasks with 1L of ZYP-5052 
media and 50ug/mL of kanamycin.78  These cells were allowed to grow for ~20 hours at 20°C before 
they were harvested through centrifugation for 10 minutes at 5000G.  The cell pellets were resuspended
in prechilled B1
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Buffer 1 (B1) 25mM HEPES (pH 7.5 at RoomTemperature) + 10mM Imidazole + 300mM NaCl + 2mM TCEP
Buffer 2 (B2) 25mM HEPES (pH 7.5 at RoomTemperature) + 300mM Imidazole +  2mM TCEP
Buffer 3 (B3) 25mM HEPES (pH 7.5 at RoomTemperature)  + 2mM TCEP
Buffer 4 (B4) 25mM HEPES (pH 7.5 at RoomTemperature)  + 10mM DTT
2.2.3 Purification
Cells were resolubilized in B1, and were passed through a prechilled French press twice at 1000PSI.  
All subsequent steps were completed at 4°C.  The lysed cells were then centrifuged at 12000xG for 30-
45 minutes.  The supernatant was incubated with nickel-NTA resin for 1 hour.  This resin was then 
rinsed with B1 until the flow-through reached an A280 below 0.1.  B2 was than passed over the resin to 
elute the bound protein into 10mL fractions.  These fractions were pooled and concentrated to 
approximately 5mL. The protein was then passed down a P6-DG column pre-equilibrated in B3.  Now 
buffer exchanged, the protein was left overnight to stir with ~1mg of SUMO protease (purified as 
described in38) to cleave the 6xHIS SUMO fusion domain from the PEPCK.  This digested protein 
sample was then incubated with cleaned nickel-NTA resin equilibrated in B3 for 1 hour.  The resin was 
washed with B3 where the flow-through containing protein was collected in 10mL fractions and 
concentrated to less than 5mL.  One final buffer exchange with P6-DG resin in B4 was completed.  The
final purified protein was concentrated to 40, 30 and 10mg/mL using E1% A280 extinction coefficients of 
17 mLmg-1 for rcPEPCK (L153D).  The protein was frozen in 30uL drops by direct immersion in liquid
nitrogen and stored at -80°C.
2.2.4 Crystallization
All L153D crystals were grown under the same conditions with variable amounts of ligands added.  In 
brief, crystals were growth at 10mgmL-1 through vapour diffusion at room temperature.  The mother 
liquor condition was 100mM HEPES pH 7.5 and 16-26% polyethylene glycol (PEG) 3350.  Drops 
were set up in 2:4, 3:3, and 4:2 μL ratios of protein:mother liquor. After drops were set they were L ratios of protein:mother liquor. After drops were set they were 
supplemented with 0.5μL ratios of protein:mother liquor. After drops were set they were L of 100mM MnCl2.  Crystals were harvested, and soaked for 1 hour in 100mM
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HEPES at pH 7.5, 30% PEG 3350, 10% PEG 400, and 5mM MnCl2. Complexes of the enzyme with 
ligand was accomplished via a combination of cocrystallization and soaking (Table 2.2).  The final 
crystals were cryocooled by direct immersion into liquid nitrogen. 
Table 2.2: Ligand addition for the crystallization experiments.  L153D GTP and ϐSP complexes were SP complexes were 
collected at University of Waterloos’ rotating copper anode x-ray source.
Data was collected at the Canadian Light Source in Saskatoon, Saskatchewan on the 08B1-1 beamline 
using a Rayonix MX300HE detector or at University of Waterloo’s home-source with Raxis IV++ 
image plate detector.  Data were indexed and scaled in HKL-200079 and final data statistics are present 
in Table 2.3 and Table 2.4.  
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Structure Ligand Added to Drop Ligand Added to Cryoprotectant
L153D – GDP (GDP+PEP) 1mM GDP 1mM GDP
L153D – GDP+PEP 1mM GDP 1mM GDP + 1mM PEP
1mM GTP
L153D – GTP 1mM GTP 1mM GTP
L15D – PEP 1mM PEP 1mM PEP
WT – GDP+PEP 1mM GDP 1mM GDP + 1mM PEP
L153D – GTP+ϐSP 1mM GTP+ 1mM ϐSP complexes were SP
L153D – ϐSP 1mM ϐSP complexes were SP 1mM ϐSP complexes were SP
2.2.5 Structure Determination 
All structures were initially solved through molecular replacement using MOLREP80  in the CCP4 
package81 using the previously solved holo-rcPEPCK structure (PDB ID# 2QEW).  These structures 
were analyzed to determine if they were in the open- or closed-states.  Closed structures were then re-
solved with the closed rcPEPCK oxalate-GTP structure (PDB ID# 3DT2).  Iterative, manual real-space 
refinement and additions of water molecules and heteroatoms were carried out in COOT82, followed by 
refinement using REFMAC5.83  Final MolProbity statistics were collected with the online server at 
http://molprobity.biochem.duke.edu/index.php.84  Final model statistics are present in Table 2.3 and 
Table 2.4.  
Table 2.3: Crystallographic data table for the two ligand complexes. The GTP complex was collected 
at the University of Waterloos’ rotating copper anode x-ray source.
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L153D GDP (GDP+PEP) L153D GDP+PEP L153D GTP (GTP+Oxalate) L153D GTP+BSP (GTP + BSP/Oxalate)
Wavelength (Å) 1 1 1.54 1
Resolution range (Å) 53.2  - 2.1 (2.12  - 2.05) 48.9  - 1.7 (1.8  - 1.7) 29.4  - 2.29 (2.37  - 2.29) 52.2  - 1.7 (1.8  - 1.7)
Space group P 1 21 1 P 1 21 1 P 1 21 1 P 1 21 1
Unit cell (Å) 60.02 118.874 86.406 90 97.521 90 60.04 118.866 86.59 90 97.396 90 45.724 119.511 60.454 90 110.952 90 60.083 118.823 86.621 90 97.273 90
Total reflections 2410808 2570756 638885 2620508
Unique reflections 73409 (7275) 129163 (12603) 25223 (1946) 132028 (13056)
Multiplicity 6.3 (5.9) 7.0 (6.8) 4.1 (3.2) 7.2 (6.7)
Completeness (%) 97.5 (97.1) 97.8 (95.8) 92.6 (71.7) 99.8 (99.1)
Mean I/sigma(I) 9.9 (1.3) 13.5 (1.5) 10.6 (1.8) 14.7 (2.3)
29.4 22.5 52.3 21.8
R-Loopmerge 0.157 (1.32) 0.111 (1.36) 0.108 (0.628) 0.099 (0.815)
R-Loopmeas 0.171 (1.44) 0.120 (1.47) 0.123 (0.729) 0.106 (0.884)
R-Looppim 0.066 (0.585) 0.044 (0.560) 0.058(0.362) 0.039 (0.339)
CC1/2 0.909 (0.627) 0.947 (0.712) 0.937 (0.776) 0.966 (0.856)
Reflections used in refinement 73381 (7275) 129081 (12597) 25222 (1947) 131931 (13053)
Reflections used for R-Loopfree 3658 (361) 6639 (671) 1164 (85) 6783 (695)
R-Loopwork 0.228 (0.318) 0.194 (0.296) 0.210 (0.298) 0.196 (0.261)
R-Loopfree 0.268 (0.342) 0.221 (0.325) 0.271 (0.379) 0.222 (0.309)
Number of non-Loophydrogen atom 10092 10444 4927 10487
  macromolecules 9724 9738 4815 9730
  ligands 100 97 47 111
  solvent 268 609 65 646
Protein residues 1238 1238 613 1238
RMS(bonds) 0.013 0.014 0.014 0.015
RMS(angles) 1.85 1.87 1.86 1.93
Ramachandran favored (%) 95.5 96.9 94 97
Ramachandran allowed (%) 4.05 3 5.56 2.84
Ramachandran outliers (%) 0.41 0.08 0.49 0.16
Rotamer outliers (%) 1.94 1.55 4.89 1.65
Clashscore 5.03 2.97 6.85 3.69
Average B-Loopfactor 32.7 25.4 58.3 23.8
  macromolecules 32.8 25.2 58.5 23.5
  ligands 31 22.6 56.4 24.2
Wilson B-Loopfactor (Å2)
Table 2.4: Crystallographic data table for the one ligand complexes.  The ϐSP complexes were SP complex was collected at
the University of Waterloos’ rotating copper anode x-ray source.
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WT GDP+PEP (GTP) L153D BSP L153D PEP
Wavelength (Å) 1 1.54 1
Resolution range (Å) 59.3  - 1.7 (1.7  - 1.7) 31.4  - 2.05 (2.12  - 2.05) 42.4  - 1.7 (1.76  - 1.7)
Space group P 1 21 1 P 1 21 1 P 1 21 1
Unit cell (Å) 62.258 118.654 86.171 90 107.771 90 62.94 119.249 86.955 90 107.612 90 60.989 118.664 90.688 90 108.032 90
Total reflections 2140022 1740850 2129427
Unique reflections 138000 (12002) 72791 (5812) 133590 (12880)
Multiplicity 7.3 (5.4) 7.1 (6.0) 7.3 (6.0)
Completeness (%) 96.5 (84.4) 94.9 (76.2) 99.2 (96.1)
Mean I/sigma(I) 48.4 (2.3) 14.9 (2.1) 23.4 (2.2)
26.9 36.4 30.3
R-Loopmerge 0.065 (0.641) 0.114 (0.765) 0.06 (0.74)
R-Loopmeas 0.07 (0.708) 0.123 (0.831) 0.064 (0.806)
R-Looppim 0.026 (0.293) 0.045 (0.318) 0.023 (0.314)
CC1/2 0.987 (0.928) 0.967 (0.86) 0.985 (0.904)
Reflections used in refinement 137671 (11989) 72679 (5809) 133413 (12859)
Reflections used for R-Loopfree 6861 (573) 3671 (250) 6567 (614)
R-Loopwork 0.246 (0.534) 0.309 (0.402) 0.221 (0.391)
R-Loopfree 0.272 (0.548) 0.377 (0.439) 0.25 (0.408)
Number of non-Loophydrogen atom 10267 9576 9986
  macromolecules 9631 9542 9560
  ligands 68 32 24
  solvent 568 2 402
Protein residues 1225 1214 1214
RMS(bonds) 0.015 0.015 0.014
RMS(angles) 1.92 1.96 1.88
Ramachandran favored (%) 97.1 90.4 95.9
Ramachandran allowed (%) 2.79 7.71 3.32
Ramachandran outliers (%) 0.08 1.91 0.75
Rotamer outliers (%) 2.73 4.83 1.57
Clashscore 3.43 9.63 4.84
Average B-Loopfactor 32 44 36.2
  macromolecules 31.9 44.1 36.2
  ligands 27.9 35.8 31.6
  solvent 35.3 26 37.3
Wilson B-Loopfactor (Å2)
2.3 Results
2.3.1 L153D - PEP
The PEP L153D structure is as expected, with PEP binding in the outer-shell of the active site in the 
PEP release state (Figure 2.3).  The enzyme globally is open, most similar to the holo structure (PDB 
ID# 2QEW).  The R- and P-loop are both ordered but also in an open state, while the Ω-loop is open 
and disordered.  Interestingly, there are differences in the two molecules of this structure in the ASU.  
Molecule A, is very well ordered throughout the entire structure. Molecule B on the other hand is 
ordered throughout the N-terminal domain but becomes quite disordered through the PEPCK-(C 
terminal) domain (residues 310-400 and 500-580). 
Figure 2.3: PEP bound to L153D.  This figure shows PEP and M1 metal bound to the hysteretic mutant
with the experimental 2Fo-Fc electron (rendered at 1.7σ)) density maps in blue mesh.  The density is 
cropped for clarity. The R-, P-, and Ω-loop are shown in red, purple and yellow respectively.  The 
various ligands are coloured by atom type, with carbon as green, oxygen as red, nitrogen as blue, 
phosphorous as purple, and Mn2+ as grey.
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2.3.2 L153D - βSP
The location of βSPSP is unexpected, with βSPSP binding in the outer-shell of the active site in the PEP 
release state in  both of molecules in the ASU (Figure 2.4).  In molecule A, βSPSP is also in an the 
expected conformation coordinating with the M1 metal.  Due to resolution constraints, the modelling of
βSPSP in the molecule with two conformations was challenging and only the general location could be 
inferred.  Both molecules are globally open, although the C-terminal domain is slightly rotated towards 
the active site.  The R-loop is ordered but in an open state, the P-loop is ordered in molecule A, but 
disordered in molecule B, and finally the Ω-loop is open and disordered.  As discussed above in section
2.3.1, molecule A is very well ordered throughout the entire structure while molecule B is ordered 
throughout the N-terminal domain but becomes quite disordered through the PEPCK-(C terminal) 
domain (residues 330-380 and 400-435).  
Figure 2.4: βSPSP bound to L153D.  This figure shows βSPSP and M1 metal bound to the hysteretic mutant
with the experimental 2Fo-Fc (rendered at 1.5σ)) electron density maps in blue mesh. The density is 
cropped for clarity. Panel A shows only one βSPSP bound in the PEP site.  Panel B shows βSPSP bound both
in the PEP site, as well as in the OAA site coordinating with the M1 metal.  The R-, P-, and Ω-loop are 
shown in red, purple and yellow respectively.  The various ligands are coloured by atom type, with 
carbon as green, oxygen as red, nitrogen as blue, phosphorous as purple, and Mn2+ as grey.
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2.3.3 L153D - GTP (GTP + Oxalate)
The location of GTP is as expected, binding to the P-loop (Figure 2.5).  After modelling the nucleotide 
and M1/M2 metals, there was positive Fo-Fc electron density around the M1 metal facing the PEP/OAA 
site.  Although the resolution is relatively low, oxalate was easily modelled in this positive density 
coordinating with the M1 metal as previously described.   The enzyme is globally closed (PDB ID# 
3DT2).  The R- and P-loop are ordered and closed, while the Ω-loop is partially disordered.  
Throughout each molecule, both the N- and C-terminal domains they are  ordered and well modelled. 
Figure 2.5: GTP structure (oxalate and GTP bound) with L153D.  This figure shows oxalate, GTP and 
metals bound to the hysteretic mutant with the experimental 2Fo-Fc electron density maps (rendered at 
1.7σ) for ligands, 3.5σ) for metals) in blue mesh. The density is cropped for clarity. The R-, P-, and Ω-
loop are shown in red, purple and yellow respectively.  The various ligands are coloured by atom type, 
with carbon as green, oxygen as red, nitrogen as blue, phosphorous as purple, and Mn2+ as grey.
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2.3.4 L153D - GTP + βSP bound to L153D.SP
The location of GTP and βSPSP is as expected, binding to the P-loop and R loop while coordinating with 
the M1 metal respectively (Figure 2.6).  After modelling the nucleotide, M1/M2 metals, and βSPSP there 
was negative Fo-Fc  density around the sulfate.  Reducing the occupancy βSPSP to 0.5 resolved this but 
created positive difference density around the carboxylate and carbonyl moieties.  Oxalate modelled at 
the remaining 0.5 occupancy resolved well, suggesting a mixed population of βSPSP and oxalate.   Both 
molecules in the ASU are globally closed (PDB ID# 3DT2).  The R- and P-loop is ordered and closed, 
while the Ω-loop is also ordered and closed.  Throughout each molecule, both the N- and C-terminal 
domains they are ordered and well modelled. 
Figure 2.6: GTP and βSPSP structure (βSPSP/oxalate and GTP bound) with L153D.  This figure shows 
oxalate, GTP and metals bound to the hysteretic mutant with the experimental 2Fo-Fc electron density 
maps in blue mesh (rendered at 1.7σ) for ligands, 3.5σ) for metals). The density is cropped for clarity. 
Both βSPSP and oxalate are modelled with 0.5 occupancy.  The R-, P-, and Ω-loop are shown in red, 
purple and yellow respectively.  The various ligands are coloured by atom type, with carbon as green, 
oxygen as red, nitrogen as blue, phosphorous as purple, and Mn2+ as grey.
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2.3.5 L153D – GDP+PEP and GDP (GDP+PEP) 
The GDP is bound as expected and previously described coordinating to the P-loop (Figure 2.7).  PEP 
however, is modelled cradled around the M1 metal, in a geometry that could be expected in a 
catalytically competent conformation prior to phosphoryl transfer in the OAA forming direction.  
Unexpectedly, this ligand complex was also found the the cocrystal structure of GDP by itself.  There 
are two molecules in the ASU.   Both molecules in the ASU are globally closed (PDB ID# 3DT2).  The 
R-, P-, and Ω-loop is ordered and closed.  Throughout each molecule, both the N- and C-terminal 
domains they are ordered and well modelled. 
Figure 2.7: GDP and PEP bound to L153D.  This figure shows the GDP and PEP structure, but also 
represents to findings from the GDP structure.  This figure shows PEP, GDP and metals bound to the 
hysteretic mutant with the experimental 2Fo-Fc electron density maps (rendered at 1.7σ) for ligands, 3.5σ)
for metals) in blue mesh. The density is cropped for clarity. The R-, P-, and Ω-loop are shown in red, 
purple and yellow respectively.  The various ligands are coloured by atom type, with carbon as green, 
oxygen as red, nitrogen as blue, phosphorous as purple, and Mn2+ as grey.
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2.3.6 WT - GDP + PEP (GTP)
The GDP+PEP complex was found to have only GTP found in the active site coordinating as 
previously described to the P-loop (Figure 2.8).  There is one molecule in the ASU.   Both molecules in
the ASU are globally open (PDB ID# 2QEW).  The R-loop is open and disordered, while the P-loop is 
ordered and partially closed as seen in the previous WT GTP bound structure (PDB ID# 2QEY).  
Finally, the Ω-loop is disordered and open.  Both the N- and C-terminal domains they are ordered and 
well modelled. 
Figure 2.8: GDP and PEP structure (GTP bound) with WT rcPEPCK.  This figure shows GTP and 
metals bound with the experimental 2Fo-Fc  electron density maps (rendered at 1.7σ) for ligand, 3.5σ) for 
metals) in blue mesh. The density is cropped for clarity. The R-, P-, and Ω-loop are shown in red, 
purple and yellow respectively.  The various ligands are coloured by atom type, with carbon as green, 
oxygen as red, nitrogen as blue, phosphorous as purple, and Mn2+ as grey.
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2.3.7 Michaelis-Menten Constants for the L153D and WT rcPEPCK
This data in Table 2.5, collected by Sarah Sullivan, is being used as a reference to understand the 
structural changes and these kinetic consequences.  These constants were determined once the enzyme 
was fully activated.  As seen, the mutant is turnover (kcat) in the OAA decarboxylating reaction is 
reduced by a factor of 5, while the kcat/Km is unaffected for OAA but is an order of magnitude lowered 
for GTP.  In the hysteretic reaction, the maximal activity is reduced by approximately one third, while 
the kcat/Km is increased by a factor of two, while the GDP kcat/Km is unaffected.  
Table 2.5: Previously determined kinetic parameters for WT and L153D mutant.  
*All rates measured in the PEP carboxylating hysteretic reaction were after ~15 minutes once the 
enzyme was fully activated*
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Enzyme
WT 51 55 52
L153D 10 84 9
Enzyme
WT 170 210 19
L153D 100 140 13
OAA + GTP → PEP + GDP + CO2
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1 x 106 1 x 106
9 x 105 1 x 105
PEP + GDP + CO
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4 x 104 9 x 104
1 x 105 9 x 104
2.4 Discussion
Before beginning the discussion, a few assumptions should be clarified.  As described above, there are 
many possibilities for hysteretic behaviour, many of which can be ruled out when using rcPEPCK as a 
model.  First, this enzyme has not shown to possess higher oligomeric states and therefore can be ruled 
out that a gain-of-function is likely not occurring. Second, although an allosteric pocket has been 
shown for this enzyme behind the P-loop of the active site this is likely not mediating the hysteresis. 
The previous characterization of the allosteric pocket was regulated by small inhibitors65, and more 
recently by anions.85 It is very unlikely that this allosteric pocket is now being regulated by substrate 
addition.  The structural results also support this conclusion as they do not show any occupancy in this 
pocket either. The only two plausible mechanisms remaining are therefore a change in the 
conformational ensemble and free-energy landscape leading to a more active conformer after turnover, 
or the production of a new allosteric pocket – likely at the mutational site.  With a suitable crystal form 
that can form open, closed, and intermediary states, high resolution data can be obtained to attempt to 
discern the mechanistic origins of hysteresis in L153D PEPCK, and give further insights into hysteretic
behaviour in general. 
 In this study, the PEP and βSPSP bound structure serve as the initial inactive states, while the complexes 
of both PEP-GDP and βSPSP-GTP serve as the end-points for each reaction prior to activation. The 
oxalate-GTP/GDP complexes would serve as the intermediary state.  Although a complete ensemble of 
structures are likely necessary in fully comprehending the structural changes in the free-energy 
landscape, these initial structures can lend insight into distinguishing between the two potential 
mechanisms stated above.  
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2.4.1 Rationalizing Kinetic Data 
The kinetic data (Table 2.5) described the kinetic consequences of the mutation.  These measurements 
were completed after steady-state was achieved, some time after the hysteretic transition had 
completely occurred.  This data shows that the mutation does not only cause the hysteretic behaviour 
but also changes the free-energy landscape from the hysteretic active enzyme when compared to WT.  
In both directions, the mutants total maximal rate of turnover as measured by kcat is reduced, an effect 
that is clearly not bidirectional as the OAA decarboxylating reaction is affected more severely.  If kcat of
WT is mostly controlled by rates of phosphoryl transfer38, the new mutant kcat may be at least partially 
driven by conformational changes associated with product release.  
In the OAA decarboxylating reaction, the product release step may be impaired if the enzymes 
conformational equilibrium is now shifted to remain closed when in this product state (GDP-PEP-CO2).
It is evident from the structural data that the enzyme binds GDP alongside contaminating PEP and 
closes, suggesting a stickiness of this state.  The closest WT structure available is a complex with 
phosphoglycolate (PEP analogue) and GDP (PDB ID# 3DTB).65  These structures shows WT rcPEPCK
open, suggesting that the mutation may be changing the free-energy landscape to form a 
thermodynamic well when GDP and PEP are present, leading the 5 times reduction in kcat for this 
reaction.  
In the PEP carboxylating reaction, the GTP-OAA state may be destabilized as both the GTP cocrystal, 
and GTP-βSPSP structure both seem to sequester contaminating oxalate, or some analogue like it.  This 
would at face value suggest that L153D when bound with GTP, selects for the intermediary enolate 
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over OAA, stabilizing the intermediate state.  Inhibition data (not shown) testing oxalate against both 
reactions suggest that the binding constant for the enolate is unchanged from WT to the hysteretic 
mutant (Ki = 9μL ratios of protein:mother liquor. After drops were set they were M for each).  The lack of change in binding constant for oxalate suggests that rather 
than fully selecting for the intermediary state, L153D rather preferentially destabilizes the GTP-OAA 
state.   Under this model, the modest reduction in kcat is simply because of this the equilibrium between 
the intermediary state and product state is now shifted towards the enolate, potentially stalling this the 
carboxylation reaction, albeit less severely than the GDP-PEP stabilization in the OAA decarboxylating
reaction.  
The catalytic efficiency differences (kcat/Km) coincide with the structural data presented.   The very 
modest increase in PEP binding by a factor of two could be due to the GDP form, preferentially 
adopting a more accepting mode for PEP binding, as evidence by the GDP structure having PEP bound.
The order of magnitude decrease in binding of GTP for L153D than WT is harder to discern.  The 
structural evidence may be found in PEP and βSPSP structures.  Based on investigating the B-factors and 
electron density in the C-terminal domain, there seems to be a destabilization occurring in at least one 
of the molecules in the ASU of the solved structures.  This destabilization is not seen in the most 
homologous structures of the WT enzyme (PDB ID# 2QF1 – OAA, PDB ID# 2RKA – 
phosphoglycolate).29  Although these structures are not directly comparative and the crystal packing is 
different, it still suggest that L153D is the cause of this destabilization.  Destabilization of the C-
terminal domain was shown in a previously characterized mutant, E89A/D/Q40.  This mutant was 
designed to remove an important interaction linking OAA/PEP binding to the closure of the lid.  The 
E89A mutation specifically led to a closed R-loop in which it resides, but the lid was only able to 
partially close, as a salt bridge was removed between E89 and H470.  This partial closure of the Ω-loop
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likely manifested as a lowly populated second conformer of the C-terminal domain.  Although the C-
terminal domain is disordered in the L153D and E89 mutants, it is unlikely that this is caused by the 
same phenomena as the disorder of the E89 mutants are when in the intermediary and Michaelis-
Menten complexes, whereas in the L153D it is only when singly occupied by βSPSP or PEP.  It does 
highlight that the C-terminal domain may be a more dynamic domain of the enzyme, while the N-
terminal domain may be more rigid in general.  Regardless, this disorder in the L153D structures 
suggests that the holo enzyme, and PEP/OAA bound state, are more dynamic than the WT, which may 
manifest as increasing difficulty to turnover, or bind other substrates.  As the destabilization is in the C-
terminal domain, it is not surprising that the GTP binding is preferentially affected over OAA as the 
GTP binding domain is a part of the C-terminal portion.  This destabilization preferentially effects the 
triphosphate nucleotide as opposed to the diphosphate nucleotide as suggested from the previous model
of GTP-OAA destabilization and GDP-PEP stabilization as manifested in the structural data.  It may be 
that the GDP-PEP stabilization can offset the binding penalties whereas the GTP-OAA destabilization 
cannot.  
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2.4.2 Proposed Mechanism of Hysteresis
The studied loop here, situated at the hinge between the N- and C-terminal domains, shows how the 
coupling of this loops energetic state relates to the overall conformation of the enzyme.  There must be 
a specific coupling between the local transitions at this hinge with the ligation state and global 
rearrangements necessary for activity. Altering this loop through the point mutant tested here, has 
changed the energetics of the loop such that, in general, the enzyme has decoupled the ligation state 
with the conformations necessary for catalysis.  This is best highlighted through the GDP cocrystal 
structure preferentially binding PEP without CO2 and closing, or the GTP structure binding some 
enolate-like molecule, as modelled by oxalate.  This ties the dynamics of the mutagenized loop with the
dynamics throughout the rest of the enzyme and explains a potential origin for kinetic deficits 
measured.
To understand the specific mechanism of hysteresis, that is the ability for the enzyme to relieve this 
kinetic deficit by turning over, is likely achieved by an alleviation of the major thermodynamic barriers 
caused by the mutation.  As described in the rationale behind the L153D mutation, this new hydrophilic
residue will prefer a disordered solvent exposed state coincident with the global closed conformation.  
The observed structural data presented suggests that this mutant is behaving as predicted, by 
preferentially closing.  In this above mentioned mechanism, potentially after turnover, the decoupling 
of the mutagenized loop is now reset to a more “normal” coupling, where this hinge loop will now 
transiently order and bury towards the enzyme, shifting the global conformational to an open state and 
preventing the enzyme from prematurely closing without full ligand occupancy.  
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The unidirectionality of the hysteresis cannot be explained by the destabilization of both the PEP and  
βSPSP states.  When measuring the PEP carboxylation reaction, the saturating quantities of PEP and GDP 
close the enzyme before CO2 binding, causing the lag until the landscape changes to remove it.  In the 
OAA decarboxylating reaction, the saturating ligands are OAA and GTP, and the small amounts of PEP
produced are only found in the active site after the chemical steps.  Once released the PEP is removed 
by the coupling reaction (pyruvate kinase and lactate dehydrogenase), preventing rebinding and 
premature closure shown in the PEP carboxylating reaction with GDP.  As mentioned previously, the 
sticky closure upon GDP-PEP binding would still occur in the OAA decarboxylating reaction, but only 
once after the end of chemistry, resulting the large reduction in kcat.  This bottleneck likely continuously
persists and cannot be removed as evidence from the lack of hysteresis in this direction.  
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2.4.3 Allosteric Ligand Binding and Protein-Water Interface
As mentioned earlier, one plausible mechanism for hysteresis is allosteric regulation.  One interest 
observation that requires attention is in many, but not all, WT closed structures of PEPCK a PEG 
molecule is found in the hinge region of the enzyme (Figure 2.9).  This suggests that this region could 
be a site of allosteric regulation, possibly binding small molecules to influence to conformational 
equilibrium.  L153(D), proximity to this PEG molecule is such that it is likely directly contributing to 
the binding.  The L153D structure with PEP does have a PEG molecule present, whereas the WT 
phosphoglycolate structure does not.  Alternatively, the L153D structure with βSPSP does not have a 
PEG, similar to its WT counterpart with OAA.  Although PEG binding is not totally consistent with 
closure, it is an observation that cannot be ruled out.  It is by all means possible that some other 
molecules other than PEG could be binding at this site, influencing its dynamics.  Although unlikely, 
during the kinetic assays when the hysteresis is monitored, some molecules present may bind to this 
region and influence the hinge dynamics. Further studies should be completed to determine what the 
consequence of ligand binding at this site are, as well as probe for specific ligands if possible.   
As this hinge region and mutation are all on the surface, it is likely having a dynamic effect within the 
protein as well as in regards to the solvent fluctuations.  It has been noted the coupling of both α-(bulk) 
and βSP-(hydration shell) fluctuations to protein dynamics through a proposed “solvent-slaving” 
phenomena.(reviewed in 86)  This mutation from a hydrophobic leucine to hydrophilic aspartic acid may also 
be influencing the conformational dynamics of the enzyme through the solvent interface.  This, 
however, is experimentally impossible to determine without the use of in silico techniques and even 
then is likely an extremely large feat. 
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Figure 2.9: PEG Binding at hinge.   This figure shows L153D PEP structure hinge region with PEG 
bound with experimental 2Fo-Fc electron density maps (rendered at 1.5σ))  in blue mesh. The density is 
cropped for clarity. The N- and C-terminal domains are coloured in red and green respectively.  The 
various ligands and L153D mutation are coloured by atom type, with carbon as green, oxygen as red, 
and nitrogen as blue.
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2.5 Summary of Results
Based on the known biochemical information of PEPCK, two causes of the observed hysteresis are 
possible.  The first, and most likely, is the mutagenized loop is now preferentially stable in the 
disordered solvent exposed conformation, leading to favouring the global closed state.  Throughout 
turnover, this hinge loop now samples more “normal” conformations effectively resetting itself, shifting
its equilibrium closer to the proper wild-type open-closed states.  This resetting changes in the 
energetic landscape leading to a more active enzyme as it can more readily traverse its catalytic cycle 
without prematurely closing.  The second, could be a slow but tight binding allosteric regulator leading 
to a change in the energetic landscape. 
The accompanied kinetic data can be rationalized with the presented structural data.  The reduction in 
kcat, specifically in the OAA decarboxylating reaction is likely due to a stalling of the enzyme PEP/GDP
release. In contrast to this significant stalling, the modest reduction is kcat for the PEP carboxylation 
reaction may be due to a destabilization of GTP-OAA state, and the equilibrium shift towards the 
enolate intermediary state.  Clearly, based on the difference in kcat between the two reactions, the 
equilibrium shift to stabilize the closed GDP-PEP state is shifted further than the GTP-OAA and 
enolate states.  The increase in catalytic efficiency for PEP may be due to a stabilizing of the GDP 
bound state induce a conformational change that is with an increase affinity for PEP as the GDP crystal 
having PEP bound in a closed conformation.  The reduction in catalytic efficiency in GTP may be due 
to a destabilization of the C-terminal domain, although the preferential closure once GDP and PEP bind
may offset this penalty for GDP.  
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The structural evidence suggests that the unidirectional hysteresis may be caused by the mutants ability
to close upon PEP and GDP binding leading to a low energy thermodynamic well.  Under experimental
condition, saturating quantities of PEP and GDP are present, which may induce premature closure 
before CO2 can bind and the enzyme can turnover.  This would manifest as a large reduction of the 
observed rate.  After turnover, the enzyme has reset the coupling of this hinge loop with the transition 
to the closed state upon ligand bind.  That is, the enzyme now the active form which remains open long
enough for CO2 to bind, and therefore turnover correctly. In the OAA decarboxylating reaction, this 
stalling occurs potentially after turnover, manifesting as a large reduction in kcat, but will not manifest 
as burst kinetics (inactivation over time) as PEP is removed from the experiment through the coupling 
enzyme.  
The allosteric preposition is plausible, as seen in the structural data PEG molecules can bind in this 
hinge region, preferentially when the enzyme is closed.  Although PEG is not found in the kinetic 
assays, other molecules may be regulating this hinge region by interacting in a similar fashion to PEG.  
Although this allosteric binding should be studied further, because not every closed structure has PEG 
bound suggests that this binding may be not as important as other structural changes going on 
throughout the enzyme.  
In closing, this single point mutant has conferred drastically different kinetics as well as structural 
differences that are unseen in the WT enzyme.  This highlights how the single isozyme specific 
differences can cause significant changes in structural and function, showing the complexity of the 
energetic landscape.  Further experiments, specifically addressing the transition between inactive and 
active conformations are necessary to be sure of the interpretations.  
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3.0 Thermal Adaptions of PEPCK
3.1 Introduction
In order to better understand the diversity of protein sequences and their corresponding energy 
landscapes, thermally adapted isozymes have long been studied as they must operate under vastly 
different environmental parameters while maintaining the same chemical outcome.  In different thermal
regimes, enzymes must adapt in order to maintain fulfilling cellular needs under differing thermal 
energy availability.  Much of the focus on these studies has been on understanding the molecular 
mechanism that allow thermophilic enzymes to maintain their folded state at such high temperatures.87  
Mutational studies in attempts to create a thermal adapted enzymes from a mesophilic scaffold have 
been disappointing, indicating that specific residue changes are not enough to change the thermal 
dependency of the enzyme.88,89  Understanding how the global features of the enzyme contribute to the 
function under different thermal conditions, although more convoluted,  may lead to better outcomes.
With respect to flexibility and dynamics, thermally adapted proteins can be categorized as existing on a
spectrum, where psychrophilic enzymes are generally proposed to be more flexible and the 
thermophilic counterparts are more rigid at a given temperature.90  It was shown by Petsko, that the 
flexibility and dynamics of a given enzyme are conserved at the temperatures (~Topt) the enzymes exist 
at in vivo.91 This suggests that proteins adapt to maintain similar levels of kinetic flux and 
conformational motion, and therefore energetic landscape, at the temperatures that they have evolved to
operate at.  Psychrophiles, with their increase in flexibility generally have an accompanied decrease in 
thermostability, in contrast to rigid thermophilic enzymes that must maintain their tertiary structure at 
high temperatures where unfolding is more likely.90  Thermophilic enzymes adapt for increased rigidity 
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by increasing hydrophobic core packing, increased salt-bridge content, decreased interactions with 
solvent at the protein-solvent interface, as well as an increased number of prolines, increased π-stacking
and cation interactions, and increased disulfide content.(review in 87)  Initially, a two-state model for thermal
denaturation was proposed. This classical model suggests that an enzyme-catalyzed rate will increase 
with temperature based on the Arrhenius equation, until an optimum has been reached.  After this 
optimum, the enzyme thermally denatures and the activity drops rapidly.  A new three-state model, 
known as the equilibrium model, has been proposed.92,93 In this model, above the Topt the enzyme does 
not initially denature but rather is folded and becomes reversibly less active with increasing 
temperature (with a Keq associated with the equilibrium between folded active and folded inactive 
states).  At sufficiently high enough temperatures, thermal denaturation occurs and the enzyme is 
irreversible inactivated.  Thermal denaturation has been attributed to increased vibrations of atoms, 
disrupting intermolecular bond network and ultimately a collapse of the tertiary structure.  Cold 
denaturation is much less understood.  The proposed mechanism of cold denaturation is thought to be 
one where as temperatures decrease and surface waters becomes more ordered and function as a 
clathrate cage. This resultant removal of important protein hydration leads the protein to unfold, fueled 
by a favourable increase in entropy of the system.94–97
The inherent flexibility and rigidy of psychro- and thermophilic enzymes has functional consequences 
as well.  The increased flexibility of psychrophiles gives them an increase in catalytic prowess at low 
temperatures over their rigid counterparts.90 This flexibility allows these enzyme to use less thermal  
energy to transverse barriers of its free-energy landscape transitioning through substrate bound, 
transition, and product release states. Each free-energy barrier to move the enzyme-ligand system 
through this trajectory must be overcome through stochastic thermal motions.  Low temperature 
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flexibility adaptations help offset the decrease in thermal energy available by allowing these transitions 
to happen more readily, that is, by reducing the enthalpy of activation.98  For thermophilic enzymes, the
increased rigidity prevents denaturation, but also is tuned to utilize the amount of thermal energy 
available to traverse these structural transitions to maintain flux.  These thermophiles are proposed to 
adapt their entropic barriers as the enthalpic ones are easily overcome with the thermal energy of their 
environments.  Lowering of the entropy barriers is proposed to occur through a reduction in the sheer 
number of conformational states accessible. This change in the driving force in reducing the free-
energy requirements of catalysis are known as the enthalpy-entropy compensation of adaptation.99
Functional and structural work detailing the conformational changes of PEPCK catalysis suggest that 
PEPCK may be a good system to further understand the thermal adaptations of dynamics, and thus the 
associated free-energy landscapes.   For PEPCK to operate efficiently, there must be a series of 
concerted conformational changes of the R- and P-loop upon substrate binding with the maintained 
closure of the Ω-loop lid long enough for the chemical steps to take place.38  It could be theorized that 
at high temperatures, both the intrinsic rates of chemistry and the entropic favourability of the 
disordered open state of the lid will increase simultaneously.  Based on this hypothesis, one might 
speculate that PEPCKs must evolve the nature of this lid to tune the balance between the closing and 
opening of this lid with intrinsic response of the chemical reaction to temperature.  For example, at low 
temperatures where chemistry is slow, the lid must stay closed long enough for the chemical steps to 
occur but not so long as to hinder product release.   Enzymes under different temperature selection may
lower or raise free-energy barriers, and their respective entropic/enthalpic contributions,  associated 
with particular motions to maintain proper flux.  To begin to gain some insight into how PEPCKs 
balance conformational states and the associated free-energy barriers, three thermally adapted isozymes
47
of GTP-dependent PEPCK were studied.  These enzymes encompass a broad range of temperatures and
were selected based upon changes to known important residues in Ω-loop dynamics.   Specifically the 
Ω-loop was examined as it is unlike the other functionally important loops that have been 
characterized, as it transitions conformation states without interacting with substrates/products.  Thus, 
it was hypothesized that its sequence would be less constrained by the nature of the chemical reaction 
and more sensitive to changes necessary for function under different temperatures.  Based on this 
criteria, enzymes from three sources were selected: Polaromonas naphthalenivorans a psychrophile 
(Topt, 20°C)100, Rattus norvegicus the mesophile (Topt, 37°C) and the standard structural and functional 





The GTP-PEPCK (EC: 4.1.1.32) protein sequence from Rattus norvegicus was described in 2.2.1. 
Polaromonas naphthalenivorans (referred to as  polarPEPCK)(WP_011799537.1) and  
Hungateiclostridium thermocellum (referred to as clostPEPCK) (Clostridium thermocellum)(A3DJE3)  
were codon optimized for Escherichia coli and synthesized by GenScript (See Section 7.2).  GenScript 
cloned the separate genes into the pESUMO-Star (Kan) vector (LifeSensors) between the BSA1 and 
XHO1 sites so that the final expressed protein had the SUMO 6xHIS fusion tag at the N-terminus.  
Upon cleavage of the fused protein, the resultant protein would have no additional amino acids. 
3.2.2 Expression
The expression of all enzymes was carried out in a fashion identical that described in 2.2.2. 
3.2.3 Purification
All isozymes of PEPCK were purified in the same manner, with the exception that clostPEPCK was 




To determine each kinetic constant, all other substrates were held constant and the assays were 
completed in duplicate.  For the Arrhenius plots, saturating concentrations of all substrates were used.  
The addition of glycerol to increase the viscosity of the reaction was varied dependent on temperature 
to maintain 2.4 centipoise at each temperature.102  All assays were completed in pre-equilibrated kinetic 
assay mixes at a final volume of 1mL with the use of a temperature controller. The temperatures were 
verified with a thermocouple for accuracy.  A CaryUV100 spectrophotometer was used to monitor the 
reduction of NADH to NAD+ in the coupled assays at 340nm. 
As previously shown, OAA can spontaneous decarboxylate to pyruvate in the presence of metals.103  To
measure this background rate the standard assays were used without the addition the PEPCK enzyme.  
All rates have been normalized for this background rate depending on the metal mix used.    
OAA + GTP → PEP + GDP + CO2
The standard assay mix was composed of 100mM HEPES pH 7.5, 10mM DTT, 300μL ratios of protein:mother liquor. After drops were set they were M NADH, 
0.5mM GTP, 2mM MgCl2 (4:1 nucleotide:metal ratio), 100μL ratios of protein:mother liquor. After drops were set they were M MnCl2, 500μL ratios of protein:mother liquor. After drops were set they were M OAA, 1mM ADP, 50μL ratios of protein:mother liquor. After drops were set they were g 
pyruvate kinase (PK), 5U lactate dehydrogenase (LDH), and 2.5μg of GTP PEPCK.  Reactions were 
started with the addition of OAA. 
OAA + GTP → Pyruvate 
The standard assay mix described above in the OAA→PEP section was used with the modified to not 
include the coupling enzyme pyruvate kinase in order to measure the enzyme-catalytzed 
decarboxylation of OAA.
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PEP +GDP + CO2 → OAA + GTP
The standard assay mix was composed of 100mM HEPES pH 7.5, 10mM DTT, 300μL ratios of protein:mother liquor. After drops were set they were M NADH, 1mM 
GDP , 4mM MgCl2 (4:1 nucleotide:metal ratio), 100μL ratios of protein:mother liquor. After drops were set they were M MnCl2, 10mM PEP, 50mM KHCO3-  (bubbled 
with dry ice),  10U of MDH and 2.5μL ratios of protein:mother liquor. After drops were set they were g of GTP PEPCK.  Reactions were started upon the addition of 
GTP PEPCK.  
3.2.5 Kinetic Data Analysis and Equations
Michaelis-Menten and Arrhenius plots were derived from plots created in SigmaPlot11 
EnzymeKinetics module using equation 3.1 and equation 3.2 respectively. Inflection temperatures of 
each Arrhenius plot for the biphasic changes in Ea were determined based on visual inspection and the 
highest R2 value for the fitted line. 
 
v=
V max ,app [S ]
K m,app+[ S]
              (3.1)
                     
k=A e
−Ea
RT   (3.2)
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3.2.6 Crystallization
PolarPEPCK cocrystals with GTP and oxalate were grown at 20mg/mL through vapour diffusion at 
4°C in drops supplemented with 2mM oxalate and 2mM GTP.  The mother liquor condition was 
100mM TRIS-Cl at pH 8.0, 0.8M LiCl2 and 30-40% PEG 8000.  Drops were set up in 2:4, 3:3, 4:2 μL ratios of protein:mother liquor. After drops were set they were L 
ratios of protein:mother liquor. Crystals were harvested, and soaked for 1 hour in 100mM TRIS-Cl at 
pH 8.0, 0.8M LiCl2 and 38% PEG 8000, 10% PEG 400, and 1mM of both oxalate and GTP. Crystals 
were cryocooled by direct immersion into liquid nitrogen. 
Data was collected at the Canadian Light Source in Saskatoon, Saskatchewan on the 08B1-1 beamline 
using a Rayonix MX300HE detector.  Data was indexed and scaled in HKL-200079 and the final 
statistics data are presented in Table 3.1.  
Three additional structures were collected under the same conditions but with 100μL ratios of protein:mother liquor. After drops were set they were M MnCl2  either co-
crystallized or soaked during the cryoprotection. In the first structure MnCl2 (1mM) was soaked into the
crystal, forming Mn2+(M1)-GDP-oxalate polarPEPECK.  The second structure was co-crystallized with
MnCl2, (100μL ratios of protein:mother liquor. After drops were set they were M) forming Mn2+(M1)-GTP-oxalate polarPEPCK.  The third and final structure was a co-
crystal with Mn2+ (1mM) and Mg2+ (5mM) forming Mn2+ (M1) – Mg2+ (M2) – GTP-oxalate 
polarPEPCK.  This data was collected on the University of Waterloo’s home source rotating copper 
anode diffractometer with a Raxis IV++ image plate detector. Data were indexed and scaled in HKL-
200079 and the final statistics are presented in Table 3.1.
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3.2.7 Structure Determination
The highest resolution data set collected from the synchrotron was solved by merging two datasets of 
the same crystal, with the first dataset being a short exposure low-resolution pass and the second a 
longer exposed higher-resolution pass.  This first structure, GDP-oxalate polarPEPCK, was solved 
through molecular replacement using the previously solved mtbPEPCK (PDB# 4R4333) and 
MOLREP80 in the CCP4 package.81  Iterative rounds real-space refinements and additions of water 
molecules and heteroatoms were carried out in COOT82, followed by refinement using REFMAC5.83 
Final validation was carried out using MolProbity, http://molprobity.biochem.duke.edu/index.php, and 
final model statistics are presented in Table 3.1.84
The additional metal-bound structures were solved solved in an identical fashion to that outlined above 
expected the initial GDP-oxalate polarPEPCK structure was used as the starting model for the 
molecular replacement in MOLREP.80,81 Final model statistics are present in Table 3.1.
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Table 3.1: Crystallographic data table for the three polarPEPCK structures.
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GDP-LoopOxalate polarPEPCK
Wavelength (Å) 1 1.54
Resolution range (Å) 56.6  - 1.41 (1.46  - 1.41) 32.7  - 2.14 (2.22  - 2.14)
Space group P 21 21 21 P 21 21 21
Unit cell (Å) 68.121 85.988 113.232 90 90 90 68.318 85.914 114.281 90 90 90
Total reflections 8083610 1465173
Unique reflections 127745 (12020) 37233 (3369)
Multiplicity 12.7 (5.0) 11.1 (8.5)
Completeness (%) 99.5 (94.7) 99.1 (91.4)
Mean I/sigma(I) 18.6 (1.58) 11.6 (1.9)
17.5 34.4
R-Loopmerge 0.14 (0.98) 0.20 (1.07)
R-Loopmeas 0.14 (1.08) 0.21 (1.14)
R-Looppim 0.03 (0.46) 0.06 (0.38)
CC1/2  0.91 (0.56) 0.91 (0.63)
Reflections used in refinement 127741 (12020) 37233 (3369)
Reflections used for R-Loopfree 6395 (612) 1842 (158)
R-Loopwork 0.159 (0.266) 0.186 (0.267)
R-Loopfree 0.178 (0.271) 0.245 (0.304)
Number of non-Loophydrogen atom 5522 4953
  macromolecules 4920 4759
  ligands 63 48
  solvent 539 146
Protein residues 614 614
RMS(bonds) 0.015 0.014
RMS(angles) 1.88 1.81
Ramachandran favored (%) 97.9 97.2
Ramachandran allowed (%) 2.12 2.45
Ramachandran outliers (%) 0 0.33
Rotamer outliers (%) 0.39 1.21
Clashscore 2.75 2.54
Average B-Loopfactor 20.7 34.8
  macromolecules 19.7 34.9
  ligands 27.9 35
  solvent 29.1 32.2
Wavelength (Å) 1.54 1.54
Resolution range (Å) 30.9  - 1.79 (1.85  - 1.79) 30.52  - 2.001 (2.072  - 2.001)
Space group P 21 21 21 P 21 21 21
Unit cell (Å) 68.383 85.742 113.686 90 90 90 68.489 85.557 112.857 90 90 90
Total reflections 1707490 1665108
Unique reflections 60604 (4360) 45085 (4145)
Multiplicity 11.5 (5.7) 13.1 (6.7)
Completeness (%) 95.2 (69.4) 99.1 (91.9)
Mean I/sigma(I) 24.1 (2.5) 21.2 (2.2)
26 31.63
R-Loopmerge 0.10 (0.61) 0.12 (0.64)
R-Loopmeas 0.10 (0.68) 0.12 (0.69)
R-Looppim 0.03 (0.27) 0.03 (0.24)
CC1/2 0.96 (0.80) 0.96 (0.82)
Reflections used in refinement 60603 (4360) 45085 (4145)
Reflections used for R-Loopfree 3037 (227) 2277 (219)
R-Loopwork 0.168 (0.292) 0.1740 (0.2648)
R-Loopfree 0.198 (0.335) 0.2120 (0.3076)
Number of non-Loophydrogen atom 5179 5167
  macromolecules 4794 4746
  ligands 62 66
  solvent 323 355
Protein residues 614 614
RMS(bonds) 0.015 0.015
RMS(angles) 1.87 1.9
Ramachandran favored (%) 98.2 97.4
Ramachandran allowed (%) 1.8 2.6
Ramachandran outliers (%) 0 0
Rotamer outliers (%) 1 2
Clashscore 1.68 4.8
Average B-Loopfactor 26.5 32.8
  macromolecules 26.2 32.2
  ligands 32.1 36.6
  solvent 30.2 40.1
Mn2+-LoopGDP-LoopOxalate polarPEPCK
Wilson B-Loopfactor (Å2)




As it is well established that thermophiles are more resistant to chemical denaturants and heat, 
inactivation time-courses were completed for the three isozymes (Figure 3.1).104  For the polar- and 
rcPEPCK, they were completely inactive when incubated for 10 minutes at 55°C.  ClostPEPCK 
however was most resistant at this temperature and retained partial activity until 50 minutes.  
Surprisingly, clostPEPCK was most sensitive to moderate (37°C) and cold temperatures (4°C).  The 
observation of cold denaturation was not surprising but the moderate temperatures was not expected.   
Hungateiclostridium thermocellum besides being a thermophile, is also anaerobic, and the inactivation 
may be due to an oxidation event.  PolarPEPCK is more resistant to inactivation than its mesophilic 
counterpart at modest temperatures, which is interesting but very challenging to determine a causal 
mechanism.  Fortunately, the enzymes are stable and were stored at 4°C during the other kinetic 
experiments making the collections accurate and reproducible. 
Figure 3.1: Inactivation of thermally adapted PEPCK. This figure shows a time course for A) 
polarPEPCK, B)rcPEPCK, and C)clostPEPCK inactivation when incubated at 55°C (closed triangles), 
37°C (open circles), and 4°C (closed circles). 
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3.3.2 Arrhenius plots - Overview
To further understand the functional properties of the three thermal isozymes, Arrhenius plots were 
completed for each the PEP carboxylation and OAA decarboxylation reaction directions (Figure 3.2, 
Table 3.2).  Unfortunately, a relatively narrow temperature window (~5-40°C) was obtained for the 
OAA carboxylation reaction as at high temperature the spontaneous decarboxylation of OAA to 
pyruvate began to outcompete the enzymatic rates for conversion of OAA to PEP.  Viscogens were also
added to the reaction mixtures at constant centipoise values to determine if the kcat measured was being 
controlled by diffusive events. RcPEPCK, in the PEP carboxylating reaction direction, with viscogen at
high temperatures has a very low R2 value (0.28) due to a low number of data points used but 
ultimately the fit best described the data.  PolarPEPCK after 40°C began to become less-active, but was
not observed to undergo complete inactivation (Figure 3.2).  During the inactivation time-course, 
polarPEPCK was stable at 37°C and during collection at these temperatures above 40°C, the rate is 
stable.  Because of the thermal degradation of the coupling enzyme malate dehydrogenase, the 
suspected temperatures necessary to inactive the meso- and thermophilic enzymes was unable to be 
experimentally achieved.  
3.3.3 Arrhenius plots - PEP carboxylation reaction at low temperature
Arrhenius plots can be used to understand the activation energy for the rate-determining step 
controlling kcat (that is, after or including the committed step).  Typically, Arrhenius plots are described 
to be linear, but non-conforming trends have also been seen.105  As shown in the PEP carboxylation 
reaction, polarPEPCK exhibits typical behaviour, with no slope changes across until a maximum 
threshold was reached, whereas the mesophilic and thermophilic enzymes both have slight downward 
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curvature (Figure 3.2).  The observed curvature in Arrhenius plots have been hypothesized to have 
different mechanistic origins,105 but most generally this curvature can be interpreted as either a change 
in the activation energy or the rate limiting step.  More specifically,  a previous event which was rate 
limiting at low temperatures has been replaced by a different event as temperature increases.  
 Based upon the slopes of the plots, the activation energies are 83, 100, 130kJ/mol for the polar-, rc, 
and clostPEPCKs respectively.  Based upon these numbers a trend is observed in which increasing 
thermophilicity is correlated with an increase in the observed energy required to achieve the transition 
state.    When comparing the derived pre-exponential factors across the low temperature regime of the 
three tested enzymes, the same trend of increasing A with thermophilicity is also observed.  
Accordingly, when comparing the low temperature Ea or pre-exponential factor for the PEP 
carboxylation for all enzymes, viscogen has no effect (Table 3.2). 
3.3.4 Arrhenius plots - PEP carboxylation reaction at high temperature
For each of the three enzymes, there is a change in the slope of their Arrhenius plots after a particular 
break-point (Figure 3.2).  For the polarPEPCK, the enzyme transitions to becoming less active, whereas
in the meso- and thermophilic PEPCKs both Ea and A decrease. Although there are not many data 
points for the inactivation stage of polarPEPCK, it does appear that the addition of viscogen to 
polarPEPCKs influences only A and not Ea in contrast to the higher temperature variants, viscogen 
seems to lower both the Ea and A.
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Figure 3.2: Arrhenius plots for the PEP decarboxylation of thermal isozymes of PEPCK.  This figure 
shows the Arrhenius plots for A) polarPEPCK, B)rcPEPCK, and C)clostPEPCK for both the reaction 
without viscogen (open circles) and with viscogen (closed circles). In panels B and C, the circle and 
square represents the inflection point for the two measured slopes in table 3.2 for the plot without 
viscogen and with viscogen respectively.  
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3.3.5 Arrhenius plots - OAA decarboxylation reaction
Over the temperature range measured, the decarboxylation rates for the three enzymes were linear 
(Figure 3.3).  The Ea for all three enzymes are lower than the PEP carboxylation reaction, suggesting 
that the OAA decarboxylation reaction is more favourable with than the reverse reaction, and may be 
measuring a different process.  This is in line with the enzymes in vivo preferences that have been 
described.43 Through inspection of the raw data, viscogen addition has no change on either rc- or 
clostPEPCK (Figure 3.3).  However the fit data shows that upon calculating the Arrhenius parameters 
there are differences (Table 3.2) however it is likely that these differences are attributed to errors within
the associated measurements rather than mechanistic differences.  PolarPEPCK on the other hand does 
appear to maintain the Ea but raise A with addition of viscogen.  
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Figure 3.3: Arrhenius plots for the OAA decarboxylation of three thermal isozymes of PEPCK.  This 
figure shows the Arrhenius plots for A) polarPEPCK, B)rcPEPCK, and C)clostPEPCK for both the 
reaction without viscogen (closed circles) and with viscogen (open circles). 
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polarPEPCK + Viscogen 0.95
rcPEPCK (low temperature) 0.99
rcPEPCK (high temperature) 0.95
rcPEPCK + Viscogen (low temperature) 0.98
rcPEPCK + Viscogen (low temperature) 0.28
clostPEPCK (low temperature) 0.99
clostPEPCK (high temperature) 0.99
clostPEPCK + Viscogen (low temperature) 0.99
clostPEPCK + Viscogen (low temperature) 0.97
polarPEPCK 0.96
polarPEPCK + Viscogen 0.95
rcPEPCK 0.96
rcPEPCK + Viscogen 0.93
clostPEPCK 0.89
clostPEPCK + Viscogen 0.96
PEP + CO
2
 + GDP → OAA + GTP E
a 
(kJ/Mol) A (s-1) R2
-10 000 ± 840 83 ± 7 37 ± 2.8
-9400 ± 420 78 ± 3.5 34 ± 1.4
-12 000 ± 440 100 ± 3.7 44 ± 1.5
-5700 ± 500 47 ± 4.2 23 ± 1.5
-11 000 ± 570 92 ± 4.7 40 ± 1.9
-1789 ± 1477 15 ± 12 11 ± 4.5
-16 000 ± 410 130 ± 3.4 56 ± 1.4
-9800 ± 440 82 ± 3.7 36 ± 1.4
-18 000 ± 1200 150 ± 10 63 ± 4.2
-5100 ± 350 42 ± 3 20 ± 1.1
OAA + GTP →  PEP + CO
2
 + GDP 
-7100 ± 510 59 ± 4.2 26 ± 1.7
-11 000 ± 1000 91 ± 8.3 39 ± 3.5
-8600 ± 360 71 ± 3 31 ± 1.2
-11 000 ± 1300 88 ± 11 38 ± 4.5
-8000 ± 1200 66 ± 10 29 ± 4.2
-12000 ± 1200 98 ± 10 42 ± 3.9
3.3.6 Michaelis-Menten Parameters of Thermal Isozymes
The Arrhenius plots were generated using saturating substrate concentrations, thus removing 
information about the any event prior to the first irreversible step.  The kcat/Km ratio, otherwise known 
as the catalytic efficiency, can give information about the steps leading up to and including the 
irreversible step.  Below the break-point the kcat/Km ratio is the same for each rc- and clostPEPCK at the
two temperatures obtained (Table 3.3).  However, above this breakpoint, the kcat/Km ratio increases, 
suggesting that the steps leading up to the irreversible step are becoming more favourable.   In contrast,
in polarPEPCK at elevated temperatures in which is observed to reversibly inactivating the kcat/Km 
decreases (Table 3.3).  
Table 3.3: Michaelis-Menten parameters for thermal isozymes of PEPCK at different temperatures.
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m






810 ± 87 5.8 ± 0.19 7.2 x 103
120 ± 8.7 6.0 ± 0.01 5.0 x 104
130 ± 14 1.9 ± 0.01 1.5 x 104
2500 ± 650 23 ± 1.4 9.2 x 103
200 ± 23 13 ± 0.34 6.5 x 104
540 ± 60 1.7 x 104
3400 ± 290 92 ± 3.2 2.7 x 104
330 ± 34 71 ± 1.7 2.2 x 105
510 ± 37 46 ± 1.1 9.0 x 104
5900 ± 1000 47 ± 3.0 8.0 x 103
830 ± 110 230 ± 7.1 2.8 x 105
870 ± 70 200 ± 4.3 2.3 x 105
3.3.7 Substrate Binding of Polaromonas naphthalenivorans PEPCK
To further understand the molecular details of the catalytic mechanism, structural studies were 
completed on the psychro- and thermophilic enzymes.  ClostPEPCK was not amenable to 
crystallization under conditions that were explored.  PolarPEPCK however, was successfully 
crystallized and four structures were solved of the closed state with oxalate, GDP/GTP, and/or the M1 
and M2 metals.  The series of structures was stimulated as it was observed in the first structure solved 
of polarPEPCK, that there was an unexpected binding conformation of oxalate, and GDP was present 
instead of the co-crystallized GTP (Figure 3.4A).  As shown, oxalate is found in an staggered 
conformation, no metals (M1 nor M2) are present, and GDP is bound.  In the second structure 
determined, Mn2+ was soaked in to the identically prepared crystals after crystallization (Figure 3.4B).  
This metal could diffuse into the closed active site, and did bind the M1 metal stabilizing the 
coordinated form of oxalate as seen previously.62   In these crystals, GDP was found to be the 
nucleotide present in the active site.  In an attempt to obtain the final Mn2+-Mn2+-oxalate-GTP complex,
low concentrations of Mn2+ were co-crystallized and soaked.    This co-crystal structure did have Mn2+ 
in the M1 position, accompanied with oxalate and now GTP.  Surprisingly, the M2 metal is still not 
observed to be bound in concert with the GTP nucleotide.  A final structure where high concentrations 
of Mn2+ and Mg2+ were cocrystallized alongside GTP and oxalate yielded the expected fully occupied 
active site as previously shown.62
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Figure 3.4: Ligand states for polarPEPCK structures.  This figure shows the various ligands found in 
the structures solved of polarPEPCK.  Panel A represents the structure without Mn2+ cocrystallized or 
soaked.  This structure had oxalate in a staggered conformation with GDP.  Panel B represents the 
structure where Mn2+ is soaked into the crystal.  This structure has Mn2+ at the M1 site with oxalate 
complexing with the metal, and GDP.  Panel C represents the structure where Mn2+ was cocrystallized.  
This structure has Mn2+ at the M1 site, oxalate coordinating with the metal, and GTP.  Panel D 
represents the structure where both Mg2+ and Mn2+ were cocrystallized with GTP and oxalate.  This 
structure shows the fully occupied active site with Mn2+ at the M1 site, Mg2+ at the M2 site, and oxalate
and GTP bound to these metals.  The experimental 2Fo-Fc electron density maps  (rendered at 1.7σ) for 
ligands, 3.5σ) for metals) are shown in blue mesh.  The density is cropped for clarity. The R-, P-, and Ω-
loop are shown in red, purple and yellow respectively.  The various ligands are coloured by atom type, 




3.3.8 Ω-Loop Closure - Latch Stabilization
The goal of crystallizing the closed conformation of polarPEPCK was to determine how a 
psychrophilic PEPCK has adapted to change the mechanism of closure to its low-temperature 
environment.  To examine this process, two areas of the lid were focused upon based upon prior work 
on rcPEPCK (Figure 3.5).  First, the latch, accounting for the loop itself which is shown to be important
in maintaining a closed state (Figure 3.5A).  The second region important for the operation of the lid is 
the hinge region, which has been shown to undergo conformational changes to fold the lid over the 
active site (Figure 3.5B). 
Figure 3.5: Two Ω-loop closure sites.  The overall structure is rcPEPCK bound with Mn2+(M1)-Mn2+
(M2)-oxalate-GTP (PDB ID# 3DT2).  Panel A represents the area of oxalate binding, and the latch 
region of the  Ω-loop that is responsible for closure.  Panel B represents the hinge region of the Ω-loop 
which is necessary for closure.  The R-, P-, and Ω-loop are coloured in red, purple and yellow 
respectively. 
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All four polarPEPCK structures were essentially identical besides with the expection of the ligands 
found in the active site.  It is unsurprisingly that even in cases were the metals are absent and oxalate is 
in the staggered conformation the enzyme is closed.  For the lid to close, both the R- and P-loop must 
be ordered (upon ligand association) to remove steric hindrances of the lid.  As seen from these 
observed structures, the metal binding appears to no influence on these active site loop transitions as 
long as the substrate requirements are filled.  Because of this, the two structures used for this 
comparison between the psychro- and mesophilic PEPCKs are the cocrystallized polarPEPCK 
structure, with M1-oxalate-GTP bound, and rcPECK M1-M2-oxalate-GTP bound (PDB ID# 3DT2)
(Figure 3.6).  Both the residues responsible for substrate (oxalate) recognition (Figure 3.5A and B) and 
the stabilizing forces required for latch closure are examined (Figure 3.6C and D).  Unsurprisingly, it is 
observed that the substrate recognition is the same between the two isozymes. Upon binding of oxalate 
and GTP, both the R- and P-loop move towards in active site.  Nε of R87 guanadine of the R-loop 
forms a salt-bridge with the carboxylic acid of oxalate.  The P-loop upon rearrangement, brings the 
hydroxyl of S286 into proximity to form a H-bond with this carboxylate moiety. Together these 
movements allow the R-loop to effectively pair with the Ω-loop upon closure. 
There appears to be more extensive contact between the latch and the adjacent R-loop in the mesophilic
enzyme (Figure 3.5C and D).  First, H470 has forms a salt-bridge with  E89 as E469 exhibits two 
hydrogen bonds with the backbone amide of E89 and the hydroxyl of S90.  Furthermore, two backbone
H bonds, between the R87 carbonyl and the amide of E468, and between the A467 carbonyl and the 
amide of R87s are the final stabilizing forces.  In total, this amounts to 5 interactions stabilizing the 
latch of the lid closed.  In comparison, the psychrophilic lid has 3 stabilizing contributions.  The first is 
at the latch of lid between the backbone T466 amide and the carbonyl of R84.  The second, is actually 
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two hydrogen bonds shared between R473 from the hinge region of the lid coordinating with the both  
oxygens of the carboxylate of E86.  
Figure 3.6: Latch region of Ω-loop in closed rc- and polarPEPCK. Panel A shows holo-rcPEPCK 
(PDB#2QEW) in brown and closed-rcPEPCK (PDB#3DT2) in grey while showing the interactions 
responsible for substrate (oxalate) recognition.  Panel B shows the closed-polarPEPCK (Mn2+-oxalate-
GTP) in ice blue showing the interactions responsible for substrate (oxalate) recognition.  Panel C 
shows the interactions necessary for maintaining lid closure in the closed-rcPEPCK state. Panel D 
shows the interactions necessary for maintaining lid closure in the closed-polarPEPCK state.  The R-, 
P-, and Ω-loop are coloured in red, purple and yellow respectively.  Atoms are coloured by type with 













3.3.9 Ω-Loop Closure - Asymmetric Hinge Closure
The hinge region was previously identified as being an important dynamic element in the closure of the
Ω-loop (Figure 3.7).37  A comparison between rcPEPCK open and closed state transition (Figure 3.7A 
and B) and the psychrophilic closed state (Figure 3.7C) is shown.  Unfortunately, this crystal forms 
does not allow for structural determination of holo polarPEPCK, so only one end point is known.  
When comparing the rcPEPCK open and closed state, it can be seen that the N-terminal βSP sheet hinge 
region is unchanging.  The N-terminal hinge is fixed by one H-bonds between R461 and the adjacent 
E588 with an additional stabilizing force from the non-hinge R437 to hold E588 in place.  The C-
terminal hinge is the variable region, where H477 electrostatically interacts with E591.  E591 rotates to 
an “in” position, closing this interaction distance.    In the closed polarPEPCK structure there are no 
interactions from the N-terminal region, although the non hinge hydrogen bond between the conserved 
R434 and E590 is retained.  The C-terminal hinge region has the only contact between the hinge and 
surrounding structure, between R474 and the aforementioned E590.
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Figure 3.7: Hinge region of Ω-loop in closed rc- and polarPEPCK. Panel A shows holo-rcPEPCK 
(PDB ID# 2QEW) hinge region unanchored.  Panel B shows the closed-rcPEPCK (PDB ID# 3DT2) in 
grey showing the interactions responsible for hinge anchoring necessary for closure.  Panel C shows the
closed polarPEPCK interactions responsible for hinge anchoring necessary for closure.  The R-, P-, and
Ω-loop are coloured in red, purple and yellow respectively.   Atoms are coloured by type with carbon in














Before interpreting the results, a generalized discussion on the mechanistic meaning of the Michaelis-
Menten, Arrhenius parameters, and viscogen effects may be beneficial.   These parameters will be 
discussed in the context of the catalytic cycle of PEPCK.  PEPCK catalysis can be summarized into a 
few elementary steps.  First, the lid must be open to allow substrate to bind.  Second, the lid must close.
Third, the first chemical step (OAA decarboxylation) and the formation of the enolate, representing the 
first irreversible step, must occur.   Together it is postulated that these three steps contribute to the 
observed kcat/Km.  Fourth, the second chemical step occurs (enolate phosphorylation).   Finally, the lid 
must reopen for product release.  Steps 3 and onwards, would contribute the kcat,  but the observed rate 
constant would be dominated by the slowest, or rate determining step.  Arrhenius parameters 
interpretations are not as clear cut, as they were formulated for non-enzymatic chemical reactions.  Ea, 
the activation energy is approximately the enthalpy of activation (ΔHH‡) while the second and final 
kinetic parameter discussed with the pre-exponential factor, A, can be thought to as a proxy for 
activation entropy (ΔHS‡).  This value is an extrapolation of the systems behaviour at infinite T, thus 
acting as a barrier(Ea)-less reaction or that the energetic cost is so much smaller than the energy 
available.  This removes the contribution of the enthalpy of activation from the total free-energy cost, 
leaving only entropic barriers. Viscogens effectively increase the solvent friction, which will impact 
any diffusive properties through solvent.  These diffusive properties include conformational dynamics 
with α-fluctuations (motions coupled to bulk solvent) being more affected than βSP-fluctuations 
(hydration shell).  α-fluctuations will control large conformational changes such a domain motions and 
surface loop motions, while βSP-fluctuations control internal dynamics such as rotamer motions.106 
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3.4.1 Mechanistic Interpretation of Kinetic Adaptations of PEPCKs
In the PEP carboxylation reaction at low temperature, increasing thermophilicity leads to an increase in
Ea (ΔHH‡) which is in agreement with the literature (reviewed in 99).   Thermolabile enzymes achieve 
higher turnover rates at lower temperatures by lowering the enthalpy of activation concomitantly with 
their apparent increase in flexibility. The number of interactions that must be broken and formed, and 
the resultant free-energy difference, is lower for a more flexible enzyme as there are less interactions 
stabilizing its conformation than a thermostable, rigid enzyme.  To maintain structural integrity at high 
temperatures more intermolecular interactions must hold the tertiary structure of the enzyme.  This rate 
constant is also unaffected by viscogen, suggesting that conformational changes are not the primary 
driving force in determination of the rate.  Previous work has suggested that for rcPEPCK, the rate 
determining step is the phosphoryl transfer in both chemical reaction directions, which would be less 
effected by increase in solvent friction.38  At high temperatures, the slope has changed.  For 
polarPEPCK, the enzyme begins to lose activity with increasing temperature.  The shape of the 
Arrhenius plot is reminiscent of the aforementioned equilibrium model, as the enzyme is reversibly 
inactivated.  During the time-course of the experiments at these high temperatures, the rates were not 
fluctuating suggesting that the enzyme was not becoming thermally denatured with time.  Due to 
experimental constraints with the mesophilic and thermophilic variants, higher temperatures were not 
achieved to determine if they under a similar inactivation.   Furthermore, with the few data points 
present beyond the maximal activation for polarPEPCK, it does appear that viscogen presence does 
further reduce activity, through the pre-exponential factor.  This suggests that the inactivation of the 
enzyme is through disrupting entropy driven conformational changes associated with turnover, such as 
the balancing between closure of the Ω-loop with turnover.  The rc- and clostPEPCK suffer similar 
reaction changes with increasing temperature, where after the inflection temperature the slopes 
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decreases leading to both a lowering of Ea and A.  The new friction-dependency suggests that in fact the
rate determining step has changed from the aforementioned phosphorylation to a conformational one.  
It is likely that the lid dynamics have been perturbed.  The viscogen data suggests that at high 
temperature the lid opening step reduces Ea (favourable reduction in enthalpy of activation) and A 
(disfavourable reduction of enthalpy of activation) thermodynamic parameters.  This suggests that at 
high temperatures the barriers to disrupt bonds to reopen is more favourable (enthalpy based) and 
entropy now dictates turnover.  With entropy driving the flux, at high temperatures the lid is most likely
to remain open.  What may be occurring is that at very high temperatures, the “irreversible” step is not 
chemical now as the propensity for this to occur is  high, but rather the lid ordering is now vastly less 
likely to occur.  Essentially, upon lid closure, the phosphorylation will always occur as the thermal 
energy present creates a “barrierless” reaction. 
 The Michaelis-Menten parameters derived with varying temperature (Table 3.3) were compiled to see 
the change in the catalytic efficiency (kcat/Km) with temperature.  After the inflection point, 
polarPEPCK catalytic efficiency decreased.   At these high temperatures, the lid will be most 
favourably disordered.  In line with the lower kcat/Km, representing binding steps before the first 
chemical one, the inactivation may be due to an inability for the lid to order itself closed long enough 
for the phosphorylation step to occur.   In this, the enzyme will release bound substrates before 
commitment through its catalytic cycle leading to the observed reduction in kcat/Km.  This behaviour has
been seen in another Ω-loop hinge mutant, H477R.  Although the origin of the inability for the lid to 
order is different, a similar outcome was achieved where it was proposed that the enzyme capture of the
substrate (and closure) was slower than the release of OAA.  This manifested as many futile encounters
occurring before successful transition through the reaction coordinate.37   For the higher temperature 
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variants, after the break-point catalytic efficiency improves.  This improved catalytic efficiency is 
counter to the Arrhenius data suggesting at high temperatures lid ordering is the rate-determining step, 
as one would suspect that as in the case of polarPEPCK substrate would diffuse out of the active site.  
It may be that the higher temperature variants remained bound as they await lid closure, as opposed to 
the polarPEPCK where they may diffuse out.  There is still some discussion as to the effect of 
thermophilicity on substrate binding, where some often thought because psychrophilic enzymes 
typically have a higher Km at a given temperature they are unable to bind their substrates as tightly.107,108
This is inaccurate in the sense that the catalytic efficiency, and not the Km, is more indicative of the 
binding steps.  It was proposed that as temperature increases for a psychrophile, the active site binding 
loops are more flexible and thus cannot bind the substrate.  Later, it was computationally shown that 
the active site flexibility is nearly identical across the thermally adapted enzymes, and perhaps the 
global flexibility may be dictating changes in binding efficiency.109110  It may be that polarPEPCK 
reduction in catalytic efficiancy is not due to the active site loops flexibility, in line with the 
conservation of the R- and P- loops and oxalate-GTP structures presented here, but is rather a 
decoupling of the global dynamics and ligand binding.  Under this model, the higher temperature 
variants would better be adapted to maintain their global dynamics under the temperatures tested and 
would not suffer from a decrease in catalytic efficiency. 
In the OAA decarboxylation reaction, the narrow temperature range does not allow a comparison 
between low and high temperatures.  For the meso- and thermophilic PEPCKs, viscogen had no 
apparent effect on the Arrhenius plots.  This suggests, as previously stated, the phosphorylation steps 
are rate limitings for those two variants.38  PolarPEPCK however, does appear to be influenced by the 
presence of viscogen, leading to an increase in Ea as well as A.  This suggests that viscogen presences 
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helps facilitate turnover through entropic means. This would suggest that the polarPEPCK enzyme kcat 
is at least partially controlled by lid reopening in contrast to its counterparts studied here.  What may be
occurring, but is highly speculative, is that under viscogen presence, the non-productive lid-reopening 
step has been slowed which allows a higher proportion of chemical steps to be completed creating a 
more efficient enzyme.  
3.4.2 Mechanistic Interpretation of Structural Adaptations of PEPCKs
Without the open polarPEPCK structure the mechanistic interpretation of the transition of this lid from 
open to closed state is speculative, although the data does suggest that there may be a conserved 
mechanism of closure between the psychro- and mesophilic PEPCKs studied.  To begin, the ligation 
state of the three structures lacking one or both metals were unsurprising.   RcPEPCK is co-crystallized
with Mn2+ as it induces nucleation of the crystals, so all structures solved of this isozyme has a metal 
bound to the M1 and M2 site (if nucleotide is present).  Of the other PEPCKs solved, 3 structures, 2 
from Mycobacterium tuberculosis and one from Thermus thermophilus, are missing metals when bound
with either nucleotides or a ligand occupying the OAA/PEP site (PDB ID# 4WPU, 4RCG, 2PC9). 
What this suggests is that the substrates of PEPCK can bind without metals, but from kinetic 
experiments the enzyme cannot turn over without these metal requirements (experiments not shown).   
Most interestingly, the fact that Thermus thermophilus PEPCK doesn’t bind the M2 metal when GTP is
bound suggests that this is not a temperature adaptation, but rather an issue of metals availability.  
Based on the polarPEPCK structures, there does appear to be cooperativity between the M1 metal 
presence selecting for which nucleotide will bind.  When no metals are present through the experiment,
74
GDP binds preferentially.  When the M1 metal is soaked in after the fact, GDP is still bound, 
suggesting that GDP will bind prior to the metal presence and cannot be freely exchanged.  This is 
unsurprisingly as the structure is closed and the lid is closed, making it likely very hard to completely 
reopen for the bulkier substrate release.  Back soak experiments, where the crystals were left in ligand 
free cryoprotectant for ~24 hours, did not allow the structure to relax and oxalate, and GDP were still 
observed to be found in the active site.  Alternatively, when the metal is co-crystallized, GTP is selected
for.  This is the first evidence that the M1 metal is playing a role is nucleotide binding.  A proposed 
mechanism for M1 selectivity of the nucleotide species is likely based on the M1 cationic charge 
stabilizing the γ-phosphate of GTP, whereas in GDP this large anionic charge is too far away for the 
M1 to stabilize it. 
The maintenance of the closed lid of PEPCK is important for the efficient turnover of the enzyme.  To 
maintain this closure, PEPCKs employ two areas of the lid, denoted the latch and hinge.  The latch, 
which consists of the main loop, interacts with the R-loop.  As shown, the mesophilic enzyme utilized 
more interactions (5 vs 3) than its psychrophilic counterpart.  Of these interactions, there is one 
conserved backbone-backbone hydrogen bond.  The other stabilizing contribution of the psychrophile 
is actually not from the latch region to R-loop, but rather is an arginine from the hinge, that extends 
across away from the hinge and towards to the R-loop.  One could hypothesize that this interaction 
would be significantly controlled through entropic means.  Arginine side-chains are highly entropic as 
they have many freely rotatable bonds.  The probability of this arginine to be in this extended 
conformation is likely quite low, meaning that for this interaction to be sustained the side chain must 
adopt a lowly populated conformer.  
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The second structural feature of the lid that is required for the folding of the lid over the active site is 
the hinge region which consists of the entry/exit N- and C-terminal βSP sheets of the Ω-loop and the 
adjacent α helix. The rcPEPCK isozyme has been extensively studied to determine how this hinge 
changes during closure.37  In brief, this hinge is asymmetrically anchored through the N-terminus, as 
shown by the unchanging electrostatic interactions between open and closed states.  In contrast, the C-
terminal hinge is changing upon closure, where a new salt bridge is formed.  This asymmetry appears 
to be conserved in the psychrophilic enzyme, where the lack of N-terminal interactions suggests that in 
the open state, there would still be an absence of stabilizing forces.  The only interaction holding the 
hinge in this closed conformation occurs from the C-terminus, by one electrostatic interaction.  The 
sheer number of interactions maintaining the closed state that simply speaking, higher temperatures 
require the enzyme to employ more stabilizing forces to keep it closed.  This pertains to both the hinge,
as well as the latch regions.  To offset the influence of temperature driving unfavourable entropically 
driven disorder, more enthalpic forces must be used to lower the free-energy of the conformational 
state. Although there are no thermophilic PEPCK structures of the GTP-dependent isoform, an ATP 
utilizing PEPCK from Thermus thermophilus has been deposited in the PDB as part of the RIKEN 
Structural Genomics/Proteomics Initiative (RSGI). This structure (PDB ID# 2PC9) has ATP bound, but 
is in an open state. Due to the lid being open, the latch interactions cannot be discerned but some 
information on hinge dynamics can be interpolated.  The hinge region of the Thermus thermophilus 
PEPCK is predominately composed of hydrophobic and π-interactions as opposed to the general H-
bonding and electrostatic stabilizing from the lower temperature variants (Figure 3.8).    Any 
suggestion as to how this hinge operates would be mostly speculative beyond this high level 
observation but is consistent in adaptation in this dynamic elements with the above analysis. 
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Figure 3.8: Hinge region of Ω-loop in open Thermus thermophilus PEPCK (PDB#2PC9). A shown, the
hinge region is predominately hydrophobic and π-interactions.  1 Hydrogen-bond is shown with the 
black dotted line.   The R-, P-, and Ω-loop are coloured in red, purple and yellow respectively.   Atoms 
are coloured by type with carbon in green, oxygen in red, nitrogen in blue, phosphorous in purple, 
manganese in grey. 
Hydrophobic bonds are shown to increase in strength as temperature coincidentally increases.111  The 
proposed mechanism of action is that at higher temperatures, water is driven away from enthalpic H-
bonds and entropy dominates.  In this setting, water is effectively removed from water H-bond 
networks and into bulk solvent, thus strengthening the hydrophobic interactions.  As water network are 
driven towards bulk solvent, this would also reduce hydrophilic interactions such as the obvious H-
bonds, as well as ionic interactions.  As Thermus thermophilus (Topt~68°C) and other thermophilic 
organisms must live under these failing water networks, they may employ more hydrophobic 
interactions in order to dynamically transition through their reaction coordinate.  This may explain the 
hydrophobic nature of the hinge region of Thermus thermophilus PEPCK, and the obvious bias of 
electrostatic and H-bond interactions used by the lower temperature isozymes described. 
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3.5 Summary of Results
This account is a detailed approach to understanding the thermal adaptation of enzymes in the context 
of a dynamic, mechanistic understanding, rather than the typical thermostability experiments. It appears
that the general design principles in creating thermozymes are fairly well established, but the specific 
changes are, like much of protein biochemistry, not well understood.   With further experimentation and
validation, PEPCK could be included in the few enzymes that are well studied for their thermal 
adaptations (see 112 for review of thermal adaptation study model enzymes). 
These new results show PEPCKs lowering Ea, while increasing A with increasing thermophilicity, 
suggesting that thermophiles lower the entropic barriers whereas psychrophiles lower the enthalpic 
ones.   PEPCKs also show a non-linear Arrhenius plot for the PEP carboxylation reaction, where at low
temperatures chemical steps are rate limiting, changing at high temperature to lid-closure.  
PolarPEPCK specifically undergoes a reversible inactivation with increasing temperatures, while 
suffering a decrease in catalytic efficiency may be due to an increase in global dynamic fluctuations 
preventing the ligand bound state.  In contrast, the meso- and thermophilic enzymes have an increased 
in catalytic efficiency where their rigidity may not allow for the aforementioned decoupling at the 
temperatures tested.  In the OAA decarboxylation reaction, for the temperature window measured, the 
rate limiting step seems to be in-line with the previously suggested chemical steps, although 
polarPEPCK appears to be somewhat controlled by dynamic events.  Interestingly, viscogen presences 
helps polarPEPCKs activity, suggesting slowing lid reopening is beneficial.  The likely, but untested, 
conclusion is that upon slowing lid reopening more chemical events can go through to completion. 
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Structural evidence suggests that the dynamic elements (Ω-loop) responsible for catalysis, but not 
substrate binding, are adapted.  The structural evidence shows that the psychrophilic PEPCK has 
lowered the number of enthalpically driven salt/H-bond interactions to maintain the closed state of the 
enzyme, while thermophilic PEPCKs may use hydrophobic interactions for these dynamic switches.  
This is once again, in line with the enthalpy-entropy compensation described above.   
More models are required if we are to understand, and to utilize first principles in creating thermally 
adapted enzymes for whichever application is needed.  Directed evolution seems to be the most 
probable way to adapt a molecular scaffold to a new temperature regime113–115, but this does not answer 
the fundamental mechanistic questions.  Furthermore, the most exciting addition to the investigating of 
thermally adapted enzymes is the understanding that the protein-water interface may be the source of 
adaptation to a temperature regime.110  These advances and using more well characterized model 
enzymes  will allow us to be able to determine what the true characteristics for thermal adaptations are 
as opposed to unique strategies employed by specific enzymes.   These studies must not only probe the 
thermostability and low resolution thermodynamic trends, but also specific changes the mechanisms of 
dynamic changes enzymes must undergo to be proficient. 
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4.0 Biochemical, Structural, and Kinetic Characterization of PPi-Loop
PEPCK from Propionibacterium freudenreichii 
4.1 Introduction
Studying the differences between mutants or isozymes of PEPCK gives a method to understand subtle 
changes in the dynamics and the corresponding free-energy landscape.  The more changes added, one 
could imagine a more drastic adjustment of its landscape. Furthermore, adding additional motifs and 
domains to the PEPCK scaffold may impart new substrate requirements, quaternary state changes, 
allosteric regulation and or other functionalities.  Fortunately, a third PPi  dependent isoform of PEPCK 
is quite divergent from its nucleotide counterparts in both primary sequence and structure, which may 
offer insight into the relationship between these gross changes and function.  This form of PEPCK can 
offer a new system to probe these structural rearrangements on their consequences while maintaining a 
level of control through a similar chemical outcome.  
In the late 1960s and into the early 1970s, PPi PEPCK (then known as phosphoenolpyruvate 
carboxytransphosphorylase) from Propionibacterium freudenreichii (PfPEPCK) was studied  in a series
of papers.  These biochemical investigations began to shed light on many details of this enzymes 
biochemical/physical properties including its metal dependencies, kinetic constants, CO2 utilization, 
and quaternary state changes upon ligand binding.61,116–120  Based on the prior work, the most obvious 
differences between the PPi- and nucleotide dependent PEPCKs were determined to be that PPi 
dependent PEPCK utilizes pyrophosphate as its phosphoryl substrate, it has a bias for the traditionally 
“reverse” PEP to OAA reaction, and molecular weight size difference being almost twice the size of 
nucleotide dependent PEPCKs (~127kDa for PPi-, 70kDa for ATP/GTP-PEPCK). In general, PPi 
dependent PEPCK predominately works through the carboxylation of PEP  to form OAA, while also 
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having the ability to perform a pyruvate kinase like activity reminiscent of the side-reaction of the 
nucleotide dependent PEPCKs described above.118 These studies also suggested that like the nucleotide-
dependent enzymes, PPi PEPCK required divalent metal cations for its chemical reaction, with Co2+ 
observed to be the most activating species.121,122   In the 1968 paper investigating if CO2 or bicarbonate 
was being used as the substrate for carboxylation of PEP it was shown through both radiochemical and 
spectrophotometric approaches that CO2 was the most likely substrate.116  The initial characterization of 
PPi PEPCK evaluated quaternary structure changes and its downstream regulation of the enzymes 
activity.  Although quaternary state changes have not been found within GTP dependent PEPCKs and 
all enzymes characterized to date have been shown to be monomers, ATP dependent PEPCKs have 
been found to exist as multimers. Trypanosoma bruci and Trypanosoma cruzi PEPCK both have been 
shown to form dimers,34,119   while even higher order structures have been reported, with 
Saccharomyces cerevisiae PEPCK forming tetramers and Urochloa panicoides forming hexamers.124,125 
The 1970 investigations showed that OAA, malate, and fumarate, all substrates of the TCA cycle 
downstream of where PEPCK would operate in the PEP to OAA direction, induce dimerization and 
subsequent inactivation of the enzyme.120  This indicates a product inhibition mechanism operating to 
regulate PPi dependent PEPCK  activity.  In addition to this inactivating dimer, a tetramer was also 
described, although active and short-lived it would dissociate into active dimers, however no 
mechanism for tetrameter formation was deduced.  Based on these prior studies, a general scheme for 
the dynamic quaternary state changes was proposed (Figure 4.1).
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Figure 4.1: Proposed quaternary structure changes for PPi dependent PEPCK. Adapted from O’Brien 
and Wood 1974.120  Squares indicate active forms of the enzyme, while circles indicate inactivated 
forms.  
In 2015, Chiba et al reintroduced  PPi dependent PEPCK to the research community by trying to 
understand the evolutionary link between it and nucleotide dependent PEPCKs.58  With such little 
sequence conservation between PPi dependent PEPCK  and the nucleotide dependent PEPCKs, it was 
concluded that these two classes of enzymes likely arose from divergent sources.  This paper also 
indicated that PPi dependent PEPCK from Entamobae histolytica, forms heterotrimers from 3 different 
isoforms found in this parasite.  Most recently, Chiba et al published the first crystal structure of a PPi 
PEPCK from Actinomyces israelii (AiPEPCK) and re-evaluated their previous conclusions as the active
site architecture and catalytic residues between PPi and nucleotide dependent PEPCKs are widely 
conserved (those responsible for M1 metal, PEP/OAA, and phosphate binding).31   The Chiba study 
divided the AiPEPCK structure into four different lobes and N and C terminal core domains where the 
active site is situated.  It was shown that AiPEPCKs employ a histidine which occludes nucleotides 
from binding to the phosphate binding site. Finally, the observed dimer interface was described.31 
Although this structure was very informative in adding to the understanding PPi PEPCKs, the lack of 
updated biochemical data, specifically for AiPEPCK, leaves many questions open.  With the wealth of 
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biochemical data from our labs studies on the rcPEPCK that was unknown to the 1970 researchers 
studying PPi PEPCKs, this study aims to update the current understanding of this class of enzyme.  In 
this study, I used the originally characterized PPi PEPCK from  Propionibacterium freudenreichii 
(PfPEPCK) and completed a comprehensive investigation of this enzyme’s structural and functional 
properties.  All of the new information presented below, coupled with our current knowledge of  
nucleotide dependent PEPCKs, has allowed to discern the few similarities and many differences of this 
enzyme when compared to nucleotide dependent PEPCKs.  Further, this foundation of biochemical 
data for the PPi  PEPCK, will allow future studies to probe interesting questions with regards to the 




The PPi PEPCK (EC. 4.1.1.38) protein sequence from Propionibacterium freudenreichii 
(WP_013160152.1) and Actinomyces israelii (WP_043560275.1) were codon optimized for 
Escherichia coli and synthesized by GenScript (see Section 7.3).  GenScript cloned these gene 
individually into the pESUMO-Star (Kan) vector (LifeSensors) between the Bsa1 and Xho1 sites so 
that the final expressed proteins had the SUMO 6xHIS fusion tag at the N-terminus.  Upon cleavage of 
the fused protein, the resultant proteins have no additional amino acids. 
4.2.2 Expression
The expression and purification for both PfPEPCK and AiPEPCK were identical and are outlined 
below.   Four flasks with 50mL (supplemented with 50ug/mL of kanamycin) of LB media was 
inoculated and grown overnight at 37°C from glycerol stocks of PPi PEPCK (BL21-DE3).  These cells 
were centrifuged for 5 minutes at 5000G and the resultant pellets were resuspended into four flasks 
with 1L of ZYP-5052 media and 50ug/mL of kanamycin.78  These cells were allowed to grow for ~20 
hours at 20°C before they were harvested through centrifugation for 10 minutes at 5000G.  The cell 
pellets were resuspended in prechilled B1 (Table 4.1).
Table 4.1: Buffer composition for protein purification for PPi PEPCKs
84
Buffer 1 (B1) 50mM TRIS-OH (pH 8.0 at RoomTemperature) + 10mM Imidazole + 300mM NaCl + 2mM TCEP
Buffer 2 (B2) 50mM TRIS-OH (pH 8.0 at RoomTemperature) + 300mM Imidazole +  2mM TCEP
Buffer 3 (B3) 50mM TRIS-OH (pH 8.0 at RoomTemperature)  + 2mM TCEP
Buffer 4 (B4) 50mM TRIS-OH (pH 8.0 at RoomTemperature)  + 1M NaCl + 2mM TCEP
4.2.3 Purification
Once the cells were resolubilized in B1, they were passed through a prechilled french press twice at  
1000PSI.  All subsequent steps were completed at 4°C.  The lysed cells were then centrifuged at 
12000G for 30-45 minutes.  The supernatant was incubated with nickel-NTA resin for 1 hour.  This 
resin was then rinsed with B1 until the flow-through reached an A280 below 0.1.  B2 was then passed 
over the resin to elute the bound protein into 10mL fractions.  These fractions were pooled and 
concentrated to approximately 5mL. The protein was then passed down a P6-DG column pre-
equilibrated in B3.  Now buffer exchanged, the protein was left overnight to stir with ~1mg of SUMO 
protease (purified as described in39) to cleave the 6xHIS SUMO fusion domain from the PPi PEPCK.  
This digested protein sample was then incubated with cleaned nickel-NTA resin equilibrated in B3, for 
1 hour.  The resin was washed with B3 where the flow-through containing protein was collected in 
10mL fractions.  This now SUMO fusion free sample of PPi PEPCK was applied to HighQ anion 
exchange resin pre-equilibrated in B3 running on a Bio-Rad fPLC.  A linear gradient was applied 
overnight from B3-B4 where the elution was collected.  Peaks active for PPi PEPCK and clean via 
SDS-PAGE analysis were then pooled and concentrated.  One final buffer exchange with P6-DG resin 
into B3 was completed.  The final purified protein was concentrated to 20mg/mL using E280 1% 
extinction coefficients of 10.9 and 11.4 (as determined with ExPASy ProtParam tool) for Pf- and 
AiPEPCK respectively.  The protein was frozen in 30uL drops by immersion in liquid nitrogen and 
stored at -80°C.
4.2.4 Analytical Size-Exclusion Chromatography
Size-exclusion chromatography was utilized to determine the molecular weights of the ligand induced 
quaternary changes. An ENrich SEC650 10x300 column from Bio-Rad was used.  100μL ratios of protein:mother liquor. After drops were set they were L injections at 
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5mg/mL were run down the pre-equilibrated column at 1mL/min.  The standard buffer was 25mM 
HEPES pH 7.5 and 10mM DTT, with ligands added at varying concentrations to supplement the buffer.
4.2.5 Crystallization
“Dimeric” crystals (furthermore called malate-crystal) were initially grown at 10mg/mL through 
vapour diffusion at 25°C.  The mother liquor condition consisted of 100mM HEPES pH 7.5, 200mM 
MgCl2, 10% ethylene glycol, 7.5% isopropanol, 10-20% PEG 2000.  Drops were set up with 2:4, 3:3, 
4:2 μL ratios of protein:mother liquor. After drops were set they were L ratios of protein:mother liquor with 10mM of malate in each drop.  These initial crystals were 
unsuitable for diffraction and were harvested for seeds by collecting all crystals (with a plate 
morphology) from one drop into a stabilization solution consistent with the mother liquor condition 
with the addition of 10% PEG 400.  A dilution series was created, and 0.5uL of these seeds were added 
to a fresh set of drops 24 hours after equilibration started.  Crystals with a plate morphology grew with 
significant thickness and were harvested back into the stabilizing solution and soaked for 1 hour in the 
presence of 20mM malate and 1mM FeCl3.  Crystals were cryocooled by direct immersion into liquid 
nitrogen. 
“Monomeric” crystals (furthermore called holo-crystal) were grown at 20mg/mL through vapour 
diffusion at 25°C.  The mother liquor condition was 100mM Bis-Tris-Propane pH 8.0, 100mM NaCl, 
100mM sodium formate, and 6-16% PEG 4000.  Drops were set up in 2:4, 3:3, 4:2 μL ratios of protein:mother liquor. After drops were set they were L ratios of 
protein:mother liquor. Crystals were harvested, and soaked for 1 hour in 100mM Bis-Tris-Propane at 
pH 8.0, 100mM NaCl, 100mM sodium formate, 20%PEG 2000, 10% PEG 400, and 1mM FeCl3 
cryoprotectant. Crystals were cryocooled by direct immersion into liquid nitrogen. 
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Data were collected at the Canadian Light Source in Saskatoon, Saskatchewan on the 08B1-1 beamline 
using a Rayonix MX300HE detector.  Data were indexed and scaled in HKL-200079 with final statistics
present in Table 4.2.
4.2.6 Structure Determination
The first structure solved was the higher resolution malate-crystal form through molecular replacement 
with the previously solved AiPEPCK (PDB ID# 6K31).  The model used was pruned in CHAINSAW 
and then used with MOLREP in the CCP4 package.80,81  Iterative rounds of  real-space refinements and 
addition of water molecules and heteroatoms  were carried out in COOT82 and REFMAC5.83 
Automatic local restraints were utilized throughout the refinement process. Final MolProbity statistics 
were collected with the online server at http://molprobity.biochem.duke.edu/index.php.84
The second structure, the ‘holo-crystal’, was solved using molecular replacement with molecule A of 
the malate structure and solved as described above. Final model statistics are present in Table 4.2.
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Resolution range 67.7  - 3.2 (3.31  - 3.2) 74.8  - 2.65 (2.75  - 2.65)
Space group P 21 21 21 P 1
Unit cell 140.466 212.189 253.293 90 90 90 134.131 146.952 151.094 82.702 83.999 70.798
Total reflections 5764402 3620682
Unique reflections 124714 (12315) 304269 (29413)
Multiplicity 13.1 (11.3) 3.8 (3.7)
Completeness (%) 99.6 (99.5) 97.1 (93.8)
Mean I/sigma(I) 16.3 (1.3) 10.4 (2)
Wilson B-Loopfactor 101.89 46.73
R-Loopmerge 0.14 (1.95) 0.118 (0.757)
R-Loopmeas 0.15 (2.04) 0.137 (0.884)
R-Looppim 0.04 (0.86) 0.07 (0.453)
CC1/2 0.91 (0.51) 0.93 (0.72)
Reflections used in refinement 124688 (12315) 304220 (29413)
Reflections used for R-Loopfree 6206 (643) 15255 (1531)
R-Loopwork 0.272 (0.352) 0.217 (0.316)
R-Loopfree 0.29 (0.374) 0.234 (0.354)
Number of non-Loophydrogen atom 34809 72238
  macromolecules 34799 70969
  ligands 4 8
  solvent 6 1261
Protein residues 4391 8948
RMS(bonds) 0.013 0.013
RMS(angles) 1.64 1.66
Ramachandran favored (%) 97.1 97
Ramachandran allowed (%) 2.75 2.87
Ramachandran outliers (%) 0.18 0.17
Rotamer outliers (%) 0.67 1.81
Clashscore 1.71 2.32
Average B-Loopfactor 134 54.9
  macromolecules 134 55.2
  ligands 106 19.4
  solvent 64.4 38.1
4.2.7 Kinetics
To determine each kinetic constant, all other substrates were held constant and the assays were 
completed in duplicate.  All assays were completed at 25°C in pre-equilibrated kinetic assay mixes at a 
final volume of 1mL with the use of a temperature controller.  A CaryUV100 spectrophotometer was 
used to monitor the reduction of NADH to NAD+ in the coupled assays at 340nm. 
 As previously shown, OAA can spontaneous decarboxylate to pyruvate in the presence of metals.103 
To measure this background rate the standard assays were used with the exception that PPi PEPCK was
not present in the assay mix.  All rates have been normalized for this background rate depending on the 
metal mix used unless otherwise specified.    
OAA + PPi → PEP + PO4- + CO2
The standard assay mix for OAA decarboxylation was composed of 100mM HEPES pH 7.5, 10mM 
DTT, 300μL ratios of protein:mother liquor. After drops were set they were M NADH, 250μL ratios of protein:mother liquor. After drops were set they were M PPi, 1mM MgCl2 (4:1 PPi:Metal ratio), 100μL ratios of protein:mother liquor. After drops were set they were M FeCl3 (or other M1 metal 
substitute), 500μL ratios of protein:mother liquor. After drops were set they were M OAA, 1mM ADP, 50μL ratios of protein:mother liquor. After drops were set they were g PK, 5U LDH, and 2.5μg of PPi PEPCK.  Reactions were 
started upon addition of OAA. 
OAA + PPi → Pyruvate 
The standard assay mix described above in the OAA→PEP section was used with the exception that 
pyruvate kinase was not present in order to measure the enzymatic production of pyruvate from OAA. 
6μL ratios of protein:mother liquor. After drops were set they were g of PPi PEPCK were used for these experiments.
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PEP + PO4- + CO2 → OAA
The standard assay mix for PEP carboxylation was composed of 100mM HEPES pH 7.5, 10mM DTT, 
300μL ratios of protein:mother liquor. After drops were set they were M NADH, 10mM PO4-,, 40mM MgCl2 (4:1 PO4-:Metal ratio), 100μL ratios of protein:mother liquor. After drops were set they were M FeCl3 (or other M1 metal 
substitute), 1mM PEP, 50mM KHCO3-  (bubbled with dry ice),  10U of MDH and 2.5μL ratios of protein:mother liquor. After drops were set they were g of PPi PEPCK. 
Reactions were started with the addition of PPi PEPCK.  
PEP + PPi  → Pyruvate  
The standard assay mix described above in the PEP → OAA section was used for the pyruvate-kinase 
like reaction with the exception that LDH was added in substitution of MDH.
IC50 Determination for both OAA → PEP and PEP → OAA reactions
To determine the IC50 for various characterized inhibitors of PEPCK, the assays were completed under 
the same conditions as above, with the only exceptions being a concentration of 50μL ratios of protein:mother liquor. After drops were set they were M OAA and 
100μL ratios of protein:mother liquor. After drops were set they were M PEP were used in the respective reactions.  
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4.2.8 Kinetic Data Analysis and Equations
Michaelis-Menten  and substrate inhibition constants were derived from plots created in SigmaPlot11 
EnzymeKinetics module using equation 4.1 and equation 4.2 respectively.
Ki values determined from the full progress curves were derived from the kinetic constants derived 
from Equation 4.1 when  replotted on graphs kcat/Km vs. [I] and 1/kcat vs. [I] to determine the Ki of both 
competitive and non-competitive inhibition, using equations 4.3 and 4.4, respectively. 
IC50 values were plotted with GraphPad Prism8 using equation 4.5.  Ki values were determined from 
these IC50 values using equation 4.6. 
v=
V max ,app [S ]
K m,app+[ S]
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4.3 Results and Discussion
4.3.1 Ligand induced quaternary state changes through size-exclusion 
chromatography
The previous biochemical assessments completed in the 1970s evaluated the quaternary state changes 
under ligand influence by sedimentation.126  These state changes were then monitored for activity in 
which the dimer arising from monomers was found to be inhibitory.  This dimerization was induced by 
OAA, malate, and fumarate.  All substrates and malate were tested to confirm these findings (Figure 
4.2, Table 4.3).  Surprisingly, PEP at 10mM was found to shift the monomer closer towards the dimer 
form.  As discussed at length later, PEP was observed to elicit substrate inhibition at sufficiently high 
concentrations.  This new data indicates that in addition to malate, OAA, and fumarate, PEP can 
contribute to the inhibitory dimerization.  This quaternary regulation from malate, OAA, and fumarate 
is likely a feedback mechanism to shut off flux through PPi PEPCK as these are all downstream 
metabolites to PPi PEPCK.  In this scenario, PEP-induced dimerization is counter-intuitive as the 
organism would likely want to maintain flux under circumstances of high PEP and may be artifactual, 
showing some level of promiscuity in this dimer-inducing binding site.    Finally, AiPEPCK was tested 
for quaternary state changes under various conditions.  AiPEPCK was found to be a dimer when no 
ligands are present31 and was unable, under all conditions tested, to form a monomer.  This may 
indicate that AiPEPCK is constitutively dimeric.  With the environmental conditions and known kinetic
consequences determined for the formation of the dimer, high resolution crystal structures were 
determined to hopefully lend insight into structural transitions between the monomer and dimer. 
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Figure 4.2: Size exclusion traces from various runs.  Based on previously ran standards 13.4mL is the 
elution volume denoting approximately 127kDa and 12.2mL is approximately 250kDa.  Red – 
AiPEPCK with no ligands, Blue – PfPEPCK 1mM OAA, Green – PfPEPCK 10mM malate, Yellow – 
PfPEPCK 10mM PEP, Grey – PfPEPCK 1mM PEP, PfPEPCK10mM PPi – Black, Orange – PfPEPCK 
with no ligands.
Table 4.3: Estimated quaternary states based on size-exclusion molecular weight estimation for both 
PPi PEPCK from P. Freudenreichii and A. israel.
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Size-LoopExclusion Molecular Weight Estimates
Ligands
No ligands present Monomer Dimer
1mM PEP Monomer Dimer
10mM PEP (Shift to) Dimer
Monomer
Monomer
1mM OAA Dimer Dimer
Monomer
10mM Malate Dimer Dimer
Dimer
150mM NaCl Dimer









4.3.2 Crystal Structures 
With the quaternary state changes now fully characterized for Pf- and AiPEPCKs, the atomic details are
necessary to understand how the dimer prevents the enzyme from catalyzing the  conversion of PEP to 
OAA.    To do so, two crystal forms of the PfPEPCK were solved, one without any ligands present and 
one with 10mM malate co-crystallized to induce the dimer formation.  Both crystal forms were a series 
of dimers, with the malate-structure having 8 molecules in the ASU making 4 sets of dimers, while the 
holo-structure had 4 molecules in the ASU corresponding with 2 sets of dimers.  The interface surface 
areas, and dimer RMSDs after global alignment are described in Table 7.3.1.  As previously mentioned,
the coordinating active site residues responsible for coordinating substrates/metals of the previously 
solved AiPEPCK enzyme, and now PfPEPCK, are completely conserved compared to the previously 
solved GTP- and ATP-dependent PEPCKs and therefore will not be discussed below. 
4.3.3 All Crystals Induce Dimerization
Upon inspection of both the holo- and malate-crystals, they are in fact sets of dimers similar to what 
has been described previously (Figure 4.3).31   This observation suggests that this dimer is in fact a 
conserved quaternary structure of PPi PEPCKs (at least for those which forms dimers), and 
crystallizing this enzyme may not be amenable to see the holo-enzyme as it preferentially forms a 
stable dimer in crystallo.  This does indicate that the dimer is a local free-energy minima, as there is 
some propensity to form in absence of the inducing ligands.   This does not rule out the possibility that 
other crystal forms could yield different conformations, or potentially a new co-crystal form of PEP and
PO4- (or their analogues) may allow us to see the Michaelis-Menten complex.  As seen from the RMSD
values (Table 7.3.1), the relative positions of the dimers are essentially the same between both of the 
PfPEPCK structures solved.  There are two particular regions that vary across the different monomeric 
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units.  The first region, is a helix (residues 31-51) that changes register in comparison to the adjacent 
structural elements.  The second variable region is a domain spanning residues 490-607 that is found to 
be in different conformations between all structures and will be further elaborated on below.  Like with 
the variable helix, this domain can be found in three general positions (see Figure 4.4B and C for the 
domain and helix respectively). Each monomer can be classified based on these positions of the 
variable helix and domain.  It does appear that there may be some coupling between this helix and the 
conformation of the domain.   For instance, monomers (chains ADEFG) from the malate-crystal have 
the same position of both the helix and domain.  The second grouping is with chains BCG and AD of 
the malate- and holo-crystals, while the third group is chains B and C of the holo-crystals.  For 
simplicity, the  structural alignments of all dimer pairs are not shown.   
Figure 4.3: Alignment of malate-crystal dimer (grey, chains A-F) and AiPEPCK dimer (coral, chains 
A-A’) anchored during superposition with chain A. 
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Figure 4.4: Representative alignment of various monomers of PPi PEPCK. Panel B shows the domain-
500, while panel C shows helix 31-51.  Chains are coloured as holo-A – ice blue, holo-C – gold, 
malate-A – grey, AiPEPCK A – coral.
4.3.4 Relative Conformation of Domain-500 
As described above, the vast majority of the enzyme structure is conserved among dimer pairs.  When 
aligning the individual monomers of the two structures, the core of the enzyme is unchanged (Figure 
4.4).  As mentioned, one domain spanning residues 490 to 608 (of the previously described lobe 231) 
was variable and in most part, the most difficult area to model into the electron density maps (Figure 
4.5).  This domain, furthermore referred to as domain-500, contains one of the loops responsible for the
dimer interface interactions (loop 590-600).  Although there is a plasticity to the location of this 
domain, the overall folded structure of the domain and the interface are conserved.  This indicates that 
the relative position changes of this domain is, at least with the current information, inconsequential to 
the dimer formation as long as the interface is maintained.   The relative dynamic nature of this domain 
may be important for sampling many different locations to correctly insert this loop into its contacting 
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pocket of its mate, allowing for dimer formation.  This domain may “sense” for its partner and establish
the first contact in the dimer, after which the second interface can properly align.  Further studies 
evaluating this particular domain, as well as its coupling to helix 31-51 may be important in 
understanding the dimerization phenomenon.  
Figure 4.5: Malate-crystal monomer (chain A: grey) with the domain-500 shown in purple. The entry 
and exit points of this domain are very close to one another as it begins from a 2-strand βSP-sheet.
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4.3.6 Dimer Interfaces
Although the dimer structures are conserved between the Ai and Pf PEPCK isozymes, the interface 
interactions are variable.  These differences may be important in uncovering the nature of the 
constitutive dimer form of the AiPEPCK in comparison to the ligand induce form of the PfPEPCK.   
Chiba et al previously described the AiPEPCK interfaces and will be used as a reference in the 
comparison.31  The malate dimer from chains A-F was used as it is the best modelled dimer, although 
when comparing every dimer pair from both malate-crystal and holo-crystal these interfaces are 
generally well modelled and congruent. 
Figure 4.6: Dimer interface interactions for both PfPEPCK and AiPEPCK.  Panel A and B are for 
interface 1 and 2 respectively from the malate-crystal (dimer A-F).  Monomer of chain A is represented 
in dark grey, while chain F is in light grey.  Panel C and D are representations of interface 1 and 2 
respectively from AiPEPCK (dimer A-A’).  Monomer of chain A is represented in coral, while chain A’ 
is in like pink. Atoms are coloured by type with carbon in chain colour, nitrogen as blue, and oxygen as





















Interface 1 is the corresponding dimer surface of this previously described domain-500.  A loop (590-
600 PfPEPCK numbering) containing interacting residues is shown (Figure 4.6A and C).  This loop 
inserts to interact with its dimer mate through mostly conserved interactions, although the backbone H-
bond of the amide of I591and the carbonyl of W622 (PfPEPCK numbering) is missing in the PfPEPCK
interface (Figure 4.6C). Although this tryptophan is conserved, the positions of the backbone amide and
carbonyl increased the distance from 2.9Å in the AiPEPCK structure to 4.7Å in PfPEPCK.  In brief, 2 
backbone hydrogen bonds stabilize this interface, the first of which is between the carbonyl of I591 and
the amide of L624, while the second is between the carbonyl of L624 and the amide of N593.  The side
chain of N593 also forms two hydrogen bonds with the backbone amide and carbonyl of T626 (S640 in
AiPEPCK).
Interface 2 is more variable between the two isozymes (Figure 4.6B and D).  Although previously 
described elsewhere31, AiPEPCKs interface consists of a backbone hydrogen bond between the amide 
of A443 and the carbonyl of A730, a hydrogen bond between the terminal amide of Q425 and 
carboxylic acid of D731, and finally a tridentate hydrogen bond network between the backbone 
carbonyl of P733, the hydroxyl of S736, and the carbonyl of A450 all coordinating with the indole of  
W467 (Figure 4.6B).  Panel C shows the interface for PfPEPCK.  First, the AiPEPCK A443-A730 
backbone H-bond is removed for the side chain amine of K426 forming three H-bond network with the 
hydroxyl of T714, the carbonyl of D711, and the carboxylic acid of D715.  Secondly, AiPEPCKs Q425 
H-bond with D731 has been replaced for two H-bonds between D412 and the backbone of carbonyl of 
T714 and the amide of V716.  Thirdly, the tridentate H-bond network of W453 is conserved although 
the proline is now V716.  In addition to these two H-bonds, it is likely that the V716 sidechain may 
form a hydrophobic interaction with W453 phenyl ring.  Finally, a bidentate H-bond network has been 
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introduced between the side-chain amide of Q717, carboxylic acid of E721 and the backbone carbonyl 
of T415.  
In total, the AiPEPCK dimer is stabilized through a total of 9 H-bonds (5 at interface 1, and 4 at 
interface 2), while PfPEPCK is stabilized through a total of 12 H-bonds (4 at interface 1 and 8 at 
interface 2) with an additional hydrophobic interaction at interface 2. This is somewhat surprising as it 
could have been hypothesized  that the constitutive dimeric AiPEPCK would have more stabilizing 
forces to maintain the quaternary structure.  Therefore, it is hypothesized that the basis for the 
constitutive dimeric form of the AiPEPCK is likely influenced by some other factors yet to be 
determined.  One potential reason would be its primary sequence differences lock this enzyme into a 
conformation that allows the dimer to form after translation, whereas the PfPEPCK must have a ligand 
present to switch it from the unknown dynamic holo-state to its rigid stable dimer.  Unfortunately, with 
the current information, the conformation of the holo-state of the PfPEPCK  is unknown and therefore 
it cannot be infer what the dynamic transition from monomeric to dimeric might look like. 
4.3.7 Active Site Loops
In the previous paper first describing the structure of PPi PEPCK, it was observed that the catalytic 
residues between both the PPi- and GTP-PEPCKs were completely conserved.31  Although not 
surprising, as the same substrates are being used (and products produced) a comparison of the 
important active site loops may be insightful to understand the mechanistic details of this enzyme.  It 
does appear that the three active site loops previously characterized are structurally conserved (Figure 
4.7), while the sequences are quite different (Figure 7.3.1). It is not entirely unreasonable to assume 
there would be some molecular rearrangements of these active site loops upon ligand binding, 
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transitioning from an “open” state to a chemical competent “closed” one, or in contrast to activation, 
upon dimer formation creating a impotent conformation.  This transition is well characterized in 
rcPEPCK, where the loops undergo a transition from a disordered state to an ordered state as described 
earlier.  In contrast, in the three PPi PEPCK structures, all of these loops are well modelled indicating 
that they are not disordered.  This suggests that the dimeric state may rigidify the catalytic loop, 
preventing proper coordination of ligands for the carboxylation of PEP.  The kinetic data presented later
are consistent with this interpretation, although it does appear that the dimer will allow for OAA 
decarboxylation. A co-crystal structure of the dimer and OAA/βSPSP would be very useful in 
understanding how this enzyme in its dimeric form can facilitate chemistry of one of the two reactions. 
Both the R- and P-loop look to be in a conformation that is similar to that of both the open holo-state or
closed-state in the rat cytosolic enzyme (Figure 4.7A).  The Ω-loop however is in a new, rather 
unexpected conformation where it looks to be pinned back away from the active site (Figure 4.7B).  
Typically, unless PEPCK is closed upon ligand binding, or perturbed through mutations, the Ω loop is 
typically disordered in its open state where in all three dimer structures of PPi PEPCK the Ω-loop is 
ordered.  Upon further investigation, there are four interactions between the Ω loop and the surrounding
periphery.  The first interaction is a H-bond between the N-terminal hinge βSP-sheet carbonyl of M842 of 
the loop and guanidine of R808.  As described in detail previously, a mutation study of rat cytosolic 
PEPCK investigating the mechanism of lid closure showed that these βSP sheet hinge regions are 
important.37  In brief, the N-terminal hinge is anchored throughout the open to closed transition, 
whereas the C-terminal hinge acts as a switch to allow for a folding event and subsequent closure of the
active site.  Without a catalytically competent closed state, we cannot determine that this interaction is 
similar to the anchoring as seen in the nucleotide forms. The rest of the interactions stabilizing the 
pinned conformation of the Ω-loop are throughout the loop.  The first is between the amine of K845 
and the hydroxyl of S472 of the P-loop.  This may indicate a level of cooperativity between PPi/PO4- 
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binding inducing a conformational change of the P-loop and the closure of the Ω loop, similarly see in 
the nucleotide dependent forms.29 The final two interactions are H-bonds between the backbone amide 
and carbonyl of A852 and the hydroxyl of T998 and the guanidine of R1001 respectively.  
Figure 4.7: Structural Alignment of rc and malate-PfPEPCK active site loops.  Panel A - structural 
alignment of malate-PfPEPCK and rcPEPCK complex with GTP and intermediate analogue oxalate 
(PDB ID# 3DT2), and the holo structure of rcPEPCK (PDB ID# 2QEW).  Malate-PfPEPCK loops are 
coloured as followed, Ω-loop gold, P-loop purple, R-loop red.  RcPEPCK loops are coloured as 
followed, Ω-loop yellow (closed conformation), P-loop pink, R-loop salmon.   The holo structure loops
are show in green.  Panel B – shows the molecular interactions between the Ω-loop and its surrounding 
residues.  All other atoms are coloured by type; carbon is green, nitrogen is blue, red is oxygen, purple 








4.3.8 Malate Binding Site
Although malate was both co-crystallized and soaked into the malate-crystals, no malate was found in 
the structure.  This was an unexpected observation, as malate was present throughout the crystallization
experiment and cryo-protection to ensure its presence.   The current data suggests the active site is 
likely not the binding site, as there are no accessibility constraints providing evidence as to why malate 
would not be present.  There are two alternative hypotheses as to why malate was not bound.  The first, 
and least likely option, is that the concentration of malate was not high enough to occupy its binding 
site.  This is unlikely as gel filtration data suggests that 10mM is enough to induce complete 
dimerization, although the kinetic data suggests 20mM is only modestly higher (1.5 times) than the 
expected Ki.  Using a higher affinity inhibitor such as OAA or βSPSP may be more amenable.  The second
hypothesis is that the dimerization occurs in a two step fashion, where malate binds to the monomeric 
form and inducing a dimer-competent conformer.  Upon dimer formation, the binding efficiency of 
malate is decreased and malate is not needed to maintain the dimer.  
4.3.9 Insights into Tetramer Formation
In the 1972, the tetramer of PfPEPCK was first determined and was further characterized.126  This 
tetramer was active, and dissociated into active dimers but was short lived.  An electron micrograph 
was collected to show the tetrameric form of the enzyme but it appears that it had to be fixed with 
glutaraldehyde prior to imaging.126  To date, there has been no evidence that this tetrameric form can be 
induced from monomers.  What is most likely is that this tetramer is an artifact of  resolubilizing the 
crystals which were produced as a final purification step in the initial biochemical characterizations.  
Supporting this later idea, upon investigating the three crystallographic forms and their lattice 
arrangements, a common tetrameric species is observed (Figure 4.8).  It may be possible that the 
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crystallization of these enzymes not only preferentially selects for the dimer, but these dimers can stack
with one another to form a stable tetramer.  This tetramer may be transiently stable upon the breakdown
of the lattice during resolubilization but ultimately, may be artifactual to the crystallization process. 
Figure 4.8: Crystal lattice tetramer.  Panel A –  holo-crystal lattice. Panel B –  malate-crystal lattice.  
Panel C –  AiPEPCK crystal lattice.  The observed tetramer is in green, while the other monomeric 
units are in grey.  The dimeric form of PPi PEPCK is shown in coral, and an alternative tetramer found 
in the malate-crystal is shown in gold although this tetramer is not found in the other crystal forms.
4.3.10 Actinomyces israelii PEPCK kinetics
In light of the new structural information deposited (PDB ID# 6K31), AiPEPCK was expressed and 
purified to compare its kinetic properties with that of PfPEPCK. Under all conditions tested, it was 
observed that this enzyme was inactive.  This is in agreement with the size-exclusion data  presented 
earlier (Figure 4.2 and Table 4.3) indicating that AiPEPCK is always found to be dimeric and therefore 
it may be a possibility that the role for this protein is non-enzymatic.  Furthermore, the metabolic role 
of PEPCK is likely fulfilled by the two other GTP-dependent isozymes found in Actinomyces israelii.
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4.3.11 Metal activation of PPi PEPCK
The initial biochemical characterization of PfPEPCK examined metal activation.61  They indicated that 
Co2+ was the most activating cation for the both the OAA- and PEP-forming reactions being 
approximately 3 times more activating than Mn2+ (or Zn2+ which is 2 times more activating than Mn2+).  
In addition, for the pyruvate kinase reaction, Cu2+ was 2 times and 6 times more activating than Co2+ 
and Mn2+ respectively.  When these metal activation experiments were revisited, similar results were 
obtained (Table 4.4).  Mn2+ and Zn2+  are both similarly activating for the OAA-producing reaction - 
however Co2+ could not be effectively tested as it precipitated heavily in the reaction mix and no 
activity was measured once partially solubilized.  Unfortunately for the 1969 study, Fe2+ was not tested, 
which in the current studies was observed to be the most activating cation for PfPEPCK.  This is the 
first indication that Fe2+ as being the true M1 metal cofactor for any PEPCK.  Fe2+ has been tested with 
nucleotide dependent PEPCKs, but it has never been shown to be most activating among divalent metal
cations when the reaction is supplemented with Mg2+.33  As iron can be found in a 3+ or 2+ state, the 
true electronic state of iron is unknown.  Reducing agents appear to be vital for the maximal activity of 
the enzyme (data not shown) in both these studies and those previous, suggesting that Fe2+ may be the 
preferred oxidation state.117 Further x-ray absorption near edge spectroscopy (XANES) experiments 
should be completed to confirm these initial findings. 
Table 4.4: Metal activity specific activity measurements.  Reactions were completed under the PEP → 





Metal Activation of PEP → OAA Reaction
Specific Activity (μmolminμmolminmolmin-1mg-1)
FeCl3 14 ± 0.5
CaCl2 1.9 ± 0.2
CoCl2
MgCl2 1.8 ± 0.2
MnCl2 4.8 ± 0.3
NiCl2 1.1 ± 0.1
CuCl2 4.2 ± 0.2
ZnCl2 4.7 ± 0.1
4.3.12 PEP carboxylation reaction
The finding that Fe2+ is is the most activating M1 metal makes the previous kinetic data and Michaelis-
Menten parameters more difficult to compare as cobalt was used in their standard assay reactions.  
From the previous studies, the PEP carboxylation reaction had a specific activity approximately 5 times
higher than that of the OAA decarboxylation reaction.117  This is in agreement with this study as the 
PEP carboxylation reaction is approximately an order of magnitude more active than the reverse OAA 
decarboxylation reaction (Table 4.5 and 4.6).  Functionally, Propionibacterium freudenreichii has been 
characterized as a carbon fixing organism through PPi PEPCK activity, in line with the preferred PEP 
carboxylating reaction measured.127–129   This clear bias towards PEP carboxylation has not been seen in 
GTP/ATP dependent PEPCKs, as all isozymes studied have relative rates are much closer to another 
other and all showing a preference for PEP synthesis.  Further kinetic characterizations with different 
PPi PEPCKs will indicate if this catalytic bias is specific to this isozyme or more ubiquitous among this
class of enzyme.  Although in most cases GTP/ATP PEPCKs catalyze the conversion of OAA to PEP 
more favourably as seen in both in vivo and in vitro data, GTP/ATP PEPCKs potentially preferring the 
PEP to OAA reaction have been noted.  Of the studies where both reactions were studied, Case et al 
noted that the GTP dependent PEPCK from Mycobacterium smegmatis catalyzed the PEP 
carboxylation reaction with a specific activity of 43μmolmin-1mg-1 in contrast to the observed 
12.3μmolmin-1mg-1 in the opposing direction.  When evaluating the kcat/Km ratio for these reactions for 
the PEP carboxylating (0.97x105 M-1s-1 ) and OAA decarboxylation (37x105 M-1s-1) reaction OAA binds 
tighter by a factor of approximately 30.24  With this significantly different catalytic efficiency for the 
two reactions, M. Smegmatis PEPCK is still likely a predominate OAA decarboxylating PEPCK.  Even 
in this case, the opposing kinetic parameters exemplify that GTP/ATP dependent PEPCKs flux is more 
bidirectional than that of PPi PEPCK.  The lack of significant kinetic differences among the ATP/GTP 
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dependent PEPCKs studied indicate that rcPEPCK, the best studied isozyme, is a good proxy for 
comparing PPi and nucleotide utilizing PEPCKs.  Henceforth, the main comparative enzyme discussed 
will be the rat cytosolic form.   
The reported PEP Km  (74μL ratios of protein:mother liquor. After drops were set they were M) here is almost an order of magnitude smaller than that previously 
reported (Km=530μM).126 This original higher Km is more in line with the values reported for nucleotide
PEPCKs with the rat cytosolic enzyme Km being 294μM.39    The previously reported values of PO4-  Km
(Km =  1.25mM) are approximately one half  of that here (Km = 2.3mM) but still generally quite high.  
The seemingly high Km , and resulting lower kcat/Km of PO4- is not likely to be consequential  in the 
cellular context .  Due to its metabolic importance, inorganic phosphate/polyphosphates are found to be
in high concentration in vivo.  An estimation of inorganic phosphate concentrations of 50mM based on 
elemental composition of Saccharomyces cerevisiae was proposed by van Eunen et al 2009, and other 
literature suggests cellular concentrations between 10-75mM.130–133  This indicates that the the excess 
inorganic phosphate in the cellular environment would saturate the enzyme. The CO2 concentrations 
recorded below were derived based on the conversion to estimate CO2 from bicarbonate.134  The 
previous study of PfPEPCK recorded a CO2 Km of approximately 550μM (at pH 7.8), four fold higher 
than the updated value (Km = 130μM). Referring back to the literature on GTP/ATP dependent PEPCK, 
KHCO3- (or NaHCO3-) values are typically listed, but by estimating CO2 concentrations (assuming pH 
7.5), typically CO2  Km values would range between 0.4 and 2mM with many of the recordings for the 
low end being attributed to parasitic isozymes of PEPCK. One remarkable exception to this is the ATP 
dependent PEPCK from Trypansoma cruzi where the reported Km of HCO3-  is 25.7μL ratios of protein:mother liquor. After drops were set they were M (CO2 = 
2.8μL ratios of protein:mother liquor. After drops were set they were M).21   When evaluating all of these Km, kcat and kcat/Km ratios, all evidence is in agreement that this 
enzyme is working unidirectionally to facilitate PEP carboxylation and CO2 fixation, as opposed to 
107
nucleotide dependent PEPCKs bidirectional nature.   A low Km (and subsequent higher kcat/Km ratio) 
indicate the PEP and CO2 binds quite tightly the enzyme, allowing flux through the enzyme during low 
concentration of both PEP and CO2. 
Table 4.5: Kinetic constants derived from PPi-PEPCKs conversion of PEP to OAA. Substrate 
inhibition constants are bolded  for PEP.  All background rates have been subtracted. 
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4.7 ± 0.02 6.3 ± 0.2 45 ± 1.5
PEP PEP PEP
74 ± 9.0 2300 ± 310 130 ± 15 63 ± 2.3 52 ± 2.7 47 ± 1.3
PEP + CO2 + PO4
- → OAA + PPi
Km (μmolminμM) kcat (μmolmins-1) kcat/Km (μmolminM-1s-1)
MgCl2 MnCl2 FeCl3 MgCl2 MnCl2 FeCl3 MgCl2 MnCl2 FeCl3
5.2 ± 0.7 0.07 ± 0.03 26 ± 3.1 9.0 x105 9.0 x 107 1.7 x 106





8.5 x105 2.2 x 104 3.6 x 105
Ki = 6300 +/- 920
4.3.13 OAA decarboxylation reaction
Although the flux through PPi PEPCK is very likely to be through the PEP carboxylation reaction there 
is still some propensity for the decarboxylation reaction (Table 4.6).  The previously reported Km value 
of OAA is approximately 470μM, an order of magnitude higher than this new documented value (Km = 
42μM).117  This new reported Km value is similar to the Km of rcPEPCK (Km = 52μM).39  The 
pyrophosphate Km reported here (Km = 5.5μM) is 40 times lower than the first account (Km = 
440μM).117  The  kcat/Km ratio reported indicate that in vivo, there will likely be some flux through the 
OAA decarboxylation reaction as the binding efficiency of both sets of substrates are similar.  
Table 4.6: Kinetic constants derived from PPi-PEPCKs conversion of OAA to PEP.  Substrate 
inhibition constants are bolded under Ki for PPi.  Background rates have been subtracted.
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OAA OAA OAA
42 ± 9.8 5.5 ± 1.4 4.9 ± 0.4 4.9 ± 0.4
OAA + PPi → PEP + PO4- + CO2
Km (μmolminμM) kcat (μmolmins-1) kcat/Km (μmolminM-1s-1)
PPi PPi PPi
1.5 x 106 1.4 x 105
K
i
 = 1300 ± 510
4.3.14 Pyruvate kinase and OAA → pyruvate reactions
The initial biochemical characterization of PPi PEPCK showed two specific reactions could be 
catalyzed by the enzyme while using PEP under different conditions.  First, the PEP carboxylation 
reaction is the predominate reaction and this is in line with the new kinetic data presented here using 
the true metal cofactor of the enzyme, Fe2+.  The second, half-reaction occurs in the absence of CO2 
where PEP is initially dephosphorylated, and subsequently protonated to form pyruvate.61   CO2 was 
found to be a potent inhibitor of the pyrvuate kinase reaction (Ki = 130μM) suggesting that pyruvate is 
formed when the PEP conversion to OAA is arrested at some point in its reaction before carboxylation 
(Table 4.7).  The pyruvate kinase reaction, appears to be stimulated under a non-reducing environment 
as well.  As previously mentioned, GTP/ATP PEPCKs have been shown to form pyruvate although 
through the conversion of OAA to PEP, while there is no evidence of a pyruvate-kinase like reaction.  
This conversion can take place using the diphosphate nucleotide (half-reaction) to prevent final 
phosphorylation after decarboxylation, and there is also evidence that OAA + NTP can  form pyruvate 
albeit at a much lower rate.40 
Upon first look, the data showing pyruvate formation is in agreement with the previous studies in that 
pyruvate is formed (in both types of reactions) more readily under non-reducing conditions.  For the 
pyruvate-kinase like reaction, the earlier work reported 1.5 and 1.8μmol of pyruvate produced per min-
1mg-1 under reducing and non reducing conditions respectively.  The reported turnover rates under non-
reducing conditions are approximately 5 times higher (8μmolin-1mg-1) and on par under reducing 
conditions (2.5μmolin-1mg-1) from what has been previously reported.61 The previously reported Km 
values under non-reducing conditions for PEP and PO4- are 40μM and 660μM, respectively.  The 
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values reported here are very similar to those of the past and those of the PEP carboxylation reaction 
(Table 4.7).61
When comparing the formation of pyruvate from OAA under non reducing conditions, pyruvate 
accounts for 80% of the flux as the OAA to PEP as the kcat (non-reducing) reported has not had the 
pyruvate formation reaction subtracted (Table 4.7). This shows that under non-reducing condition, 
OAA decarboxylation to PEP is drastically reduced.  The data presented in the pyruvate formation from
OAA under standard (reducing) assay conditions can be compared with rcPECK.  This shows that all 
PEPCKs can produce pyruvate through a side reaction when OAA decarboxylation reaction is not 
completed.  When comparing this side reaction kcat, PfPEPCK produces about 1 molecule of pyruvate 
per second, where rcPEPCK is producing 0.4 molecules per second. This pyruvate production in 
rcPEPCK has been attributed to inappropriate lid-reopening when the reactive enolate species after 
decarboxylation is produced, resulting in protonation by solvent.  Although these mechanistic details 
are missing for PPi PEPCKs, the pyruvate kinase reaction (from PEP to pyruvate) protonation was 
shown to be non-specific and achiral119,  suggesting a solvent effect similar to that of rcPEPCK.135  The 
stimulation by non-reducing conditions is hard to interpret, as redox changes can have large 
consequences whether through metal, cysteine/methionine redox changes.  Any of these consequences 
could be imagined to change the chemical reaction kinetics whether through chemical steps or 
dynamics of the enzyme itself. 
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Table 4.7: Kinetic constants derived from PfPEPCKs pyruvate-kinase like reaction. Substrate 
inhibition was measured as shown bolded under the Ki for PEP.
112
PEP PEP PEP
64 ± 4.7 1000 ± 240 8 ± 0.2 7.0 ± 0.6
PEP PEP PEP








- → Pyruvate (Non-reducing)





1.3 x 105 7 x 103
PEP + PO4
- → Pyruvate (Reducing)





3.0 x 105 9.4 x 103
Ki = 3300 ± 2200
OAA + PPi → Pyruvate (Non-reducing)
kcat (μmolmins
-1) @500μM
OAA + PPi → Pyruvate (Reducing)
kcat (μmolmins
-1) @500μM
OAA + PPi --> PEP + PO4
- + CO2 (Non-reducing)
kcat (μmolmins
-1) @500uM
4.3.15 Inhibition of PPi PEPCK by analogues
The wealth of biochemical data for GTP/ATP PEPCKs has found many selective inhibitors of 
nucleotide dependent PEPCKs. Representative inhibitory mimics of all substrates, intermediates, and 
products have been previously characterized.63  Surprisingly, due to the conservation of the active site 
residues, all of these previously characterized inhibitors were found to be ineffective inhibitors of 
PfPEPCK with the exception of βSPSP which is an analogue of OAA (Table 4.8).  It is unclear however, if
this inhibition is due to a competitive mechanism or the dimerization previously shown by βSPSP (Table 
4.3).126  It is likely that in the OAA decarboxylating direction it is due to competitive effects.  
Unfortunately βSPSP can only be used to inhibit this reaction as it is also a substrate for malate 
dehydrogenase, the coupling enzyme used in the PEP carboxylation assay.   Phosphonoformate, shown 
to be another OAA analogue in rcPEPCK (PDB ID# 2RK8), has an observed Ki of 2.4mM in PPi 
PEPCK whereas against rcPEPCK its an order of magnitude more potent (Ki = 230μM).63   Oxalate is a
potent inhibitor of PEPCK (Ki = 89μM) against the PEP carboxylation reaction for GTP/ATP 
PEPCKs.63   This potency is attributed to the understanding that these PEPCKs undergo a two step 
mechanism, creating an enolate intermediate which oxalate mimics.  Interesting, it appears that oxalate 
does not inhibit PPi PEPCK, indicating that the actual chemical mechanisms may be different the 
nucleotide and phosphate utilizing enzymes, or more likely, the dynamics changes and binding that 
must occur during turnover are different enough to weaken the binding of the enolate intermediate. 
This raises the possibility that the transitions this form of PEPCK undergo may be quite unique 
compared to those of the the nucleotide PEPCKs.  Two small molecules have been structural and 
kinetically tested as PEP analogues, sulfoacetate and phosphoglycolate (sulfoacetate = PDB ID# 2RKE,
phosphoglycolate = PDB ID# 2RKA).63   When comparing both of these inhibitors in rcPEPCK, 
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sulfoacetate is in the outer-shell geometry whereas phosphoglycolate is found in both this outer-shell 
geometry and directly interacting with the M1 metal, in a proposed catalytically productive state. This 
catalytically productive PEP-GDP complex has not been seen in previous studies, until now as shown 
in Figure 2.6 with the L153D mutant.  When evaluating the inhibition of the PEP analogues between rc 
and PfPEPCK, phosphoglycolate has the same Ki of 1mM while SA is much less potent against PPi 
PEPCKs at a Ki of 3.6mM (vs 83μM against rcPEPCK).    This may indicate a particular bias for how 
PEP binds to the active site of PPi PEPCK, coordinating with the M1 metal rather than binding in a 
outer-shell in the release state.  This observation is in line with the kinetic bias PfPEPCK has for the 
PEP carboxylation reaction.  3-Mercaptopincolinic acid (MPA) was tested as it has been traditionally 
characterized as a selective hallmark inhibitor of GTP/ATP PEPCK.  Recently, MPA inhibition was 
shown to be a mixed between a competitive component in the active site as it coordinated with the M1 
Mn2+ and a non-competitive component as it was also found to be bind behind the P-loop in an 
allosteric pocket.65  Based on the lack of inhibition by other PEPCK inhibitors, it was surprising to 
observe that upon first glance, MPA surprisingly was a potent inhibitor of PfPEPCK.  However, further 
analysis showing a lack of inhibition when using Mn2+ as the activating cation demonstrated that 
consistent with its being a known chelating agent of divalent cations, this inhibition was due to a non-
specific chelation effect and not reversible active site binding.    Finally, pyruvate was tested as an 
inhibitor of PfPEPCK and it was observed that it did not inhibit.  This is significant because this can 
inform us on the nature of the pyruvate-kinase reaction.  The lack of binding of pyruvate, which would 
be expected to be seen (even weakly) if it was a product of an enzyme catalyzed reaction, and the non-
stereospecific protonation leads one to believe that it is likely a solvent effect when the chemical 
reaction is not completed.  
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Table 4.8: Inhibition data for PfPEPCK against the previously studied inhibitors of PEPCK.  M1 
metals are indicated in brackets, if not specified it is FeCl3.  N/a denotes that these inhibitors were tested








Pyruvate N/a N/a N/a
4.2 0.98 1.8
2.9 0.98 1.2
Sulfoacetate 8.5 0.98 3.6
PGA 2.4 0.87 1
Phosphoformate 5.5 0.99 2.4
Inhibitor
B-sulfopyruvate 0.1 0.86 0.046
Malate 1.6 0.83 0.47
Inhibitor
0.54 0.99 0.13
Malate 8.1 0.99 3.5
IC50 PEP --> OAA







IC50 OAA --> PEP
IC50 (μmolminmM) R2 Ki (μmolminmM)
IC50 PEP-->> Pyruvate
IC50 (μmolminmM) R2 Ki (μmolminmM)
CO2
4.3.16 Substrate Inhibition by PEP and PPi
Interestingly and in contrast to rcPEPCK and other nucleotide dependent PEPCKs, there is a substrate 
inhibition effect seen at high concentrations of either PEP (Table 4.5 and 4.7) or PPi (Table 4.6)(see 
Figure 7.3.6 for progress curves).  The only substrate inhibition previously noted in literature is with 
high concentrations of metals and bicarbonate, which may be due to a general salt effect or an allosteric
effect at the newly discovered anion-binding allosteric pocket.85,136  The PEP-induced substrate 
inhibition was observed for both the pyruvate kinase reaction and PEP carboxylation reaction.  
Therefore, the mechanism of inhibition must be altering both the carboxylation and pyruvate-kinase 
reactions, and with the size-exclusion quaternary state change data, suggests its origin is due to 
dimerization.  In contrast, PPi elicits an apparent substrate inhibition in the OAA decarboxylating 
direction which looks to be stronger than that of PEP (for the PEP carboxylating reaction) but does not 
lead to dimerization as in the case of PEP (Figure 4.2, Table 4.3).  This suggests the PPi substrate 
inhibition may be a true competitive mechanism in which it competes with the anionic OAA substrate, 
or alternatively PPi may chelate the active site metals as proposed in the previous investigations.61  
4.3.17 Inhibition of PfPEPCK by malate
Due to the previous studies highlighting malate functioning as an inhibitor, and possibly a regulator in 
vivo, of PPi PEPCK, specifically through the induction of dimerization, a more comprehensive look 
into the details of its potency was completed.117,126  Malate has an IC50 value of 8.3mM (Ki of 3.5mM) 
(Table 4.8) which is a comparable to the results in the 1966 paper from Lochmuller, Wood, and Davis 
as determined by extrapolating their IC50 plots in Figure 9 of their publication.117  This IC50 is very 
similar to the IC50 found in the pyruvate kinase reaction.  The similarity in these two reactions is the use
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of PEP as the substrate. When contrasting this to the OAA decarboxylation reaction, the inhibition of 
malate is much stronger (IC50 = 1.6mM, Ki = 470μM).  From previous kinetic data OAA does not cause 
substrate inhibition so the dimer is unlikely to affect OAA decarboxylation rates when compared to the 
monomer.  A reasonable suggestion therefore is that malate can out-compete the weaker binding OAA 
and is therefore is observed to be more inhibitory in this direction. 
As IC50 values and their subsequently derived Ki values can be unreliable, full inhibition progress 
curves were completed and the kinetic constants were re-plotted to gain more mechanistic insight into 
malate inhibition (Figure 4.9).  What is readily noticed is that the addition of increasing amount of 
malate further enhances the apparent substrate inhibition effects seen through suppression of the kcat 
(Vmax).   This substrate inhibition effect at the highest concentration of malate gave an aberrant trend in 
the re-plot (as seen in Figure 4.10), where the predominate effect switched from a kcat to kcat/Km effect 
as the malate concentration increased.  This aberrant trend is likely because the substrate inhibition has 
become so strong that is has suppressed the Vmax so that the Michaelis-Menten parameters cannot be 
accurately inferred.  Because of this, the Ki value found has left this last concentration out, leaving the 
same Ki for each kcat and kcat/Km. This data suggests that the dimer both has a competitive as well as 
non-competitive effect.  A possible mechanism based on prevents both PEP binding, as well as turnover
of the enzyme, likely through the locking of a catalytically incompetent conformation.  
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Figure 4.9: Individually progress curves fit the substrate inhibition model for malate inhibition against 
the PEP-forming reaction.  Concentrations of malate are as follows A) 0mM, B) 4mM, C) 10mM, D) 
20mM. 
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Figure 4.10: Replots from the malate inhibition progress curves. As highlighted above, the highest 
malate concentration point was left out of the calculation for the 1/Vmax effect as the Vmax substrate 
inhibition effect dominated, suppressing the true Vmax in Figure 4.9.  
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4.4 Summary of findings
The initial biochemical characterizations that were completed in the late 60’s, early 70’s brought to 
light many interesting behaviours of the PPi PEPCKs.  With the wealth of information on GTP/ATP 
PEPCKs, a comparison was due to further understand the similarities and differences between these 
two classifications of PEPCK.    This study answers the fundamental questions surrounding the basic 
functions of the enzyme, while also highlighting what differences there are between the two systems.  
This study supplies vital information to allow PfPEPCK to be used as a model system for PPi PEPCK.
Unfortunately, the crystallographic structures did not yield the information that was hoped for, as 
crystals obtained in both the presences or absences of malate yielded the inactive dimeric state of 
PfPEPCK.  Likely, the formation of the crystalline lattice is best accomplished when the monomers are 
coaxed into their dimeric form, leading to a low energy conformation.  This does not rule out that other 
crystal forms, and co-crystallization experiments will not offer the holo-, substrate-, and product-bound
complexes, but other structural tools might be more fortuitous where crystallization is not amenable.  
What can be concluded from this study in conjunction with the previous structural assessment is that 
the dimer structure is conserved across the two isozymes tested, the dimer is stabilized by two 
interfaces, and the domain-500 and a N-terminal helix are dynamic compared to the rest of the enzyme 
although the functional consequences of this conformational flexibility are unknown.  It does appear 
that there is a coupling in the positional change in register of the N-terminal helix and the location of 
domain-500.  Furthermore, the malate binding site is still unknown and without further structural data 
of the other complexes of the enzyme it is hard to say why the dimeric form is inhibitory.  The 
tetrameric state of the enzyme is likely an artifact of the crystallization used to purify the enzyme in the
initial studies, although confirmation of this is necessary to be sure. And finally, the mechanistic details
of the confrontational changes through its reaction cycle are unknown.  
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This revisit of the biochemical aspects of PPi PEPCK has allowed a few interesting conclusions, and 
further lines of questioning.  First, the PPi PEPCK M1 metal co-factor appears to be reduced Fe2+, the 
first of its kind.  This may be in-line with Propionibacterium freudenreichii oxygen sensitivity as a 
facultative anaerobe. Secondly, it has a low Km and subsequently a very high kcat/Km for CO2., 
suggesting an evolutionary adaptation as this enzymes host organism is known to be a carbon fixer 
through the use of PPi PEPCK.  This observation with the rest of the kinetic data suggests that PPi 
PEPCK is a unidirectional enzyme functioning primarily in the carboxylation of PEP, where nucleotide 
utilizing PEPCKs are more-or-less bidirectional and primarily operate in OAA decarboxylation in vivo. 
Third, the supposed pyruvate-kinase reaction is in all likelihood in fact a non-enzymatic consequence 
of the PEP carboxylation not going to completion and the intermediate is then protonated by solvent to 
form pyruvate.  Fourth, inhibition data suggests that the dynamic changes and the resultant free-energy 
costs through turnover may be significantly different for the PPi class of PEPCK. This also opens the 
avenue for therapeutic targeting as humans do not have a PPi PEPCK, whereas some pathogens (ex. 
Entamoeba histolytica) do.  Fifth, the dimerization and subsequent inactivation previously shown from 
OAA and malate is in fact be the same mechanism causing substrate inhibition of PEP, while the 
substrate inhibition by PPi is likely through a competition with substrates or a consequence of chelation 
of the M1 and M2 metals.  Finally, based on this kinetic data, the dimer likely can still bind OAA for 
the decarboxylation reaction as there is no substrate inhibition of OAA, but binding and turnover of 
PEP is much harder as seen in the kcat/Km  and kcat effect. 
In closing, this study has produced the most comprehensive biochemical study on a PPi PEPCK.   
Having the initial kinetic and structural data in hand can now allow us to further probe the details of 
this new, but old, form of PEPCK.  A comprehensive biochemical characterization of other PPi utilizing
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PEPCKs should be completed to see what characteristics are ubiquitous with this form of PEPCK or 
unique to this specific isozyme.  
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5.0 Concluding Remarks and Future Directions
The hysteretic mutant is a clear example of drastic modification of the free-energy landscape with only 
a single change.  The observed structural results showed that this allosteric loop governs catalytically 
relevant global changes through dynamic switching between a solvent buried and solvent exposed 
conformation.  In brief, by creating a more hydrophilic hinge loop this enzyme preferentially adopts a 
closed state, prematurely closing in particular circumstances and stalling the enzymes ability to 
function.   This clear example adds to the growing host of literature regarding the importance of all 
areas of the enzyme in allowing enzymes to traverse through its free-energy landscape and catalytic 
cycle.   These results suggests considering entire protein sequence/structure in our efforts to optimize 
and produce new enzymes.   Furthermore, the structural data in conjunction with previous knowledge 
detailing the series of steps in this enzyme catalytic cycle offers a plausible explanation to the observed 
Michaelis-Menten parameters for this mutant.  Although this work offers a proposal in regards to the 
cause of the observed hystersis, it still does not determine how this mutant PEPCK alleviates the 
hysteresis as it turns over. This re-establishment of the proper coupling of this hinge loop with global 
dynamics seems plausible but more evidence is required to be sure of these claims as well as offer a 
mechanism to how PEPCKs free-energy landscape is evolving. Further work in investigating the 
structural and functional changes between the inactive form, and the final activated form would be very
insightful albeit extremely challenging.   Kinetic observations of the Michaelis-Menten parameters 
determined are after the transition from inactive to active state would also offer insights into the 
functional consequences of perturbing this loop.  It is by all means likely that the kcat/Km ratio would be 
different for each of the two structures.  As PEP/βSPSP seemingly destabilized the C-terminal domains 
and CO2 does not bind in the GDP-PEP structure, it suggests that the inactive form kcat/Km for all 
substrates is dramatically altered from those of the active form and what has been reported.  Although 
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these experiments would be very challenging, if completed would offer an exquisite example of the 
importance of the total dynamics of this model system.  
PEPCKs thermal adaptation is probably the least surprising results presented, as all of the results are in 
line with the theories established within literature.  Because of the pre-existing knowledge on this 
enzyme system, this study offers very specific reasoning into the functional changes that enzymes are 
pressured into adopting as they evolve to different thermal climes.  Specifically, the kinetic data 
suggesting that at high temperatures, where the enzyme is still increasing in activity, enzyme dynamic 
perturbation leads not to a loss in substrate capture but rather its ability to efficiently traverse its free-
energy landscape.  With this, at sufficiently high enough temperatures when enzymes because 
reversibly inactivated, the data suggests that the entropically driven dynamics prevent substrate 
association.  This data does not however suggest if this loss of association is due to local or global 
causes.  The most interesting aspect of this study is the structural work detailing specific Ω-loop 
adaptations that allow for balance between open and closed states.  This data detailing the mechanistic 
changes in the latch and hinge regions of PEPCK are quite obvious in hindsight (for example, less 
interactions are required at lower temperatures) but cement design rationale that could be used in 
protein design efforts.   An interesting study may be swapping the residues responsible for the lid 
dynamics onto a different protein background, that is, taking the components of the mesophilic lid and 
placing them on the psychrophilic background.  This may offer insight, much like in the hysteretic 
study, how global and local dynamics work together to produce an a functional optimal enzyme.  A 
GTP-dependent thermophilic and hyperthermophilic variant would be a great addition in understanding
some of these molecular details, and may lend insight into the wider area of dynamic adaptation with 
temperature.  
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The PPi PEPCK study is a very significant step forward in the beginning of a research area that will 
better understand this isozyme.  A great many outstanding questions from this work can offer an initial 
avenue for continuing these studies. First,  cryoEM may be an opportunity to study the closed active 
form of the monomer, although the lower resolution may be problematic to see the nuances of the 
changes.  Alternatively, careful co-crystal structures may also show the high resolution form of the 
active conformation.  Second, the malate binding site is still unknown and a kinetic investigation of the 
potential 2-step mechanism proposed above may lend insight into this binding site.  Third, structural 
characterizations of other isozymes, particularly those that may form trimers may be insightful into 
other ways this scaffold has adapted.  Fourth, with this data presented here  and with data found 
elsewhere31, the N-terminal helix is clearly dynamic and variable across isozymes and may be 
important in the facilitation of the dimer interface.  This dynamic interplay between dimer formation 
and this helix may also offer a path to understand why some PPi PEPCKs are active, and others are 
constitutively dimeric and inactive.  This once again reaffirms the previous idea that as biochemists we 
must evaluate all parts of the enzyme, as distant areas of a protein influence each other.  Finally, based 
on the inhibition data, there may be some exciting revelations in regards to the dynamic transitions this 
enzyme undergoes in contrast to the nucleotide counterparts. This data also suggests potential 
functional differences that could be exploited in structure-based drug design, if the molecular details 
are uncovered in how this form of PEPCK operates.  It may be possible to create select inhibitors of 
pathogenic PPi PEPCKs, while leaving human GTP dependent PEPCK relatively unaffected.  This 
homage to the initial characterization of PPi PEPCKs will hopefully invigorate new studies to further 
complete the story of PEPCK, especially regarding this neglected form.
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After so many years of studies on PEPCK, new and interesting results are still forthcoming, with many 
questions rising to the surface.  These studies, along with all previous work, indicate that this enzyme is
suitable in understanding the relationship between energetics, dynamics, and function. As more careful 
studies are completed using this enzyme, it may harken its addition into the pantheon of model systems 
that have been long studied to undercover the origins of function and dynamics of proteins.  
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GDP was purchased from Combi-Blocks.  TCEP and DTT were purchased from GoldBio. GTP, PEP, 
and PPi  were purchased from ChemImpex.  PK, LDH, and MDH were purchased from Calzyme. OAA 
was purchased from Calbiochem.  Nickel-NTA was purchased from Qiagen. P6-DG desalting resin was
purchase from BioRad.  All other chemicals were purchased from the highest grade available.
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7.2 Supplemental Information for Thermal Adaptions of PEPCK

































































7.3 Supplemental data for Biochemical, Structural, and Kinetic 
Characterization of PPi-LoopPEPCK from Propionibacterium 
freudenreichii


























































Table 7.3.1: Comparison of the various dimer sets from all structures of PPi PEPCK.  The interface 
surface area was calculated from the PISA server, and the RMSD differences are from a global 
alignment through CCP4MG.
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Figure 7.3.1: Sequence alignment of the active site loops of rcPEPCK and PfPEPCK.  Aligned with 
ClustalO and coloured based on ClustalO scheme.
Figure 7.3.2: IC50 curves for inhibitors of PEPCK against the PEP carboxylation reaction. Y-axis is 
percent activity remaining. Errors bars may be hidden within the data point.
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[Carbonylethylphosphoric acid] (mM) [Pyruvate] (mM) [Sulfoacetate] (mM)
[Phosphoformate] (mM) [Phosphoglycolic acid] (mM) [Malate] (mM)
Figure 7.3.3: IC50 of three inhibitors of PEPCK and there response to changing the M1 metal.  Errors 
bars may be hidden within the data point.
Figure 7.3.4: IC50 curves for the previously described inhibitors of PEPCK against the OAA 
decarboxylation reaction. Errors bars may be hidden within the data point
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Figure 7.3.5: IC50 curves for the previously described inhibitors of PEPCK against the pyruvate kinase 
reaction. Errors bars may be hidden within the data point.
Figure 7.3.6: Substrate inhibition Michaelis-Menten plots for both PEP and PPi against PEP 
carboxylation and OAA decarboxylation reactions respectively. 
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8.1 Introduction:
Cytosine 5’-triphosphate (CTP) synthase (CTPS) is a metabolic enzyme which regulates and is 
responsible for the essential de novo production of CTP.  CTPS utilizes uridine 5’-triphosphate (UTP), 
ATP and ammonia in the production of CTP.  While in vitro, the ammonia can be provided in the form 
of free ammonia, in vivo glutamine serves as the ammonia donor through the activity of the glutamine 
amidotransferase (GAT) domain of CTPS. Evidence suggests that the ammonia produced during the 
GAT catalyzed conversion of glutamine is transferred from the GAT domain of CTPS to the 
amidoligase domain where CTP synthesis is completed via a previously described substrate 
tunnel.137   The chemical mechanism for CTP synthesis, as understood to this point, entails phosphoryl 
transfer of ATP’s γ-phosphate to UTP producing a 4-phospho-UTP intermediate which undergoes 
nucleophilic attack by ammonia resulting in the production  CTP and inorganic phosphate.138
Due to its essential cellular role, the observation that CTPS is highly regulated based on available 
nucleotides is not surprising.  GTP seems to be an activator at low concentration and an inhibitor at 
high concentrations.139-140  This allosteric regulation has been studied but no affirmative structural data 
exists to shed light on the details of this mechanism or the GTP binding location. The E. coli variant of 
CTPS is a dimer in solution forming an active tetramer upon substrate addition which polymerizes to 
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form inhibitory filaments when under particular controls, such as in the presence of high concentrations
of the product CTP.141  In contrast, the human variants form enzymatically activate filaments upon the 
addition of the substrate UTP.142  Recent, cryo-EM studies have been insightful in demonstrating the 
global conformation changes that must occur for these two isozymes of CTPS to transition between the 
tetrameric to filamentous states.  These global changes can be simply described as an increasing in 
packing of the tetramer interfaces to allow for stacking.142,143 
The crystal structure of E coli. CTPS was first solved in 2004 demonstrating the overall architecture of 
CTPS in its active tetrameric form.144 Later in 2005, in an investigation by the same group, they 
characterized the product state with both CTP and ADP bound.143  Taken together, these structural data 
in conjunction with the body of in vitro biochemical data suggests that the CTP and UTP sites only 
partially overlap through a common triphosphate binding pocket, while the pyrimidine rings of the 
respective nucleotides bind to unique sites. Both active sites are wedged between A-B-A’ interface of 
the tetramer.   This initial hypothesis on partially overlapping nature of the two nucleotide binding sites 
was recently confirmed in the determination of the human CTPS-UTP complex by cryoEM.142 
Due to its essential role in nucleotide synthesis, CTPS has been shown to be an effective therapeutic 
target against protozoan parasites,145,146 as well as several cancers.147,148  Many CTP-like small molecules
have been tested for their selective inhibition of CTPS.  Historically, the most well characterized of 
these compounds are 3-deazauridine-5’-triphosphate (IC50 ~ 18μL ratios of protein:mother liquor. After drops were set they were M) and  cyclopentenyl cytosine 5’-
triphosphate (CPEC) (IC50 ~ 6μL ratios of protein:mother liquor. After drops were set they were M).148,149  Although in vivo cellular work has generally shown them to 
be effective, CPEC has detrimental cardiotoxic effects which unfortunately does not make it an 
appropriate therapeutic candidate.150  In addition, when used as antiproliferative agents, it is found that 
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many cancers can alleviate the inhibition demonstrated by these two compounds through mutations that
also removes normal CTPS product inhibition by CTP.  It has been found that this mutational escape is 
achieved through modifications of the ribose and cytosine binding pocket of CTP and not the shared 
CTP/UTP triphosphate site.151–153  Due to the this phenomenon, these particular mutations allow for 
UTP utilization with none of the inhibition generated by CTP binding.  
In contrast to the compounds described above, gemcitabine triphosphate (dF-dCTP, Table 1) has been 
utilized as a therapeutic towards solid tumours and seems to be well tolerated.147  In light of these 
positive aspects, a series of fluorinated CTP derivatives including dF-dCTP were tested for their ability 
to inhibit CTPS (Table 8.1).154  dF-dCTP was the most inhibitory compound, being approximately 40 
times more potent than CTP, and 30 times more potent that its tightest binding monofluorinated 
counterpart and can form filaments at a lower concentration than CTP.155  This indicates that dF-dCTP 
may be a suitable starting point for further improvements then the previous generation of selective 
inhibitors. Based upon this prior work, we have undertaken the structural characterizations of these 
fluorinated analogues of CTP in efforts to determine the molecular basis for the tight binding of dF-
dCTP when compared to the monofluorinated derivatives.  It is hoped that these molecular details can 
further medicinal chemistry efforts to create more selective inhibitors of CTPS.  Based upon this new 
structural data in combination with previous kinetic work, we demonstrate the dF-dCTP potency arises 
from binding to the closed, filament forming state of CTPS.  This filament state allows for structural 
rearrangements of both inhibitor and active site to allow for the association of a cation to the 
triphosphate tail.   This presents novel opportunities to exploit enzyme interactions with this new 
molecular scaffold for the next generation of CTPS inhibitors. 
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Table 8.1: Inhibitor Structure and Potencies.  Adaptation from 154
8.2 Materials and Methods
8.2.1 Materials
Sodium malonate was purchased from Hampton Research.  CTP and ATP were purchased from 
BioBasics.  ADP was purchase from ChemImpex.  dF-dCTP was purchased from JenaBiosciences. F-
dCTP and F-araCTP was purchased from TriLink Biotechnologies.  All other chemicals were purchased
from the highest grade available.
8.2.2 Construct, Expression, and Purification
The construct used for this study has been outlined previously.156  The protein was expressed in 2L of 
LB media and was induced with 1mM IPTG at an OD600 reading between 0.6 and 0.8 for 3 hours. Cells 
were harvested by centrifugation and resuspended in Buffer 1 (B1 - 25mM HEPES pH 7.9, 1M NaCl, 
20mM Imidazole).  Cells were sonicated in 5 pulses lasting 20s each while on ice.  Lysate was spun 
down at 12 000G for 1 hour to pellet the insoluble portion.  The supernatant was removed and added to 
pre-equilibrated nickel-NTA for 1 hour. The nickel was then washed with B1 until the flow-through had
an A280 absorbance reading below 0.1.  The bound protein was eluted with Buffer 2 (B2 – 25mM 
HEPES pH 7.9, 1M NaCl, 250mM imidazole) in 10mL fractions.  These fractions were concentrated 
with an Amicon nitrogen gas concentrator using a 10kDa Millipore Ultracel© cellulose membranes.  
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Inhibitor R R’
CTP 97 ±10 H OH
F-dCTP 110 ± 7 H F
F-araCTP 35 ± 5 F H
dF-dCTP (Gemcitabine) 1.2 ± 0.1 F F
IC50 Potency (μM)M)
The concentrated protein was then buffer exchanged into Buffer 3 (B3 – 25mM HEPES pH 7.9) by 
passage through a pre-equilibrated P6-DG column from BioRad.  This protein was digested with 0.5U 
of thrombin to cleave the 6xHis tag over-night for 9 hours – any longer and the CTPS would become 
proteolysed.  Approximately 75% of CTPS precipitated.  To inactivate thrombin, 1mM PMSF was 
added.  The remaining digested protein was then added to cleaned nickel-NTA resin equilibrated in B3, 
for 1 hour.  The nickel resin was washed with B3 and the protein, now in the flow-through, was 
concentrated to 15mgmL-1..  The final protein concentration was determined by nanodrop using the E280 
1% of 6.7mLmg-1.  The protein was frozen by direct submersion in liquid nitrogen in 30μL ratios of protein:mother liquor. After drops were set they were L drops and 
subsequently stored at -80°C.
8.2.3 Crystallization and Data Collection
Crystals were grown as previously described.144  In brief, crystals were setup at room temperature but 
grown by hanging drop vapour diffusion at 4°C.  Mother liquor conditions consisted of 0.1M TRIS-Cl 
pH 8.0 (at room temperature), 5mM MgCl2 and varied concentrations of (NH4)2 SO4 between 1.15M 
and 1.4M at a ratio of 2μL ratios of protein:mother liquor. After drops were set they were L of protein at 15mgmL-1 to 2μL ratios of protein:mother liquor. After drops were set they were L of mother liquor. Crystals were harvested and
transferred into increasing concentrations of sodium malonate (pH 7.0) cryoprotectant supplemented 
with 5mM MgCl2.157  Crystals were initially placed in 1.5M sodium malonate and subsequently 
transferred to a 1.9M solution.  Finally crystals were transferred to 2.4M sodium malonate with the 
ligands present at 1mM where they soaked at 4°C for 1 hour.  Many crystals appeared to crack and ones
that were stable were then cryopreserved by submersion into liquid N2.  Data were collected at the 
Canadian Light Source in Saskatoon, Saskatchewan on the 08B1-1 beamline.  Data were indexed and 
scaled in HKL-200079 with final statistics presented in Table 8.2.
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8.2.4 Structure Determination
All structures were solved through molecular replacement using the previously determined C268A 
mutant E coli. CTPS structure (PDB ID# 5TKV) and MolRep in the CCP4 package80,142.  Iterative 
rounds of real space refinement and the addition of water molecules and heteroatoms were carried out 
with COOT, followed by refinement with REFMAC581,82. Final MolProbity statistics were collected 
with the online server at http://molprobity.biochem.duke.edu/index.php and final model statistics are 
present in Table 8.2 84. 
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Table 8.2: Collection and Refinement Statistics for CTPS Complexes
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dF-LoopdCTP dF-LoopdCTP + ATP dF-LoopdCTP + ADP
Wavelength (Å) 1 1 1
Resolution range (Å) 54  - 2.2 (2.3  - 2.2) 50  - 2.4 (2.5  - 2.4) 57 – 2.0 (2.1 – 2.0)
Space group P 21 21 2 P 21 21 2 P 21 21 2
Unit cell (Å) 158.415 108.962 129.029 90 90 90 157.748 108.763 128.86 90 90 90
Total reflections 3667046 3450292 6031925
Unique reflections 113698 (11244) 87367 (8468) 150135 (14297)
Multiplicity 15.0 (13.8) 14.3 (13.4) 13.8 (10.3)
Completeness (%) 100 (100.00) 99.7 (97.6) 99.2 (95.7)
Mean I/sigma(I) 18.8 (1.9) 15.8 (2.1) 16.7 (1.2)
34.7 35.2 37.3
R-Loopmerge 0.149 (1.286) 0.180 (1.25) 0.127 (1.9)
R-Loopmeas 0.154 (1.334) 0.187 (1.3) 0.132 (2.067)
R-Looppim 0.04 (0.357) 0.049 (0.346) 0.035 (0.630)
CC1/2 0.986 (0.930) 0.996 (0.754) 0.973 (0.754)
Reflections used in refinement 113688 (11244) 87362 (8468) 150129 (14297)
Reflections used for R-Loopfree 5636 (566) 4366 (415) 7506 (728)
R-Loopwork 0.197 (0.281) 0.194 (0.266) 0.195 (0.308)
R-Loopfree 0.213 (0.301) 0.222 (0.295) 0.219 (0.313)
Number of non-Loophydrogen atoms 8985 8996 8968
  macromolecules 8410 8402 8408
  ligands 76 124 116
  solvent 499 470 444
Protein residues 1070 1073 1069
RMS(bonds) 0.013 0.013 0.013
RMS(angles) 1.7 1.7 1.7
Ramachandran favored (%) 97.9 97.2 97.6
Ramachandran allowed (%) 2.1 2.7 2.2
Ramachandran outliers (%) 0 0.1 0.2
Rotamer outliers (%) 1.9 2.5 1
Clashscore 2.1 2.4 2.5
Average B-Loopfactor 45.6 45.5 46.7
  macromolecules 45.9 45.9 46.6
  ligands 28.9 41.9 44.6
  solvent 42.3 38.4 47.8
CTP F-LoopdCTP F-LooparaCTP
Wavelength (Å) 1 1 1
Resolution range (Å) 44  - 2.0 (2.1  - 2.0) 44  - 2.0 (2.1  - 2.0) 64 – 2.3 (2.4  - 2.3)
Space group P 21 21 2 P 21 21 2 P 21 21 2
Unit cell (Å) 164.707 103.907 131.835 90 90 90 164.419 103.506 131.562 90 90 90 158.997 108.58 129.014 90 90 90
Total reflections 5344399 6118499 4389151
Unique reflections 142128 (10570) 152954 (14592) 103170 (9913)
Multiplicity 14.0 (12.1) 14.4 (6.9) 12.9 (12.1)
Completeness (%) 97.3 (73.3) 99.6 (96.2) 99.6 (96.7)
Mean I/sigma(I) 12.7 (3.8) 16.8 (2.0) 13.8 (3.0)
33.4 33.6 48.5
R-Loopmerge 0.166 (0.851) 0.124 (0.878) 0.141 (1.741)
R-Loopmeas 0.172 (0.887) 0.101 (0.950) 0.147 (1.820)
R-Looppim 0.045 (0.248) 0.033 (0.346) 0.041 (0.524)
CC1/2 0.992 (0.971) 0.989 (0.887) 0.989 (0.920) 
Reflections used in refinement 142115 (10570) 152938 (14592) 103168 (9914)
Reflections used for R-Loopfree 7162 (518) 7766 (726) 5051 (516)
R-Loopwork 0.186 (0.269) 0.183 (0.253) 0.203 (0.277)
R-Loopfree 0.206 (0.293) 0.198 (0.265) 0.231 (0.324)
Number of non-Loophydrogen atoms 9432 9462 8678
  macromolecules 8497 8489 8394
  ligands 86 86 65
  solvent 849 887 219
Protein residues 1068 1066 1068
RMS(bonds) 0.013 0.013 0.013
RMS(angles) 1.7 1.6 1.7
Ramachandran favored (%) 98.2 98.8 97.7
Ramachandran allowed (%) 1.6 1.2 2.2
Ramachandran outliers (%) 0.2 0 0.1
Rotamer outliers (%) 0.6 0.4 2.5
Clashscore 2 2.1 2.7
Average B-Loopfactor 39.3 39.4 56.9
  macromolecules 38.9 38.7 57.1




The solved structures are all soaked crystals of the various different ligand compositions at high 
enough concentrations to get an occupancy of 1.0 at the binding sites.  
8.3.1 dF-dCTP + ATP/ADP Complexes
To determine if there were any conformational changes that were induced by binding of ATP or ADP 
with CTP analogues, dF-dCTP complexes with these nucleotides were solved.  Unsurprisingly, there 
were no observed changes between the dF-dCTP structure, and the complexes also with ATP or ADP.  
The global conformation of the crystallographic dimers are identical with a global RMSD change of 
0.22Å and 0.27Å for the ADP and ATP complexes respectively (Figure 8.1).  The B-factors of the 
residues interacting with the adenosine nucleotides are essentially comparable across all three 
structures, likely because even the dF-dCTP structure has malonate from the cryoprotectant bound in 
the ATP/ADP polyphosphate binding pocket. No conformational changes were observed between the 
three structures for any side chain rotamers as well.  The equivalency of the dF-dCTP structures 
simplifies the discussion so all comparisons discussed are going to be made in reference to the dF-
dCTP structure, but can be extrapolated to the adenosine nucleotide complexes.  
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Figure 8.1: Global alignment of the dF-dCTP complexes.  Grey is dF-dCTP, pink is dF-dCTP+ADP, 
and teal is dF-dCTP+ATP.  
8.3.2 Global Conformation Changes
Global conformational comparison between CTP and the 3 fluorinated inhibitors was completed.  The 
RMSD values are from a global superposition of the inhibitors against the CTP bound structure (Figure
8.2).  As shown from the RMSD values, both CTP and F-dCTP complexes are globally identical.  
Unfortunately, the global alignment and its RMSD values of F-araCTP and dF-dCTP do not accurately 
show the actual conformational rearrangements that are going on between the three states.  To further 
show the differences between the CTP (and F-dCTP) in comparison to F-araCTP and dF-dCTP a 
superimpostion was completed while anchoring the structures with one of the sub-units (Figure 8.2).  
The superimposition highlights the observed three global conformations.   Even though F-araCTP and 
dF-dCTP are not the same conformation, they are more similar to one another than either to the mutant 
CTP structure (PDB ID# 5TKV) or dF-dCTP.  Interestingly, the dF-dCTP structure is most similar to 
the previously solved C268A structure (PDB ID# 5TKV) with a RSMD difference of 0.4Å (as opposed 






dF-dCTP + ADP 1.49
dF-dCTP + ATP 1.53
Figure 8.2: CTPS complexes anchored alignment and RMSD variability.  The table is a comparison of 
the RMSD values of the complexes vs the CTP bound structure after a global superimposition.  The 
right panel is a superimposition when aligned through one of the sub-units.  The CTP structure is in ice 
blue, F-araCTP in coral, and dF-dFCTP is in grey.  As seen, the left sub-unit is well aligned with all of 
the molecules but in the right sub-unit each of these three structures have different global 
conformations.  
As previously mentioned, the CTP binding site is composed of 3 different sub-units of the 
crystallographic dimer, A-B-A’.  Because of this, the tetramer is necessary to understand all binding 
interactions of this pocket.  The crystallographic dimer and its symmetry mate fortunately recapitulate 
the tetrameric form of the enzyme.  All of the further analysis and observations are completed with the 
tetrameric form of the enzyme.  Furthermore, the various models were superimposed while anchoring 
chain A, and this pocket was used for the visualization so the local conformation changes can be most 
accurately described. 
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8.3.3 CTP Binding Site and Inhibitor Conformation
Along the same trend of the global conformational modes, there are three distinct local binding 
conformations for CTP and its analogues.  CTP and F-dCTP are found in the same conformation as 
represented by the CTP molecule, while F-araCTP and dF-dCTP are found in two different 
conformations, although they are quite similar (Figure 8.3).  The consequences of the global 
rearrangement of the tetramer interface can be seen in the three helices denoted.   
Figure 8.3: Ligand conformations in CTP binding pocket.  Three ligand binding modes in the CTP 
pocket of the superimposed A sub-unit.   Three helices making up the CTP binding pocket are denoted 
with chain identifier and residues numbers.  The background protein structures are CTP bound in ice 
blue, and dF-dCTP in grey, F-araCTP in coral.  All other atom colourings are as followed, green 
carbon, red oxygen, blue nitrogen, pink phosphorous, white fluorine. 
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Helix(A’) 218-228 Helix(B) 150-165
Helix(A) 115 -130
8.3.4 CTP Binding Site Interactions and Metal Binding
Many binding interactions (and subsequent bond lengths) were automatically generated through 
LigPlot+ but manual curation was needed as some interactions were missed.  The manual inspection of 
the potential interactions and bond lengths were completed in COOT.  In general, the binding 
interactions are mostly conserved (Figure 8.4).  This is unsurprising because although there are slight 
changes to the binding of the ligand and the binding pockets accommodation, the same residues are 
being used.   The circled atoms/residues show specific additions to the binding interactions between the
CTP reference and that of the inhibitor structures (Figure 8.4).  Of note, there is a new interaction 
between F227 and the F-araCTP and dF-dCTP inhibitors.  Also, as discussed later, there is evidence of 
a cation binding between the α-, βSP-, and γ-phosphates in the dF-dCTP structure which is absent in all 
other complexes (Figure 8.5).  
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Figure 8.4: LigPlot+ schematics for the solved complexes.  Atoms are coloured based on type; black is
carbon, red is oxygen, blue is nitrogen, purple is phosphorous, lime green are other atoms (fluorine or 
sodium).  Bonds for contacting residues are in brown, whereas ligand bonds are in green.  Potential 
interactions are in dashed green and suspected hydrophobic interactions are shown as ray diagrams.  
The red circles indicate new interactions that are not found in the CTP reference structures. Residues 
are labelled with their chain notation as well. 
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Figure 8.5: Gemcitabine binding.  dF-dCTP structure with the blue mesh indicating the electron 
density from the 2Fo-Fc map (rendered at 3σ)).  There is clear density for all atoms in the inhibitor as 
well as for the sodium cation.  Atoms are coloured by type; grey is carbon, red is oxygen, blue is 







8.3.5 Bond Length Analysis
CTP vs F-dCTP
The first comparison of bond lengths was between the CTP and F-dCTP structures.  Unsurprisingly, 
with the lack of change in the global conformation, inhibitor conformation, and reported IC50,   there are
no significant changes in any residue – ligand bond lengths, besides E149 which has an  increase 
(0.5Å) in bond length with the 2’-F-ribo of F-dCTP. 
F-araCTP vs F-dCTP
It is apparent that the changes between F-araCTP and F-dCTP inhibitors are the same as those for  dF-
dCTP and F-dCTP.  Because of this redundancy,  these changes will be described below in the context 
of the dF-dCTP inhibitor.
dF-dCTP vs F-dCTP
Unsurprisingly, the majority of the differences between dF-dCTP and F-dCTP are a consequences of 
dF-dCTP having the additional fluorine at the R’ (2’-arabino) position, and the corresponding metal 
ligand contact that are only found in the dF-dCTP structure .  Four other interaction changes that are 
not because of the additional 2’  fluorine are further described (Figure 8.6).  First, K223 has changed 
positions, where in the F-dCTP complex it has a closer interaction with the γ-phosphate where in 
contrast, K223 is closer to the βSP-phosphate in the dF-dCTP complex.  The net effect is shorter 
interactions from the K223 in the F-dCTP structure.  Second, K189 has also changed it relative position
between these two structures to interact with different oxygens of the triphosphate tail.  In the dF-dCTP
complex, K189 interacts with the bridging oxygen between the α and βSP phosphates while in the F-dCTP
structure this lysine coordinates with the bridging oxygen between the ribose moiety and the α 
phosphate. When looking at the specific distance differences, the changes of the two modes likely at 
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least partially negate one another as the magnitude of the changes are equivalent.  Third, S14 of the dF-
dCTP structure has moved positions to have a 1.1Å shorter H-bond between its hydroxyl and an 
oxygen of the α phosphate.  Finally, F227 has rotated towards to the cytosine ring for a potential 3.7Å 
π-stack in the dF-dCTP structure, as well as 4.4Å interaction with the 2’-F-arabino.  In the CTP and F-
dCTP, F227 is disordered based on the lack of electron density to be properly fit, preventing this 
stabilizing interaction.   
Figure 8.6: dF-dCTP and F-dCTP binding modes.  Changing binding interactions between F-dCTP 
(left, gold) and dF-dCTP (right, grey). Blue mesh indicates electron density from the 2Fo-Fc clipped to 
F227 (rendered at 1.7σ)).The additional bonds that dF-dCTP has due to the additional R’ fluorine are not
shown. 
dF-dCTP vs F-araCTP
The comparison between dF-dCTP and F-araCTP are to show the consequences that dF-dCTP has the 
additional fluorine at the R (2’-ribo) position.  Most of the new bonds are due to increase contacts with 
this R fluorine, and the corresponding metal ligand contact that are only found in the dF-dCTP 
structure. As for interactions not coordinating with the second fluorine, K223 appears to have a 
shortened contact in the F-araCTP structure with a terminal oxygen on the γ phosphate but when 
inspecting the electron density maps of F-araCTP, there is no clear density to model the Cδ, Cε,  Nζ 
atoms suggesting it is unstructured (Figure 8.7).  K187 on the other hand is structure and does have a 






Figure 8.7: dF-dCTP and F-araCTP binding modes.  Changing binding interactions between F-araCTP 
(left, coral) and dF-dCTP (right, grey).  The additional bonds that dF-dCTP has due to the additional R 
fluorine are not shown. 
dF-dCTP vs C268A + CTP (5TKV)
The final comparison is between the globally similar dF-dCTP complex and the previously solved 
structure of C268A E. coli CTPS (PDB ID# 5TKV).  The global conformational similarities discussed 
earlier, and the presence of the cation binding between the triphosphate tails of both dF-dCTP and 
C268A+CTP structure led to the comparison of interacting ligand distances.  Unsurprisingly, there are 
no significant differences between the bond lengths associated with the inhibitors.  F227 is also rotated 
in the 5TKV structure to form the π-stack with cytosine moiety of CTP reminiscent of the dF-dCTP and





8.4.1 2’-ribo substitution - Similar Inhibition by CTP and F-dCTP 
The previous investigation determined that CTP and F-dCTP inhibit CTPS with essentially the same 
potency, with IC50 values of 97μL ratios of protein:mother liquor. After drops were set they were M and 109μL ratios of protein:mother liquor. After drops were set they were M respectively.154  The global conformational comparison 
indicates that the substitution for the 2’-ribo hydroxyl for fluorine does not change the global 
conformation of the enzyme(Figure 8.2).  The observed local structure highlight only one difference 
between any of the participating binding residues, that is between E149 and the 2’-ribo group.  In the 
case of CTP binding, the E149 terminal oxygen is 2.95Å from the 2’-OH-ribo, whereas in the F-dCTP 
(2’-F-ribo) structure this bond is 3.40Å.  This increase in distance is accommodated by a slight 
movement of the ribose ring, whereas the triphosphate tail and cytosine moiety are in essentially 
identical positions.  In previous discussions, questions were raised as to whether E149 was 
protonated.154  Mutagenic studies were also completed to better understand the protonation state of 
E149. E149D was not able to be inhibited by either CTP or dF-dCTP, suggesting that the shorter 
aspartic acid residue (by ~1.5Å)  removed this very important bonding interaction.  Finally, E149Q, 
which removed the negative charge of glutamic acid and its H-bond accepting potential, had a 
relatively unperturbed effect on the inhibition of CTP and dF-dCTP.  This finding lead to conclusions 
that E149 is protonated, as E149Q amino group could donate H-bonds (and thus inhibition was 
unchanged).   E149 protonation seems likely from the previous biochemical data, and the subtle 
increase of bond length upon fluorine substitution.  The C-F bonds are unique as they are H-bond 
acceptors, polar, non-polarizable, slightly hydrophobic, and partially negative.158  If E149 is 
deprotonated, this partial negative charge of fluorine would repel with the formal negative charge on 
the oxygen of E149, likely leading to a large increase in distance between these two atoms, and 
relatively weaker binding which is not observed through the IC50 values.    If protonated, potentially the
165
“fatness”, and electronegative potential of the fluorine may lead to ever so slight alterations in the H-
bond distance as seen here but results in similar free-energy stabilization as observed from the 
biochemical inhibition and structural data.  This structural information only adds to the understanding 
of E149 protonation state and is by no means conclusive evidence of either state.  In brief, the structural
evidence suggests lack of significant changes in active site interactions with the two compared ligands 
besides a 0.5Å increase between E149 and F-dCTP, leading to a lack of global conformational change 
and results in these two compounds having essentially equivalent potency. 
8.4.2 2’-arabino Substitution -  3x Increased Inhibition of CTP/F-dCTP vs.  F-
araCTP
Although we compared structures of CTP or F-dCTP, which have the 2’-ribo position utilized, the 2’-
OH-arabino inhibitor, araCTP, was previously tested for its potency.154  It is an extremely poor inhibitor
(IC50 ~>1000μL ratios of protein:mother liquor. After drops were set they were M) clearly indicating that fluorine, rather than a hydroxyl, is important in the potency of 
this molecule at this position.  As discussed later, this may be due to the proximal residues creating a 
hydrophobic pocket.  The interpretation of this relatively small increase in binding efficiency by the 2’-
F-arabino substitution in contrast to the 2’-F-ribo is quite difficult to deconvolute.  Specifically, the 
binding interactions are different as the orientation of each of the fluorines allows for many different 
contacts. The sum effect of these different interactions is very difficult to understand and will therefore 
not be of focus.  Changes identified in bond lengths between residues and the non fluorinated atoms 
may indicate the relatively small increase in binding efficiency for F-araCTP.  As mentioned, S14 was 
observed to have a slightly shortened (~1Å)  contact with the α-phosphate terminal oxygen.  This 
decreased bond length may stabilize the inhibitor giving a modest increase in potency. 
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8.4.3 F227 Conformational Change and Filament Formation
The most significant change in the binding interactions between the F-dCTP and F-araCTP structure is 
the addition of F227 contact with 2’-F-arabino. F227 in the CTP and F-dCTP structures, as well as 
previously published structure of CTP-ADP complex (PDB ID# 2AD5) have a lack of electron density 
to model F227 in one position.  In contrast, the F-araCTP, dF-dCTP, and mutagenically “closed” 
C268A mutant (PDB ID# 5TKV) structure indicate F227 is in one position, π-stacking with the 
cytosine ring (3.7Å), and contributing hydrophobic interactions with the 2’-F-arabino moiety (4.4Å) 
(Figure 8.6).142   This new interaction that F-araCTP has is likely a significant cause for observed 
increase inhibition of this molecule for CTPS.  F227 is important in polymerization as it shifts its helix 
(as seen in Figure 8.3) rearranging the CTP pocket interface.142–144,159  This rearrangement leads to a 
global tightening and subsequent polymerization. This interaction has been previously studied to be 
important in filament formation where McCluskey et al employed two mutant forms of CTPS, F227L 
and F227A.155  These mutants were used to study the types of interactions that made dF-dCTP a strong 
filament-former.  F227A would expand the pocket, prevent any π-interaction and will slightly weaken 
potential hydrophobic interactions.  F227L prevented π-interactions while mostly maintaining 
hydrophobicity.  The IC50 data collected showed that CTP inhibition was unaffected by F227A (IC50 = 
30μL ratios of protein:mother liquor. After drops were set they were M) while the leucine mutant weakened the inhibition (IC50=340μL ratios of protein:mother liquor. After drops were set they were M) when compared the WT 
inhibition (IC50 = 81μL ratios of protein:mother liquor. After drops were set they were M).  This suggests that CTP inhibition is mostly through other auxiliary 
stabilizing forces (potentially E149 H-bonding), that the π-interaction is not vital, and hydrophobic 
interactions may be detrimental.  In context with this new structural work, the mobility of F227 in the 
CTP structure (and F-dCTP), show that this is not a necessary interaction for inhibition of these two 
molecules.  The two F227 mutants were also tested against dF-dCTP where the inhibition was 
relatively unaffected (F227 IC50 = 1.2μL ratios of protein:mother liquor. After drops were set they were M, F227A IC50 = 1.3μL ratios of protein:mother liquor. After drops were set they were M, F227L IC50 = 1.9μL ratios of protein:mother liquor. After drops were set they were M) suggesting that 
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the π-interaction is inconsequential whereas hydrophobicity nature of this pocket seems important for 
dF-dCTP inhibition.155   Although our data suggests that due to the proximity of the F227 and the 
cytosine ring there is likely a π-interaction, based on the relative orientation of the two ring structures 
this may not be the main source of strong inhibition.   The only other previously deposited structure of 
E. coli CTPS where F227 is edge-on with CTP is in C268A.  Although no rationale was offered as to 
why this mutant would preferentially adopt the “closed” state, it does shift the 216-228 helix.   
Although the cryo-EM structures of the filament suggest a more drastic “closing”, the C268A mutant 
has been used a crystallographic proxy for the filamentous state.142  In summary, the conformational 
change of F227, coupled with the subsequent global closure of the enzyme suggests that both F-araCTP
and dF-dCTP are a strong polymerizing agents and inhibitors.  In contrast CTP and F-dCTP are weaker 
inhibitors and, at least for CTP, we know will cause tetramer formation, and in some circumstances 
filaments.  Finally, the specific molecule recognition of this tight binding of the 2’-F-arabino inhibitors
may be more of a hydrophobic interaction than a π-sharing interaction based on previously collected 
kinetic data coupled and the new structural information. 
8.4.4 2’-arabino Hydrophobic Pocket
To further investigate the potential hydrophobic contributions inducing tight binding in particular 
inhibitors, we evaluated the surface of the CTP binding pocket, in which there appears to be a clear 
distinction between a hydrophilic and hydrophobic portion (Figure 8.8).  Unsurprisingly the binding 
site for the triphosphate tail is hydrophilic while the cleft corresponding with the 2’ site and the 
cytosine ring are hydrophobic.  As previously mentioned, fluorine in slightly hydrophobic in which 
desolvation of the active site upon binding may impart increase potency of fluorinated compounds over
non-fluorinated substitutes.158,160 This may be important in the vastly tighter binding of dF-dCTP and 
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the monofluorinated derivatives ability to inhibit CTPS.  The residues lining this hydrophobic pocket 
and its potential interaction with the fluorinated inhibitors was described earlier155, and the 
crystallographic data supports this previous hypothesis.  With F227 now in a stabilizing conformation, 
both V115 and I116 side chains are 3.9Å and 3.5Å away from the 2’-F-arabino moiety suggesting  
hydrophobic interactions.  This further supports the observation why the hydrophilic 2’-OH-arabino 
substitution was so ineffective.  In summary, the likely increase in potency of of F-araCTP is through a 
new stabilizing interaction with F227, as well as the exploitation of a hydrophobic pocket built by 
V115 and I116.
Figure 8.8: CTP hydrophobic binding site.  Two different orientations (offest by 90°) of the 
hydrophobic surface of the CTP binding site.  Blue surfaces indicate hydrophilicity and brown indicate 
hydrophobicity.  
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8.4.5 30x Increased Inhibition of dF-dCTP vs F-araCTP
The most important question that this study aims to shed light on is how dF-dCTP is so much more 
potent than either monofluorinated inhibitor.  The most obvious suggestion for this increase in potency 
is the additive effect of being able to exploit both the 2’-F-ribo and -arabino groups.  This is without a 
doubt very important and has even been suggested that doubly fluorinating the 2 position will actually 
lead to greater polarization of the C-F bonds, making the effects even stronger.154  An important 
observation is the similarity of the global and local conformations of CTPS between the dF-dCTP 
complex the previously solved C268A mutant (PDB ID# 5TKV).  Our dF-dCTP structure was able to 
induce this “closed” conformation that is closest towards the filamentous quaternary state, much like 
the C268A mutant.  Interestingly, both the dF-dCTP and C268A structures are the only reported E coli. 
CTPS structures to have a cation bound to the triphosphate tail of their respective ligands.  Both our 
CTP structure, and the previously deposited CTP-ADP complex (PDB ID# 2AD5), both are lacking 
this cation.  This suggest that the binding of the metal is not due to the actual chemical species, but 
rather due to the global conformation state that is sampled.  Both K187 and K223 are observed to be 
well modelled and interacting with dF-dCTP (or CTP if 5TKV).  K187 are always found in the same 
position between all inhibitor structures, whereas K223 changes conformation for the C268A and dF-
dCTP when compared to the CTP structure (Figure 8.9).  Upon further investigation, K223 interacts 
with the terminal oxygen of the γ-phosphate (2.7Å) where it is unmodelled in the F-araCTP structure.  
K187 interacts with the terminal oxygen of the γ-phosphate at a distance of 2.75Å, whereas this length 
is increased to 3.3Å in the F-araCTP structure due to change in the inhibitor location.   It is likely that 
these lysine-phosphate interactions are possible because of the global changes that occur as well as the 
local conformation of the inhibitor itself.  The consequence of these lysine-phosphate interactions is the
stabilization of the polyphosphate tail which allows for cation binding (Figure 8.9).   The cation has an 
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octahedral coordination with each terminal oxygen of the three phosphates and 3 water molecules.  
This cation binding will ultimately further reduce the energetic cost of stabilizing (and therefore induce 
tighter binding)  CTP in the case of C268A, and dF-dCTP in our structure allowing it a more potent 
inhibitor.  Based upon this hypothesis, it is likely that CTP potency is significantly increased against the
C268A mutant as this inhibited state is adopted.
Figure 8.9: dF-dCTP metal coordination.  Representative diagram of the metal binding ligands Lys187 
and 223 under bound (dF-dCTP - grey) conditions, and non-bound (CTP – steel blue).  Atoms are 





Our data presented above suggests new ligand binding interactions that may be exploited to create 
selective inhibitors of CTPS.  As previously discussed, there are already two known compounds, 3-
deazauridine-5’-triphosphate and  cyclopentenyl cytosine 5’-triphosphate that are selective inhibitors of
CTPS, although they have some unwanted side-effects and have been routinely selected against 
through mutations in cancer cell lines.151–153,161  To date, dF-dCTP is the most potent inhibitor tested 
against CTPS and here we have shown, coupled with kinetic data, the molecular details to its potent 
inhibition.  First, the 2’-F-ribo substitution over the OH functional group is relatively innocuous, as 
from the IC50 data, and over lack of global and local rearrangements suggest.  Second, the 2’-F-arabino
adds a new interaction with F227, which is likely hydrophobic in nature.  The differences in the type of 
forces contributing to binding between CTP (electrostatic/H-bonding) and dF-dCTP (hydrophobic) may
help prevent the aforementioned mutational escape of cancers for previous inhibitors of CTPS.  dF-
dCTP may utilize different types of interactions that potentially, these mutations do not diminish. Third,
we still cannot rule out additive inductive effects by doubly fluorinating the 2’ position of the ribose 
ring further polarizing the C-F bonds and increasing the molecules hydrophobicity.  Fourth, binding of 
dF-dCTP leads to a local rearrangement of the tetramer interface, which propagate to an overall 
conformational change through the entire enzyme.  This induces a more closed filament-like state.  
Finally, both global and local conformational changes allow for a positional change in K223, which can
stabilize the triphosphate tail of the dF-dCTP to allow for octahedral binding of cations, further 
reducing the energetic cost of binding.  All of these aforementioned changes between our CTP 
structure, and dF-dCTP compex likely summate to account for the increased potency of this inhibitor.  
This study hopefully lends insight into the molecular mechanism of CTP binding as well as to offer an 
avenue towards further refinement of therapeutic targets. 
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